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Abstract 
We develop an age-structured deterministic model (TBDYN3) of the transmission dynamics 
of M. tuberculosis in England and Wales since 1900. The model estimates the age-specific 
risks of developing 'primary', 'endogenous' and 'exogenous' disease and analyzes the in- 
cubation period, serial interval, lifetime risks and basic and net reproduction numbers for 
tuberculosis. 
Best-fitting disease risk estimates predict peaks in both morbidity and mortality rates 
among young adults for successive birth cohorts during the pre-chemotherapy era, which fit 
observed patterns. Model predictions attribute much of the adult morbidity until the 1940s 
to exogenous reinfection. Chemotherapy, introduced after 1950, accelerated the decline in 
the risk of infection and the overall morbidity for all age groups. 
Age and calendar year at infection are shown to determine the lifetime risks of developing 
tuberculosis, the incubation period and the serial interval. Twenty year olds faced higher 
lifetime risks of respiratory tuberculosis following infection (e. g. 26% and 17% in 1900 and 
1950 respectively) than did any other age group. Estimates suggest that about 3% and 
over 25% of diseased 20 year olds in 1900 experienced initial infections in 1900 and during 
infancy respectively. Analogous estimates are provided for other age groups and calendar 
years. 
Although tuberculous incidence and mortality declined since the 19th century, the es- 
timated net reproduction number slightly exceeded one from 1900 until 1930 and declined 
thereafter. We discuss the implications of this paradox for diseases for which epidemio- 
logical parameters can change appreciably during a serial interval. Inferences about the 
basic reproduction number for tuberculosis are drawn by simulating the introduction of 
a sputum-positive case into an uninfected population identical in demography to that in 
England and Wales since 1900. A 'founder' case would have led to about 3 secondary cases 
in 1900, to about 2 by 1950 and to less than 1 after 1960. 
2 
Contents 
Abstract 2 
Acknowledgernents 20 
Introduction 21 
1 Background 25 
1.1 The natural history of tuberculosis ....................... 
25 
1.2 Review of related work .............................. 
39 
1.2.1 Studies of the risks of developing disease ................ 
39 
1.2.2 Studies of the transmission of M. tuberculosis ............. 
49 
1.3 Models for tuberculosis .............................. 
55 
1.3.1 Transmission models for tuberculosis .................. 
56 
1.3.2 Models for parameter estimation .................... 
63 
1.3.3 Conclusions ................................. 
67 
2 Epidemiology of tuberculosis in England and Wales - data sources and 
trends 68 
2.1 Mortality rates .................................. 
68 
2.2 Notifications of Tuberculosis ........................... 
74 
2.2.1 Data sources and case definitions .................... 
74 
2.2.2 Trends in notifications ............... ............ 
75 
2.2.3 Discussion ................................. 
81 
2.3 Annual risk of infection ............................. 
84 
2.3.1' Pre-chemotherapy era .......................... 
84 
2.3.2 Chemotherapy era - after 1950 .................... 
87 
3 
2.4 BCG vaccination data .............................. 90 
3 Development and evaluation of a model for tuberculosis - TBDYN3 94 
3.1 Formulation of TBDYN3 ............................. 94 
3.1.1 Definitions of 'primary' and 'post-primary' disease .......... 94 
3.1.2 General structure of TBDYN3 ..................... 96 
3.1.3 Transitions between disease states ................... 98 
3.1.4 Incidence of disease ............ ................ 104 
3.2 Methods and input data ............................. 106 
3.2.1 Input data ........... ...................... 106 
3.2.2 Estimating the age-specific risks of developing disease ........ 107 
3.2.3 Sensitivity analyses of parameter estimates .............. 109 
3.2.4 Application to Dutch data ........................ 110 
3.3 Estimates of the risks of developing disease .................. 112 
3.3.1 Results .................................. 112 
3.3.2 Sensitivity analyses ............................ 114 
3.3.3 Effect of simplifications on the disease risk estimates obtained .... 117 
3.3.4 Disease risk estimates for the Netherlands ............... 124 
3.4 Discussion and implications for past trends in the age-specific incidence of 
disease 
........ ... 129 ........................... . 
3.4.1 Discussion .... .. . ..... 129 ................ .... . 
3.4.2 Implications for age-specific patterns in the disease incidence pre- 
dicted by TBDYN3 
........................... 132 
4 The incubation period, serial interval and lifetime risks of developing 
tuberculosis 141 
4.1 Definitions and relevance ............................. 141 
4.2 Methods ......... .............................. 144 
4.2.1 Definition of a 'causal infection/reinfection' event .......... 144 
4.2.2 Retrospective analyses of the incubation period/serial interval .... 145 
4.2.3 Prospective analyses of the incubation period and serial interval -- 148 
4.3 Results ....................................... 152 
4.3.1 Retrospective analyses of the incubation period/serial interval .... 152 
4 
4.3.2 Prospective analyses of the incubation period and serial interval -- 162 
4.3.3 Effects of sim p lifi cations on the distributions obtained ........ 180 
4.4 Discussion ..................................... 182 
4.5 Brief review of key findings ........................... 186 
5 The basic and net reproduction numbers for tuberculosis 187 
5.1 Introduction .................................... 187 
5.1.1 Relevance and definitions of the net and basic reproduction numbers 
for infectious diseases .......................... 187 
5.1.2 Definitions of the basic and net reproduction numbers for tuberculosis 190 
5.2 Method ...................................... 193 
5.2.1 Derivation of an effective contact number ............... 193 
5.2.2 Analyses of the basic and 'founder case' reproduction numbers ... 196 
5.2.3 Analyses of the net reproduction number ............... 200 
5.3 Results ....................................... 203 
5.3.1 Analyses of the basic and founder case reproduction numbers .... 203 
5.3.2 The net reproduction number ...................... 
218 
5.3.3 Effect of simplifying assumptions on the results obtained ....... 226 
5.4 Discussion ..................................... 227 
6 Discussion and conclusions 232 
6.1 Insights obtained ................................. 233 
6.1.1 The natural history of tuberculosis ................... 233 
6.1.2 The incubation period, serial interval and lifetime risks of developing 
tuberculosis ................................ 236 
6.1.3 The basic and net reproduction numbers ................ 238 
6.1.4 Concluding remark ............................ 243 
6.2 Directions for future work ............................ 243 
Summary 246 
A Formulation and results from TBDYN3 250 
A-1 PDEs describing the model formulation for TBDYN3 ............. 250 
5 
A. 2 Approximations for the partial derivatives of the age and time-specific disease 
incidence with respect to fitted parameter estimates ............. 252 
A. 3 Methods used for sensitivity analyses of disease risk estimates ........ 255 
A. 4 Results from applying TBDYN3 to Dutch data ................ 
257 
B Methods and results for the incubation period and serial interval for tu- 
berculosis 260 
B. 1 PDEs illustrating the methods used to analyze the incubation period/serial 
interval using TBDYN3 ............................. 260 
B. 2 Further results from analyses of the incubation period and serial interval .. 262 
B. 2.1 Retrospective analyses .......................... 262 
B. 2.2 Prospective analyses ........................... 266 
C The basic and net reproduction numbers for tuberculosis 278 
CA Relationship between the basic and net reproduction numbers for tuberculo- 
sis under hypothetical situations ........................ 278 
C. 2 The relationship between &(t) and i?,, (t) for tuberculosis .......... 280 
Bibliography 282 
6 
List of Tables 
1.1 Relative contribution of smear and cult u re-positive disease to notifications of 
pulmonary tuberculosis in Saskatchewan during the period 1960-1973 ... 35 
1.2 The ten-year incidence of tuberculosis following 'conversion' from tuberculin 
negativity (0-4mm to 100TU) to positivity (5+mm to 3 TU), according to 
age at 'conversion', as found by the UK MRC BCG trial during the 1950s . 41 
1.3 Results from the US Public Health Service chemoprophylaxis trial during the 
1950S ........................................ 
42 
1.4 Summary of the age-specific cumulative risks of developing pulmonary tuber- 
culosis I following conversion to tuberculin-positivity, as found by the follow- 
up study of patients during the period 1929-1944 through the Oslo Public 
Health Services .................................. 44 
2.1 Summary of notification rates of all forms, respiratory and non-respiratory 
forms of tuberculosis in the general population in England and Wales during 
the period 1965-1988, together with the relative contribution from the ISC 
population ..................................... 79 
2.2 Crude annual notification rates (per 100,000) of all forms of tuberculosis 
in the white, Indian and Pakistani ethnic groups found during the national 
surveys of notifications between 1965 and 1988 in England and Wales ... 80 
2.3 Average annual decline in the notifications of all forms of tuberculosis by age 
in white males in England and Wales between 1953 and 1988, as estimated 
by Springett et al ................................. 81 
2.4 Summary of the main events in the history of BCG vaccination in England 
and Wales ..................................... 91 
7 
2.5 Summary of BCG vaccination policy in 201 districts in England and Wales 
in 1984 ....................................... 
92 
3.1 Definitions of class variables used in TBDYN3 ................. 
99 
3.2 Definitions of transition variables used in TBDYN3 .............. 
100 
3.3 Best-estimates of the risks of developing disease, as derived using TBDYN3 
by fitting to notifications in white ethnic males in England and Wales ... 112 
3.4 Summary of the disease risk estimates obtained by repeating the fitting pro- 
cedure on 50 simulated notification data sets, derived by sampling the num- 
bers of notifications from the national tuberculosis surveys from the Poisson 
distribution .................................... 115 
3.5 Comparison between the best-fitting values for the risks of developing the 
first primary episode and endogenous disease derived assuming individuals 
cannot be reinfected, and the values obtained by including reinfection (orig- 
inal TBDYN3 model) .............................. 117 
3.6 Comparison between the best-fitting values for the risks of developing the 
first primary episode and endogenous disease derived assuming vaccination 
confers no protection against infection, and the values obtained by assuming 
77% of individuals are protected from infection for life (original TBDYN3 
model) ....................................... 123 
3.7 Comparison between the risks of developing the first primary episode, en- 
dogenous and exogenous disease derived with TBDYN3 for the Netherlands, 
and the corresponding risks derived by Sutherland et al ........... 125 
4.1 Follow-up population and disease categories used to analyze the incubation 
period and serial interval for tuberculosis prospectively ............ 151 
8 
List of Figures 
1.1 Flowchart showing the natural history of tuberculosis ............ 27 
1.2 Age-specific mortality rates from respiratory tuberculosis in males in England 
and Wales during the period 1881-1950, plotted by year and birth cohort . 30 
1.3 Distribution of time interval between 'conversion' and clinical onset of tuber- 
culosis for 243 individuals who developed disease, as found in the UK MRC 
BCG trial during 1950s ............................. 31 
1.4 Age-specific notifications of pulmonary and 'infectious' (sputum-positive) 
forms of tuberculosis in males in Norway during the period 1951-1969 ... 33 
1.5 Relative contribution of sputum-positive disease to age-specific notifications 
of pulmonary tuberculosis in males in Norway during the period 1951-1969 34 
1.6 Cumulative risks of developing tuberculosis for 733 children of white sputum- 
positive cases, according to age at first 'exposure', as found by the Williamson 
County tuberculosis study during the period 1931-1954 ........... 46 
1.7 Schematic diagram showing the structure of simple models of the transmis- 
sion dynamics for Al. tuberculosis ........................ 55 
1.8 Schematic diagram showing the structure of the model produced by Chorba 
and Sanders in 1971 ............................... 58 
1.9 Schematic diagram showing the structure of the model produced by Joesoef 
in 1989 ....................................... 59 
1.10 Schematic diagram showing the structure of the model produced by Brogger 
in 1967 ....................................... 61 
1.11 Schematic diagram showing the structure of the age-structured model pro- 
duced by Waaler in 1968 ............................. 62 
9 
2.1 Mortality rates from respiratory tuberculosis in males in England and Wales 
during the period 1847-1990 ........................... 
69 
2.2 Age-specific mortality rates from respiratory tuberculosis in males in England 
and Wales during the period 1850-1990 .................... 
71 
2.3 Age-specific mortality rates from respiratory tuberculosis in males in England 
and Wales during the period 1850-1990, plotted on a, log scale ........ 
72 
2.4 Age-specific mortality rates from respiratory tuberculosis in males in England 
and Wales during the period 1881-1950, plotted by year and birth cohort - 73 
2.5 Crude annual mortality and notification rates (non-age standardized) of res- 
piratory tuberculosis in England and Wales between 1901 and 1990 ..... 76 
2.6 Published age-specific notification and mortality rates of respiratory tuber- 
culosis in males in England and Wales during the period 1930-1989 .... 77 
2.7 Comparison between age-specific notification rates of respiratory tuberculosis 
in males in the general population in England and Wales and those estimated 
for the white ethnic group ............................ 
82 
2.8 Age-specific prevalence of tu berculi n- positive males in England and Wales, 
as found by the national tuberculin survey during the period 1949-50 ... 85 
2.9 Mortality rates from tuberculous meningitis in 0-4 year old males in England 
and Wales during the period 1860-1957 .................... 86 
2.10 Comparison between mortality rates of tuberculous meningitis in 0-4 year 
old males in England and Wales until 1957 and the corresponding notification 
rates from 1954 .................................. 88 
2.11 Prevalence of tuberculin sensitivity among schoolchildren and students tested 
as part of the national BCG vaccination scheme ................ 93 
3.1 Schematic diagram showing the overall structure of the TBDYN3 model -- 97 
3.2 Approximate risks of developing the first primary disease episode, relative 
to those experienced during the first year after infection, estimated from the 
distribution of the time interval between 'conversion' and disease onset of 
those who were tuberculi n- negative at the start of the UK MRC BCG trial 101 
3.3 Relationship between the risk of developing the first primary disease episode 
and the age at infection assumed in TBDYN3 ................. 102 
10 
3.4 Summary of the relative contribution of sputum-positive disease to age- 
specific notifications of pulmonary tuberculosis in males in Norway during 
the period 1951-1969, together with the corresponding values assumed by 
TBDYN3 ..................................... 
104 
3.5 Estimated age-specific notification rates of respiratory tuberculosis in white 
ethnic males used to derive the risks of developing disease by TBDYN3 .. 108 
3.6 Comparison between the incidence of respiratory tuberculosis in 0-74 year old 
males estimated using TBDYN3 for England and Wales, and the notifications 
used in the fitting process ............................ 
113 
3.7 Comparison between the incidence of respiratory tuberculosis in 0-74 year 
old males, derived using the best-fitting parameters assuming individuals 
could not be reinfected and experienced constant risks of developing the first 
primary and endogenous disease after age 20 years, and the notifications used 
in the fitting process ............................... 
118 
3.8 Comparison between the expected age-specific prevalence of infection in Eng- 
land and Wales in 1949, as used in TBDYN3 and the prevalence of tuberculin 
sensitivity in south urban, north urban and rural England, as found during 
the national tuberculin survey during the period 1949-1950 ......... 120 
3.9 Comparison between the incidence of respiratory tuberculosis in 0-74 year 
old males estimated using TBDYN3 for England and Wales, assuming vac- 
cination conferred no protection against infection, and the notifications used 
in the fitting process ............................... 122 
3.10 Comparison between the estimated annual risk of infection in the Netherlands 
and that in England and Wales during the period 1901-1990 ........ 126 
3.11 Comparison between notification rates of respiratory tuberculosis in males 
in the Netherlands during the period 1951-1970 and those estimated from 
survey data among white ethnic males in England and Wales ........ 127 
3.12 Comparison between tuberculous meningitis and respiratory tuberculosis mor- 
tality rates among 0-4 year old males in England and Wales during the period 
1860-1957 ..................................... 130 
11 
3.13 Comparison between tuberculous meningitis and respiratory tuberculosis mor- 
tality rates among 0-4 year old males in England and Wales until 1957, and 
the corresponding notification rates in the general population from 1953 .. 131 
3.14 Estimated age-specific incidence of respiratory tuberculosis since 1900 in Eng- 
land and Wales attributable to first primary episodes, exogenous and endoge- 
nous disease, as predicted using TBDYN3 using the best-fitting parameter 
values .................................... .... 133 
3.15 Estimated age-specific incidence of respiratory tuberculosis since 1950 in Eng- 
land and Wales attributable to first primary episodes, exogenous and endoge- 
nous disease, as predicted using TBDYN3 using the best-fitting parameter 
values .............................. .......... 134 
3.16 Comparison between the incidence of respiratory tuberculosis attributable to 
first primary episodes, exogenous and endogenous disease for males during 
the period 1901-1950 in England and Wales, as predicted using TBDYN3 
and the corresponding male mortality rates .................. 136 
3.17 Comparison between the mortality rates and incidence rates of respiratory 
and sputum-positive tuberculosis for given years during the period 1901- 
1950, as predicted using TBDYN3, and the actual mortality rates from res- 
piratory tuberculosis in the general population ................ 
137 
3.18 Comparison between the incidence of respiratory tuberculosis attributable to 
first primary episodes, exogenous and endogenous disease for males during 
the period 1955-1980 in England and Wales, as predicted using TBDYN3, 
and the corresponding notification rates for white ethnic males ....... 138 
3.19 Comparison between the mortality rates'among male cohorts born since 1880 
in England and Wales and the corresponding incidence and mortality rates 
from respiratory tuberculosis among cohorts, as predicted using TBDYN3 
using the best-fitting parameter values ..................... 139 
4.1 Distribution of the time interval since first infection of individuals who de- 
veloped respiratory tuberculosis when aged 20 years during the period 1900- 
1990, as estimated using TBDYN3 ....................... 153 
12 
4.2 Distribution of the time interval since first infection of individuals who devel- 
oped respiratory tuberculosis when aged 20 years during the period 1900-1990, 
as estimated using TBDYN3 .......................... 
155 
4.3 Distribution of the time interval since first infection of individuals who devel- 
oped respiratory tuberculosis when aged 70 years during the period 1900-1990, 
as estimated using TBDYN3 .......................... 
157 
4.4 Distribution of the time interval since the infection or reinfection event caus- 
ing the current (sput u m- positive) episode among individuals developing dis- 
ease when aged 20 years during the period 1900-1990, as estimated using 
TBDYN3 ..................................... 158 
4.5 Distribution of the time interval since the infection or reinfection event caus- 
ing the current (sputum-positive) episode among individuals developing dis- 
ease when aged 50 years during the period 1900-1990, as estimated using 
TBDYN3 ..................................... 160 
4.6 Distribution of the time interval since the infection or reinfection event caus- 
ing the current (spu tu m- positive) episode among individuals developing dis- 
ease when aged 70 years during the period 1900-1990, as estimated using 
TBDYN3 ..... ...................... 4 ........ 161 
4.7 Lifetime risk of developing respiratory tuberculosis for individuals infected 
at different ages during 1900-1990 in England and Wales, as derived using 
TBDYN3 ..................................... 162 
4.8 Comparison between the age-specific and overall lifetime risks (weighted by 
the number of individuals experiencing initial infection at each age) of de- 
veloping respiratory tuberculosis for individuals infected during the period 
1900-1990 in England and Wales, as derived using TBDYN3 ........ 165 
4.9 Distribution of the time interval between first infection and the first episode 
of respiratory disease for individuals infected in their first year of life during 
the period 1900-1990, as estimated using TBDYN3 .............. 166 
4.10 Distribution of the time interval between first infection and the first episode 
of respiratory disease for individuals infected at different ages in 1900, as 
estimated using TBDYN3 ............................ 167 
13 
4.11 Lifetime risk of developing sputum-positive tuberculosis for individuals in- 
fected at different ages during the period 1900-1990 in England and Wales, 
as derived using TBDYN3 ............................ 
170 
4.12 Comparison between the age-specific and overall lifetime risks (weighted by 
the number of individuals experiencing initial infection at each age) of deve- 
loping sputum-positive tuberculosis for individuals infected during the period 
1900-1990 in England and Wales, as derived using TBDYN3 ........ 
171 
4.13 Distribution of the time interval between first infection and the first episode 
of sputum-positive disease for individuals infected in their first year of life 
during the period 1900-1990, as estimated using TBDYN3 .......... 172 
4.14 Distribution of the time interval between first infection and the first episode 
of sputum-positive disease for individuals infected at different ages in 1900, 
as estimated using TBDYN3 .......................... 
173 
4.15 Lifetime risk of developing respiratory tuberculosis attributable to initial in- 
fection for individuals infected at different ages during 1900-1990 in England 
and Wales, as derived using TBDYN3 ..................... 
175 
4.16 Lifetime risk of developing sputum-positive tuberculosis attributable to initial 
infection for individuals infected when aged 0-70 years during 1900-1990 in 
England and Wales, as derived using TBDYN3 ................ 176 
4.17 Distribution of the time interval between first infection and the first episode of 
respiratory disease attributable to the initial infection for individuals infected 
in their first year of life during the period 1900-1990, as estimated using 
TBDYN3 ..................................... 178 
4.18 Distribution of the time interval between first infection and the first episode 
of sputum-positive disease attributable to the initial infection for individuals 
infected in their first year of life during the period 1900-1990, as estimated 
using TBDYN3 ................................... 179 
5.1 Crude incidence and prevalence of sputum-positive tuberculosis per 100,000 
males aged 0-100 years in England and Wales during the period 1901-1990, 
as estimated using TBDYN3 .......................... 195 
14 
5.2 Annual effective contact number between sputum-positive and other individ- 
uals in the population in England and Wales during the period 1901-1990, 
as estimated using TBDYN3 .......................... 
195 
5.3 Number of secondary sputum-positive cases resulting from a founder case who 
was infectious for one or two years, introduced into an uninfected population 
similar in structure to that in England and Wales during the period 1900- 
1990, as estimated using TBDYN3 ....................... 
203 
5.4 Number of incident and prevalent sputum-positive cases following the in- 
troduction of one sputum-positive individual into an uninfected population 
similar in structure to that in England and Wales in 1900,1920,1940 and 
1960, as estimated using TBDYN3. This assumes that the sputum-positive 
case was infectious for two years ........................ 
205 
5.5 Total number of incident and prevalent sputum-positive cases following the 
introduction of one sputum-positive individual into an uninfected population 
similar in structure to that in England'and Wales in 1900,1920,1940 and 
1960, as estimated using TBDYN3. This assumes that the sputum-positive 
case was infectious for two years ... ...................... 
206 
5.6 Predicted crude incidence rate of sputum-positive disease after the introduc- 
tion of a founder case, who was infectious for either one or two years, into 
an uninfected population similar in structure to that in England and Wales 
in 1900,1920,1940 and 1960, as estimated using TBDYN3 ......... 208 
5.7 Predicted crude prevalence of infection after the introduction of a founder 
case into an uninfected population similar in structure to that in England 
and Wales in 1900,1920,1940 and 1960, as estimated using TBDYN3. This 
assumes that the founder case was infectious for two years .......... 209 
5.8 Relative contribution of '1st primary', endogenous and exogenous disease to 
the predicted incidence (per 100,000 general male population) of sputum- 
positive tuberculosis after the introduction of one founder case into an unin- 
fected population similar in structure to that in England and Wales in 1900, 
1920,1940 and 1960, as estimated using TBDYN3. This assumes that the 
founder case was infectious for two years .................... 
210 
15 
5.9 Predicted annual risk of infection after the introduction of one sputum- 
positive individual into an uninfected population similar in structure to that 
in England and Wales in 1900,1920,1940 and 1960, as estimated using TB- 
DYN3. This assumes that the sputum-positive case was infectious for two 
years ........................................ 
211 
5.10 Number of secondary sputum-positive cases resulting from a founder case who 
was infectious for one or two years, introduced into an uninfected population 
similar in structure to that in England and Wales during the period 1900- 
1990, as estimated using TBDYN3, assuming that there was no decline in 
the effective contact number subsequent to his/her introduction ....... 213 
5.11 Comparison between the basic and founder case reproduction numbers for 
tuberculosis during the period 1900-1990, as estimated using TBDYN3 .. 214 
5.12 Comparison between the annual risk of infection subsequent to the intro- 
duction of a founder case into a population similar in structure to that in 
England and Wales in 1900,1920,1940 and 1960, assuming that the effective 
contact number did and did not subsequently decline ............. 215 
5.13 Relative contribution of '1st primary, endogenous and exogenous disease to 
the predicted incidence (per 100,000 general male population) of sputum- 
positive tuberculosis after the introduction of one founder case into an unin- 
fected population similar in structure to that in England and Wales in 1900, 
1920,1940 and 1960, as estimated using TBDYN3. This assumes that the 
founder case was infectious for two years, and that there was no subsequent 
change in the case-fatality rate and the effective contact number ....... 216 
5.14 Comparison between the estimated effective contact number and estimated 
number of individuals infected for the first time or reinfected in England and 
Wales during the period 1900-1990 ....................... 219 
5.15 Percentage composition (by age) of uninfected individuals in the population 
in England and Wales between 1900 and 1980, as estimated using TBDYN3.220 
5.16 Percentage composition (by age) of individuals in the 'latent' class in the 
population in England and Wales between 1900 and 1980, as estimated using 
TBDYN3 . ... ................................... 220 
16 
5.17 Percentage of individuals infected for the first time during the period 1900- 
1990 when aged 0-100 years who develop sputum-positive disease attributable 
to their infection episode, as estimated using TBDYN3 ............ 
222 
5.18 Percentage of individuals reinfected during the period 1900-1990 when aged 
0-100 years who develop sputum-positive disease attributable to this reinfec- 
tion episode, as estimated using TBDYN3 .................... 
222 
5.19 Estimates of the 'net reproduction number' for tuberculosis, as derived using 
TBDYN3 ..................................... 223 
5.20 Comparison between the estimated net, basic and founder case reproduction 
numbers for tuberculosis, as derived using TBDYN3 ............. 224 
5.21 Age distribution of the male population in England and Wales during the 
period 1900-1990 in England and Wales .................... 229 
A. 1 Summary of the 95% range of the age-specific notification rates of respiratory 
tuberculosis during the survey years (for 0-54 year olds) and for all years (for 
55-74 year olds) used in the 50 simulated data sets to analyze the sensitivity 
of the disease risk estimates ........................... 256 
A. 2 Comparison between the incidence of respiratory tuberculosis in 0-39 year 
old males estimated using TBDYN3 for the Netherlands and the notifications 
used in the fitting process ............................ 258 
A. 3 Comparison between the incidence of respiratory tuberculosis in 40-69 year 
old males estimated using TBDYN3 for the Netherlands and the notifications 
used in the fitting process ............................ 259 
B. 1 Distribution of the time interval since first infection of individuals who de- 
veloped respiratory tuberculosis when aged 50 years during the period 1900- 
1990, as estimated using TBDYN3. -. ý.................... 263 
B-2 Distribution of the time interval since first infection of individuals who de- 
veloped respiratory tuberculosis when aged 70 years during the period 1900- 
1990, as estimated using TBDYN3 ........................ 264 
B-3 Distribution of the time interval since first infection of individuals who de- 
veloped respiratory tuberculosis when aged 50 years during the period 1900- 
1990, as estimated using TBDYN3 ....................... 265 
17 
B. 4 Distribution of the time interval between first infection and the first episode 
of respiratory disease for individuals infected at different ages in 1930, as 
estimated using TBDYN3 ............................ 
266 
B. 5 Distribution of the time interval between first infection and the first episode 
of respiratory disease for individuals infected at different ages in 1960, as 
estimated using TBDYN3 ............................ 
267 
B. 6 Distribution of the time interval between first infection and the first episode 
of respiratory disease for individuals infected at different ages in 1990, as 
estimated using TBDYN3 ............................ 
268 
B. 7 Distribution of the time interval between first infection and the first episode 
of sputum-positive disease for individuals infected at different ages in 1930, 
as estimated using TBDYN3 .......................... 
269 
B. 8 Distribution of the time interval between first infection and the first episode 
of sputum-positive disease for individuals infected at different ages in 1960, 
as estimated using TBDYN3 .......................... 
270 
B. 9 Distribution of the time interval between first infection and the first episode 
of sputum-positive disease for individuals infected at different ages in 1990, 
as estimated using TBDYN3 .......................... 
271 
B. 10 Distribution of the time interval between first infection and the first episode 
of respiratory disease attributable to initial infection for individuals infected 
at different ages in 1900, as estimated using TBDYN3 ............ 272 
B. 11 Distribution of the time interval between first infection and the first episode 
of respiratory disease attributable to initial infection for individuals infected 
at different ages in 1960, as estimated using TBDYN3 ............ 273 
B. 12 Distribution of the time interval between first infection and the first episode 
of respiratory disease attributable to initial infection for individuals' infected 
at different ages in 1900, as estimated using TBDYN3 ............ 274 
B-13 Distribution of the time interval between first infection and the first episode 
of sputum-positive disease attributable to initial infection for individuals in- 
fected at different ages in 1900, as estimated using TBDYN3 ........ 275 
18 
B. 14 Distribution of the time interval between first infection and the first episode 
of sputum-positive disease attributable to initial infection for individuals in- 
fected at different ages in 1930, as estimated using TBDYN3 ........ 276 
B. 15 Distribution of the time interval between first infection and the first episode 
of sputum-positive disease attributable to the initial infection for individuals 
infected at different ages in 1990, as estimated using TBDYN3 ....... 277 
19 
Acknowledgements 
First, I would like thank my supervisor, Professor Paul Fine for his contribution to the 
development of this thesis. I have benefitted immensely from his supervision and his en- 
thusiasm for the work is greatly appreciated.. It has been a privilege and a pleasure to have 
had the opportunity learn from his enormous experience. 
I also wish to thank the Medical Research Council for their financial support, without 
which this thesis would not have been possible. 
Thanks are also due to Dr Styblo (International Union Against Tuberculosis), who 
provided data on the notifications of tuberculosis in the Netherlands. I am also grateful 
to Dr Bjartveit (Tuberculosis Screening Service, Norway) for supplying data on sputum- 
positive notifications from Norway, and to Dr Gunnar Bjune for his help in securing these 
data. I also appreciate the co-operation of the UK Government Actuary's Department in 
providing data on the age and time-specific mortality rates within cohorts born in England 
and Wales since 1841, and thank Dr John Watson (CDSC) for providing data from recent 
national tuberculosis surveys in England and Wales. 
Discussions with a number of individuals have also helped in the development of this 
thesis. I am particularly grateful to Dr Ian Sutherland (MRC Biostatistics Unit, Cambridge) 
for his comments on several aspects of the work. I have also benefitted from discussions 
with Nigel Gay (CDSC), who provided some relevant insights into modelling, and wish to 
thank Jonathan Sterne for his help in some of the statistical aspects included in this thesis. 
Thanks are especially due to Daan Muulder, who through discussions, helped to shape 
some of the assumptions incorporated in the model. I am also grateful to Dr John Watson 
(CDSC), Chris Dye and Christian Lienhardt for their comments on the work described at 
the time of upgrading. Judith Glynn has also provided useful suggestions. 
Thanks are also due to Michael Jones, who, as a fellow PhD student and long-suffering 
office companion, witnessed much of the development of this thesis, and provided a good 
source of answers to statistical queries. 
Ultimately, I would like to thank my parents and brother for providing back-up support 
and encouragement throughout the development of this thesis. 
20 
Introduction 
Tuberculosis has been declining in most developed countries at least since the beginning 
of this century. Since the late 1980s, the decline in notifications of tuberculosis has slowed 
down, and it has even reversed in several Western countries [1]. This has been attributed to 
various factors, including the emergence of HIV infection, changing patterns of immigration 
from high-risk populations, multi-drug resistant strains of M. tuberculosis, the increasing 
problem of homelessness, and changes in tuberculosis control programmes. 
The basic natural history of tuberculosis is complicated even without these factors. In- 
dividuals can develop disease either soon after infection ('primary' disease) or many years 
thereafter ('post-primary' disease) either through 'endogenous' reactivation or after 'ex- 
ogenous' reinfection. The risks of developing disease are age-dependent, and are higher 
in young adult life than among infants and young children, as indicated by birth cohort 
analyses of mortality rates from respiratory tuberculosis in developed countries from the 
pre-chemotherapy era [2-5]. The relative contribution of 'primary', 'endogenous' and 'ex- 
ogenous' forms to the disease incidence in any population is therefore a function both of 
age and of the risk of infection, which has been declining in developed countries throughout 
this century [6]. 
Hitherto, no studies have attempted to quantify the age-specific risks of devel pin 
4primary', lendogenous' and 'exogenous' disease and the effect of the decline in the risk of 
infection on the relative contribution of these forms to the decline in disease incidence in 
given age groups. In fact, only one study, that of Sutherland et al [7], which focussed on 
the disease incidence among Dutch adult males during the period 1951-1970, has estimated 
the risk of developing disease subsequent to reinfection in a developed country. 
The incubation period, serial interval and basic and net reproduction numbers of tu- 
berculosis have also received little attention in the past, even though they are the most 
21 
important parameters underlying the dynamics of any infectious disease. The incubation 
period provides information on when, given infection, an individual is likely to develop dis- 
ease, the serial interval indicates when that individual is likely to infect others, and the basic 
and net reproduction numbers describe the number of secondary infectious cases which will 
result from one infectious case under given circumstances. 
The facts that the risks of developing disease are age-dependent, and that the risk of 
infection declined over time suggest that the incubation periods and serial intervals must 
differ by age group and by calendar year. Similar considerations apply to the overall life- 
time risk of developing disease after infection, which is often stated to be 5-10% [8]. The 
fact that reinfection can occur further complicates the definitions of these parameters and 
of the basic and net reproduction numbers, since both infected and reinfected individuals 
who subsequently develop infectious pulmonary tuberculosis are secondary cases of some 
infectious source. The only published study of the basic reproduction number for tuber- 
culosis [9] considered a hypothetical population without age-structure, and assumed that 
reinfection cannot occur. There has been no published study of the net reproduction number 
for tuberculosis. 
Overall we see that the dynamics underlying the decline in tuberculosis in developed 
countries during the last century are complicated. Intuitively, these dynamics should be 
understood further before we assess the likely effect of other factors, such as the HIV 
epidemic, on the current tuberculosis situation. This has been the rationale for the work 
described in this thesis. 
Disease dynamics are difficult to study using traditional epidemiological tools such as 
case control or cohort studies, and are more easily analyzed using theoretical modelling 
techniques. Such modelling studies in turn require reliable data on the long-term tubercu- 
losis situation in a given population, which are not available for many countries. England 
and Wales are unique in this respect, as age and sex-specific mortality data have been 
published since 1847. Hence our analyses of the transmission dynamics of M. tuberculosis 
are restricted mainly to. the tuberculosis situation in England and Wales during this cen- 
tury. The age-structured model developed (TBDYN3) focuses on the following aspects of 
tuberculosis epidemiology: 
1. The basic natural history of tuberculosis. The alms are to: 
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(a) estimate the age-specific risks of developing 'primary', 'endogenous' and 'exoge- 
nous' disease, and 
(b) assess the effect of the decline in the risk of infection on the relative contribution 
of these different disease forms to the age and time-specific disease incidence and 
mortality in England and Wales. 
2. The incubation period, serial interval and lifetime risk of developing disease, with the 
aims of- 
(a) assessing the definitions of the incubation period and serial interval for infectious 
diseases and discuss their relevance for tuberculosis and 
(b) deriving estimates of these parameters according to age and calendar year. 
3. The basic and net reproduction numbers. Our aims are to: 
(a) assess their relevance for tuberculosis, and 
(b) estimate these parameters in England and Wales since 1900, and to relate their 
magnitude to the decline observed in tuberculosis during the last century. 
TBDYN3 extends the work of Sutherland et al (7], who are the only workers to have 
modelled the disease incidence in a developed country as a function of the different risks 
of developing 'primary', 'endogenous' and 'exogenous' disease. While acknowledging this 
foundation, the present work goes much further in being the first to consider the incubation 
period, serial interval and lifetime risks of developing disease, and the implications of the 
complex natural history of tuberculosis for the definitions of the basic and net reproduction 
numbers. 
Chapter 1 reviews current knowledge of the natural history of tuberculosis, and studies of 
the risks of developing disease and the transmission of M. tuberculosis in outbreak situations. 
Section 1.3 reviews models of the transmission dynamics of M. tuberculosis published by 
other workers in the past. Sections 1.1 and 1.2.1 provide the basis for the assumptions 
incorporated into TBDYN3. 
Chapter 2 describes the epidemiology of tuberculosis in England and Wales, together 
with the data used in TBDYN3. 
Chapter 3 describes the development of TBDYN3, and estimates for the age-dependent 
risks of developing disease are presented in section 3.3-1. The implications of these estimates 
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for the relative contribution of exogenous and endogenous forms to past trends in disease 
incidence in England and Wales are presented in section 3.4.2. 
The assumptions incorporated into TBDYN3 provide the basis for the analyses in Chap- 
ter 4 of the incubation period, serial interval and lifetime risks of developing tuberculosis. 
Section 4.1 assesses the implications of the complex natural history for the definitions and 
interpretation of the incubation period and serial interval in section 4.1, and distributions 
of these parameters and estimates of the lifetime risks of developing disease according to 
age and calendar year are derived in section 4.3. 
The penultimate chapter reviews the definitions of the basic and net reproduction num- 
bers as applied to infectious diseases and discusses their relevance for tuberculosis on the 
basis of estimates derived using TBDYN3. We conclude in Chapter 6 with a summary of 
the main insights obtained by this modelling work, and outline possible directions for future 
work. 
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Chapter 1 
Background 
1.1 The natural history of tuberculosis 
Tuberculosis is defined as the disease attributable to infection with Afycobacterium tuber- 
culosis (the vast majority of cases), M. bovis or AL africanum. The tubercle bacillus, Al. 
tuberculosis, generally affects the lungs, although any other organ may become involved. On 
the basis of the site affected, tuberculosis is described as either 'pulmonary' (respiratory), 
or textrapulmonary'. 
The tubercle bacillus is transmitted most commonly through coughing by an individual 
with infectious or 'open' pulmonary tuberculosis. M. bovis is typically transmitted from a 
tuberculous cow via contaminated milk. This has become rare in developed countries since 
the introduction of routine pasteurization of milk. Infection with M. bovis is associated 
classically with cervical lymphadenitis (scrofula) [10]. 
The implantation of tubercle bacilli into tissue constitutes the first stage in the natural 
history of tuberculosis. Bacilli are then disseminated via the lymphatics to the regional 
lymph nodes, which may lead to the development of a 'primary complex', comprising a 
lesion at the implantation site (usually in the lungs) and in the associated lymph nodes. 
Cell-mediated immunity to M. tuberculosis antigens develops within 2-6 weeks after first 
infection, and typically leads to the formation of granulomas and calcification around the 
primary lesions. These ultimately contain the infection, although it may take up to 3 years 
for the primary complex to resolve completely [10]. Until this occurs, bacilli may escape 
from these lesions into the blood to initiate foci elsewhere in the body e. g. in other parts 
of the lung, the kidneys etc. During the first three months after the development of cell- 
25 
mediated immunity, individuals are at greatest risk of developing serious systemic forms 
of tuberculosis, such as tuberculous meningitis and miliary tuberculosis [11]. These forms 
are particularly common in infants and young children. Lesions in the bones, joints and 
kidneys, on the other hand, may take up to three years to appear. 
Once contained in the calcified lesions, the infection generally lies dormant until the 
individual's immune response weakens, leading'to proliferation of bacilli and to clinical 
disease months or years after first infection. These calcified lesions are sometimes detectable 
by X-ray. As the sensitivity and specificity of X-rays are both considerably less than 100%, 
they do not provide conclusive evidence of infection with the tubercle bacillus. 
The tuberculin skin test is conventionally used to detect tuberculous infection. The 
standard test is by the 'Mantoux' technique, whereby individuals are injected intradermally 
with tuberculin, a soluble protein derivative of the tubercle bacillus. An induration typ- 
ically appears at the inoculated site after 48-72 hours in individuals whose T-cells have 
been sensitized to M. tuberculosis antigens. The distribution of induration sizes in the 
population under study to a given tuberculin'test determines the definition of a positive 
result. This varies between populations, since individuals who have been exposed to certain 
environmental mycobacteria or who have received BCG vaccine may also be sensitive to 
tuberculin. 
A further complication of the tuberculin test is the fact that repeated testing of unin- 
fected individuals can itself induce sensitivity (12,13]. In addition, individuals who have 
exhibited a reaction to tuberculin may lose their sensitivity with time or age [14]. Diagnos- 
ing a tuberculous infection is particularly problematical in individuals with IIIV infection 
and AIDS. Such individuals lose their cellular immunity and hence their responsiveness to 
tuberculin. Problems regarding the use of the tuberculin test in determining the prevalence 
of infection in a population have recently been reviewed by Rieder [15]. 
Disease occurring less than 5 years after first infection is conventionally defined as "pri- 
mary disease", whilst disease occurring thereafter is defined as "post-primary disease" [16]. 
These definitions are discussed in greater detail in section 3.1.1. Post-primary disease 
is believed to occur either through the reactivation of the earlier infection ("endogenous 
reactivation"), or as a consequence of reinfection with the tubercle bacillus ("exogenous 
reinfection"). On this basis, the basic natural history of tuberculosis can be summarized 
schematically as shown in Figure 1.1. 
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Figure 1.1: Flowchart showing the natural history of tuberculosis. 
27 
The relative frequency of disease through endogenous reactivation and exogenous rein- 
fection has been disputed. 
The earliest evidence for the role of exogenous disease comes from anatomical studies 
carried out during the period 1930-1950 of individuals who died from diseases other than 
tuberculosis [17]. These studies revealed what were considered to be post-primary lesions 
in 20-60% of adults and the number of such lesions increased with the age of the individual 
examined. Canetti [17] describes results from other studies, in which bacilli were taken from 
primary complexes at various stages in development and inoculated into guinea pigs. About 
85% of the calcified lesions did not yield live bacilli. On such evidence, Canetti inferred 
that bacilli may not survive indefinitely in primary complexes and therefore that disease 
through endogenous reactivation was rare. 
Further evidence for the role of exogenous disease is drawn from the tuberculosis situa- 
tion in Alaska during the 1950s [18]. This was considered to be worse than that in any other 
region in the world, with an estimated risk of infection of about 25%, and as many as 95% of 
children tuberculin-positive (induration of 8mm or more to 1TU PPD-S) by age 13-14 years. 
After the introduction of chem oprophyl axis, the risk of infection declined together with the 
incidence of disease across all ages. This decline, especially among older individuals, is 
attributed in large part to a reduction in the incidence of exogenous disease [18]. 
With the advent of chemotherapy, evidence for the existence of exogenous disease has 
been provided by changes in drug-susceptibility patterns in patients with previously treated 
tuberculosis, as illustrated by individual case reports. For example, two sons developed dis- 
ease with the same drug-resistance pattern as their mother. The sons had had prior treat- 
ment for tuberculosis with different drugs from the ones to which they were subsequently 
resistant [19], and hence could have been reinfected by their mother. 
With the refinement of phage typing and, more recently, DNA fingerprinting, it has 
become possible to ascertain whether the straIn of tubercle bacillus with which an individual 
is currently infected is identical to one with which they were infected many years previously 
i. e. whether the current episode is attributable to endogenous reactivation. In one survey 
of tuberculosis in veterans in the US Armed Forces in 1975,9 out of 26 relapsed cases had 
different phage types from those causing their previous disease episode (20]. 
Phage typing and DNA fingerprinting have also been of particular use in verifying trans- 
mission in outbreak settings [21-24]. In a famous outbreak of 42 cases associated with a 
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homeless shelter in Boston during the 1980s [21], for example, 22 cases were found to have 
identical phage types and drug resistance patterns. Moreover, the disease was attributable 
to exogenous reinfection in 7 of these cases, as indicated by previous tuberculin- positivity 
and a difference in drug susceptibility between the current and prior disease episode. 
With the low risk of infection in developed countries today, it is likely that only a 
small proportion of disease is exogenous in origin. The situation in developing countries is 
unclear, however. Studies in Bangalore during the period 1961-1966 [25] and in Madras 
during the 1970s [26], for example, found much higher incidences of disease in 'infected' 
(i. e. tu berculi n- positive), as compared with uninfected individuals. Given the high risks of 
infection in both areas, many of the 'infected' individuals could have experienced disease 
through exogenous reinfection. 
The risks of developing disease are age-dependent. This is illustrated by age-specific tu- 
berculosis mortality data in developed countrie's from the pre-chemotherapy era, which were 
a reliable indicator of the actual disease incidence. Figure 1.2(a) presents the age-specific 
mortality rates from respiratory tuberculosis in males in England and Wales between 1880 
and 1950. This shows that the mortality rates in a given year increased between adoles- 
cence and middle age, and declined thereafter, and that the peak age generally increased 
over time. The corresponding mortality rates plotted by birth cohort, as shown in Fig- 
ure 1.2(b), illustrate that after an initial high mortality rate during infancy, the greatest 
mortality rate, reflecting the greatest risk of developing disease, was experienced during 
adolescence and early adult life [3]. 
Similar analyses by sex suggest that females experience greater risks of developing disease 
during adolescence, as compared to males, and lower risks during old age. Similar patterns 
in age-specific mortality rates from all forms of tuberculosis were also found in Norway [5], 
the US [27] and in New Zealand [4]. 
Further evidence for a high risk of developing disease during adolescence in developed 
countries is provided by a study of 82,269 tuberculin-positive (6mm or greater induration 
to 1 or 10TU PPD) children aged 0-19 years in Puerto Rico, followed up for 18-20 years 
after 1949 [28]. This found that the case-rate, according to age at diagnosis, followed a 
similar pattern to that observed for mortality rates by cohort. However, this study did not 
describe the age at infection of these individuals, and thus it is unclear whether the cases 
experienced primary, endogenous or exogenous disease. 
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Figure 1.2: Age-specific mortality rates from respiratory tuberculosis in males in England 
and Wales during the period 1881-1950, plotted by year and birth cohort. 
Data source: Adelstein [3] 
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Figure 1.3: Distribution of time interval between 'conversion' and clinical onset of tu- 
berculosis for 243 individuals who developed disease, as found in the UK MRC BCG trial 
during 1950s [29]. 
The MRC BCG trial in England and Wales during the 1950s provides the most de- 
tailed available information on the risk of developing disease according to time since first 
infection [29]. Among the 12,867 tu berculi n- negative (0-4mm induration to 100TU) 14-15 
year olds chosen at ranaom and left unvaccinated, 243 individuals developed tuberculosis 
during the following 10 years. The distribution of time intervals between 'conversion' to 
tu bercull n- positivity and disease onset of these individuals is shown in Figure 1.3. This 
shows that of those who developed disease, almost 60% did so during the first year after 
'conversion'. These data are discussed in greater detail in section 1.2.1. 
The type of disease individuals develop is also age-dependent. About 60% of disease 
in children is extrapulmonary, for example, as compared with less than 40% in adults. 
Furthermore, not all forms of tuberculosis are infectious. Extrapulmonary tuberculosis 
is rarely infectious, and the infectiousness of pulmonary cases depends on the quantity 
of tubercle bacilli present, in their sputum. If such bacilli are detectable by microscopy, 
then an individual is said to be "smear-positive". Bacilli in the sputum of smear-negative 
individuals are sometimes detectable by culture: in this case, the individual is said to be 
"culture-positiv6" and "smear- negativ6". It usually takes 4-6 weeks for tubercle bacilli to 
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grow in culture, which means that there is a delay before a smear-negative tuberculous case 
receives treatment. In the case of drug-resistant tuberculosis, for which the time interval 
between onset of disease and subsequent death may be short, this delay until diagnosis is 
particularly important [30]. 
Smear-positive individuals are usually more infectious than those who are only smear- 
negative and cultu re- positive. For example, a study in Rotterdam during the period 1967-9, 
indicated that roughly 50% of 0-14 year old household contacts of smear-positive cases were 
tuberculi n- positive, compared with about 1% of individuals in this age group in the general 
population and about 6% of contacts of cult u re- positive, but smear-negative individuals [31]. 
A detailed survey of morbidity among more than 8,000 intimate and 11,000 casual 
contacts of smear-positive, cultu re- positive and culture-negative white and American-Indian 
cases was carried out during the period 1966-71 in British Columbia and Saskatchewan [32]. 
This found that in any age group, intimate contacts of smear-positive cases had a higher 
prevalence of tuberculin sensitivity than those of culture-positive but smear-negative cases. 
The proportion of 0-14 year old contacts of smear-positive cases found to be tuberculin- 
positive was also lower than that for Rotterdam (e. g. 29%, 36% and 40% for 0-4,5-9 and 
10-14 year olds respectively). The differences in the results from the two studies could have 
been a consequence of differences in methods of contact tracing or tuberculin-testing. The 
Canadian study found that a greater proportion of tuberculi n- positive contacts of smear- 
positive cases also developed disease, as compared with those of cultu re- positive cases (15.0% 
vs 3.3%). 
There are few countries with reliable data on the relative contribution of smear-positive 
disease to the incidence of pulmonary tuberculosis. Notifications of pulmonary tuberculosis 
collected in Norway since 1942 have distinguished between 'non-infectious' and 'infectious' 
cases. The latter are defined as individuals with tubercle bacilli demonstrable in the sputum, 
or cases with a cavity and/or a tendency to progressive ('phthisic') tuberculosis. Cases with 
bacilli in gastric lavage or on laryngeal swabs are considered non-infectious, unless cavitation 
and/or phthisic progression are evident. 
Given this definition of an infectious case, it is likely that the data overestimate the 
incidence of smear-positive disease, and reflects the incidence of sputum-positive (smear 
and/or cultu re- positive) disease. For reference, Figure 1.4, summarizes the age-specific 
notification rates of pulmonary and infectious forms' of tuberculosis in males in Norway, 
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Figure 1.4: Age-specific notifications of pulmonary and 'infectious' (sputu m- positive) 
forms of tuberculosis in males in Norway during the period 1951-1969. 
Source: Dr K. Styblo and Dr. K. Bjartveit (Norwegian National Health Screening Service). 
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Figure 1.5: Relative contribution of sPutum-Positive disease to age-specific notifications 
of pulmonary tuberculosis in males in Norway during the period 1951-1969. 
during the period 1951-1969. The relative contribution of 'infectious' forms to the age- 
specific disease incidence during this period is summarized in Figure 1.5. This shows a 
consistent age-specific pattern across the time period considered, with less than 20% of 
pulmonary tuberculosis in children being sputum-positive, as compared with over 60% of 
that in adults. 
Further insight into the relative contribution of smear-positive disease to the age-specific 
incid ence of pulmonary tuberculosis is provided by a study of all cases (1,844 individuals) 
notified in Saskatchewan during the period 1960-1973 [33]. Isolates were obtained from 
98.5% of the cases either directly from sputum or by gastric lavage during three consecutive 
days. The report of this study does not define the number of positive smear-exam! nations 
required before individuals were considered smear-positive. The results are summarized in 
Table 1.1. 
These results are not directly comparable to those found for Norway, where the definition 
of a 'sputu m- positive' case excludes individuals positive on gastric lavage and includes 
cavitary cases. This is reflected by the high proportion of 0-14 year olds (33%) found to 
be smear or cult u re- positive in Saskatchewan, as compared with less than 20% of their 
counterparts in Norway. Similarly, about 42% of pulmonary cases aged 15-29 years in 
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Table 1.1: Relative contribution of smear and cu Itu re- positive disease to notifications of 
pulmonary tuberculosis in Saskatchewan during the period 1960-1973 [33]. 
% age contribution to 
Age Number of cases pulmonary TB 
group Smear Culture 'Sputum' Total Smear Culture 'Sputum' 
(years) +Ive +ive only +ive pulmonary +ive +ive only +Ive 
0-14 7 103 110 315 2 33 35 
15-29 113 46 159 272 42 17 59 
30-49 134 50 184 330 41 15 56 
50+ 275 107 382 584 47 18 65 
Saskatchewan were smear-positive, and almost 60% were smear or cul tu re- positive, which 
is slightly lower than the estimates found for Norway. The estimates from Saskatchewan 
are also based on smaller number of cases, as compared with those from Norway, and are 
hence subject to greater sampling error. 
Without treatment, the case-fatality of tuberculosis varies according to the type of 
disease. The case-fatality of tuberculous meningitis during the pre-chemotherapy era ap- 
proached 100%, and, with treatment, varies according to the severity of the case at pre- 
sentation. Estimates of the case-fatality of bacillary (positive on smear or culture) cases in 
developing countries in the absence of treatment is provided by a 5-year longitudinal study 
in a rural district in South India [25]. After one and a half years, 30% of the 126 bacillary 
cases at the start were dead, 28% were cured, and 42% were still bacillary- positive. Five 
years later, 49%, 33% and 18% were dead, cured and bacillary- positive respectively. These 
data are not stratified by either age or by severity of the case, and thus these results cannot 
be generalized further. 
Other follow-up studies during the pre-chemotherapy era, reviewed by Murray and Sty- 
blo [6,34], found similar estimates of the case-fatality rate among sputum-positive cases. 
The study of Berg [35] was the most extensive, following up 6,156 smear-positive cases 
(defined as individuals with 'tubercle bacilli found by direct examination of sputum) in 
Gothenburg, Sweden, during the period 1910-1934. Cases aged 15-49 years had a case 
fatality of 31-33% during the first year after diagnosis, which dropped to 16-18% for the 
two subsequent years. The overall case-fatality for these individuals during the 20 years of 
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follow-up was about 60%1. The case-fatality among individuals aged over 50 years was over 
40% during the first year after diagnosis. This last estimate may well be unreliable, as it 
was based on a small number of cases. 
Drolet attempted to estimate age-specific case-fatality rates by comparing the number 
of reported cases against the corresponding mortality in London and in several cities in the 
US during the period 1925-1937 [36]. Overall, he found that among 0-4 year olds, there 
were twice as many reported cases as deaths, and for individuals aged over 65 years, the 
number of notified cases only just exceeded the numbers of deaths. Inferences from such data 
as to the case-fatality rate depend on assumptions about the efficiency of the notification 
process. There is evidence to suggest that notification has been relatively inefficient in many 
countries, at least until 1950 (see e. g. section 2.2). 
There are three main strategies for the control of tuberculosis, namely BCG vaccination, 
chemoprophylaxis and case-finding and treatment. 
BCG vaccination (Bacillus Calmette Gu6rin) was first used in humans in 1921 and 
has been used increasingly since then, with varied success. Evidence suggests that BCG 
does not protect against infection, but reduces the risk that infected individuals develop 
disease [37]. In England and Wales, the efficacy of BCG given during adolescence has been 
estimated at about 77%, but may decline over time [38]. A trial in South India, on the 
other hand, indicated a zero efficacy for BCG [26]. Various hypotheses have been proposed 
to explain this varying efficacy of BCG, such as masking by environmental mycobacteria, 
differences between BCG strains, differences in M. tuberculosis or genetic differences between 
populations [39]. 
The contribution of BCG vaccination to the decline of tuberculosis in developed countries 
is unclear. In the Netherlands, for example, where BCG has never been used as a mass 
control policy, the decline in the crude annual incidence of tuberculosis has paralleled that 
in other Western European countries [1]. 
Chemoprophylaxis is sometimes given to individuals who have been infected recently and 
has been used in many developed countries as a control policy. Its effect on the incidence 
of tuberculosis in developed countries today, where the annual risk of infection is low, 
is limited, since much of the disease occurs in older individuals, and is mainly through 
'Note that these estimates were not corrected for other causes of death. About 97% of the deaths in the 
entire follow-up population were attributed to tuberculosis. 
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endogenous reactivation of infections acquired long ago [6]. 
An alternative strategy for protecting 'susceptibles' is the removal of sources of infection, 
either through treatment or, in the pre-chemotherapy era, through isolation in sanatoria. 
Identifying sources of infection is often difficult. Due to the low prevalence of tuberculosis 
in developed countries, mass screening of the population is no longer recommended as a 
policy for detecting sources of infection [6]. 
Chemotherapy was introduced into developed countries during the late 1940s. In Eng- 
land and Wales, streptomycin was first used for treatment in 1947, and, together with 
PAS (para-aminosalicylic acid), became generally available by 1950. Isoniazid first be- 
came available in 1953. The case-fatality improved gradually following the introduction of 
chemotherapy, as found by a follow-up study of all sputum-positive cases aged over 15 years 
notified in Birmingham (England) during the period 1947-1959 (40). Individuals notified 
in 1947,1950,1953,1956 and in 1959 had overall case-fatality rates of 65%, 38%, 29%, 
25% and 27% respectively during 10 years of follow-up. The case-fatality rate for cases 
notified in 1947 exceeds that found by the follow-up study in Bangalore during the period 
1961-1966 [25] (see page 35). This is attributable to deficiencies in the notification process 
in England and Wales (see section 2.2), which meant that only the most severe cases, and 
hence those with the highest case-fatality rates were likely to be reported. 
These estimates of the case-fatality ratios depend on the severity and the age of the case 
when treatment was initiated. About 45% (155 out of 333) of the cases followed up from 
1959 were aged over 45 years, as compared with 38% (196 out of 521) of those followed up 
from 1956. This accounts for the slight excess in the estimated case-fatality rate among 
individuals followed up from 1956, as compared with that for counterparts followed up from 
1959. 
Multiple drug regimens lasting up to 15 months, and consisting of as many as 5 drugs, 
are now used to treat clinical tuberculosis. Short course regimens, lasting 9 months have 
been used in England and Wales since 1976 (41] and have a good cure rate for patients 
who adhere to the full course. A controlled follow-up study of short-course chemotherapy 
regimens started in 1972 in England and Wales found that out of 665 patients available for 
follow-up after 54 months, none of the 52 deaths were attributable to active tuberculosis [41]. 
In both developing and developed countries, treatment compliance is a problem, and 
inadequate treatment predisposes to the emergence of drug-resistant bacilli. This was 
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highlighted as a severe public health problem during the early 1990s, particularly in New 
York City, where several outbreaks of multi-drug resistant tuberculosis occurred in hospi- 
tals [22,23,42] and in state prisons [30,43]. Most of the cases affected in these instances were 
infected with HIV, and thus had a high risk of developing tuberculosis after infection [44]. 
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1.2 Review of related work 
1.2.1 Studies of the risks of developing disease 
It is often stated that individuals face a 5-10% lifetime risk of developing tuberculosis after 
infection [8]. This lifetime risk depends on many factors, such as the individual risks of 
developing 'primary', 'endogenous' and 'exogenous' diseases, the age at which infection is 
acquired, the risk of reinfection and the mortality rates experienced subsequent to initial 
infection. Consequently, it is unlikely that the overall lifetime risk is identical for all age 
groups or that it has remained constant over time. 
Similarly, these factors determine the distribution of the time interval between infection 
and disease onset (conventionally known as the incubation period), and the serial interval 
(the time interval between two successive cases in a chain of transmission) for tuberculosis, 
which are two of the most important parameters underlying the dynamics of any infectious 
disease. 
In the past, no. study has attempted to link together these individual factors to obtain 
age and time-dependent estimates of the overall lifetime risk of developing disease, and 
the incubation period and serial interval for tuberculosis. Instead, many observational 
studies of the natural history of tuberculosis have focussed on either the risks of (primary) 
disease shortly after infection, or on the risks among 'infected' - i. e. tuberculi n- positive - 
individuals. The observed risks among the latter, in turn, are a function of the time since 
initial infection (often not known) and of the risk of reinfection and subsequent exogenous 
disease. 
Some of the more extensive observational studies are reviewed below. One other study, 
that of Sutherland et al [7] estimated the risks of developing 'primary', 'endogenous' and 
texogenous' disease using a model-based approach. This is described in section 1.3.2. 
1.2.1.1 The UK MRC BCG trial 
The UK MRC BCG trial during the 1950s provides the most reliable data on the risk 
of developing disease following 'infection' and its trend with time since infection. These 
estimates are based on 12,867 tuberculin-negative (0-4mm induration to 100TU) 14-15 
year olds chosen at random as controls and left unvaccinated, and followed up with 14 
month cycles of tuberculin tests and chest X-rays. 
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The magnitude of the disease risk estimates depend on the criterion for tuberculin sen- 
sitivity used for defining 'infection'. About 4.7% (121 individuals) of those who 'converted' 
after the start of the trial from tuberculin negativity (0-4mm induration to 100 TU) to 
positivity (induration of 5mm or more to 3 TU), developed disease over the ten years fol- 
lowing 'conversion' [29]. This compares with the 8.1% (108 individuals) of those who had 
an induration of 8mm or more to 3 TU after 'conversion' who developed disease over the 
same period [612. 
A further limitation of the data from the MRC trial is that about 125 initially tuberculin- 
negative individuals also developed disease but did not have a documented positive tuber- 
culin test and were excluded from the disease risk estimates. Hence the number of individ- 
uals who had been infected after the start of the trial and who were at risk of developing 
disease, but had no documented positive tuberculin reaction, is not known. 
The date of 'conversion' for these individuals was assumed to coincide with the first 
abnormal chest X-ray or clinical symptoms. Given the regularity of the tuberculin testing 
procedures, this should not have overestimated the 'true' date of conversion by more than 
14 months. On the basis of this assumption, the distribution of the time interval between 
'conversion' and disease onset was obtained for the unvaccinated individuals who developed 
disease (see section 1.1 on page 31). This provided the first ever indication that most of 
those who develop disease do so during the first year following 'infection t3 . 
The disease risk estimates from the study, based on the 121 individuals who developed 
disease following a documented tuberculin 'conversion' (5+mm induration to 3TU) were 
also broken down by age at 'conversion'. These are summarized in Table 1.2. These results 
indicate that the risk of developing disease decreased with the age at 'conversion', and was 
about 10.5% for 14 year olds, as compared with about 2.4% for individuals aged over 19 
years. This is inconsistent with age-specific patterns in the mortality rates among cohorts of 
2 This estimate is based on the most recently published review of the risks of developing disease [6], which 
cites an analysis of the data in 1967 (29]. The cited report however, gives disease risk estimates of 7.5% for 
individuals with indurations of 8mm or more. 3 Note that the first estimate of this distribution was based on 238 cases (113 and 125 cases among those 
with and without a documented tuberculin conversion respectively). All subsequent reviews of the trial base 
this distribution on 243 cases [6], but do not show the numbers who had had a positive tuberculin test. The 
final report of the BCG trial states that there were 248 cases in total among initially tuberculin-negative 
individuals, although the distribution of the time interval between tuberculin 'conversion' and disease onset 
has not been updated since [38]. 
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Table 1.2: The ten-year incidence of tuberculosis following 'conversion' from tuberculin 
negativity (0-4mm to 100TU) to positivity (5+mm to 3 TU), according to age at 'conver- 
sion', as found by the UK MRC BCG trial during the 1950s [29]. 
Age at 'conversion' (years) 
14 15 16 17 18 19+ All 
No. of 'converters' 57 580 761 398 336 418 2,550 
No. of cases 6 38 42 17 8 10 121 
'Risk' of disease 10.5 6.6 5.5 4-3 2.4 2.4 4.7 
individuals during the pre-chemotherapy era in developed countries, which suggested that 
the risks of developing disease increased during young adult life (see page 30 in section 1.1). 
There are several possible explanations for this apparent inconsistency. 
First, individuals who converted when aged over 17 years during the BCG trial had 
experienced at least 4 tuberculin tests by that time, which could have led to boosting in 
their tuberculin response (see section 1.1). This could have resulted in an overestimate in 
the number truly infected, and thus an underestimate in the true risks of developing disease. 
Second, the risks of developing disease among those who converted when aged over 19 
years were based on small numbers of individuals, and thus may be unreliable. 
Third, given the decline in the risk of infection, a greater proportion of individuals 
who 'converted' when aged 14 years could have been reinfected and experienced exogenous 
disease, as compared with those who converted when older. 
The study also provided estimates of the disease risks according to the degree of tuber- 
culin sensitivity at the start [38]. The annual disease incidence during 20 years of follow-up 
was greatest (1.04 per 1,000 per year) among individuals with an induration of 15mm or 
more to 3TU, as compared with 0.45 per 1,000 per year among individuals with a 5-14mm 
induration to 3TU and 0.98 per 1,000 per year among tuberculin-negative (unvaccinated) 
individuals. These results are consistent with those from other studies, which we describe 
below. 
1.2-1.2 US Public Healtb Service chemoprophylaxis studies 
Other data on the risks of developing disease given recent and distant infection, and ac- 
cording to the age of individuals, are provided by the US Public Health Service cherno- 
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Table 1.3: Incidence rate of disease during ten-year follow up of the US Public Health 
Service chemoprophylaxis trial during the 1950s [45] according to: 
(i) initial tuberculin reaction and 
(R) the age at enrolment among individuals who were either initially tuberculin-positive, or 
who converted to tuberculin-positivity during the first year of the trial. 
Size of Total Risk 
population number of (per 1,000 
followed up cases followed up) 
(i) Tuberculin reaction 
10+mm 4,992 147 29.4 
5-9 mm 1,616 31 19.2 
Tuberculin 'converters': 
(0-5mm induration at entry, 867 32 36.9 
5+ mm after 12 months. ) 
(ii) Age at enrolmentt 
<15 3,132 52 16.7 
15-34 
35-54 
55+ 
2,344 98 42.3 
1,724 53 30.9 
796 12 15.2 
t Note that the risk estimates exclude cases among individuals who were non-reactors both at 
recruitment into the study and 12 months thereafter. 
prophylaxis trials carried out during the 1950s among contacts of active tuberculosis cases. 
These studies were reviewed by Ferebee [45]. Table 1.3 summarizes the incidence rates of 
disease according to the size of the initial tuberculin reaction (to 5TU PPD-S) and the age 
at enrolment for the control group. 
Considering the results according to the size of the initial tuberculin reaction, this shows 
that the risk of disease during follow-up was highest (36.9 per 1,000) among 'converters' 
to tuberculin-positivity, as compared with that among initial tuberculin reactors. This 
estimate of the risk of developing disease following conversion is slightly lower than that 
found for the UK MRC BCG trial (see Table 1.2), and could be a consequence of differences 
between the age composition of the group of 'converters'. Alternatively, the differences 
could reflect differences in the risk of infection, which may have been higher during the UK 
study. This could have also led to a greater proportion of individuals in the UK study being 
reinfected during follow-up and experiencing exogenous disease as compared with that in 
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the US. Overall, these results agree with the MRC data in that the risks of developing 
disease immediately after tuberculin 'conversion' exceeded those many years thereafter. 
The results in Table 1.3 also indicate that the risks of developing disease may be age- 
dependent - individuals enrolled when aged 15-34 years experienced the highest risks (42.3 
per 1,000 individuals followed up), compared with those for 0-14 year olds and those aged 
over 55 years. Given that the number of 'converters' to tuberculin-positivity in these age 
groups is not provided, it is unclear whether the high risk for 15-34 year olds reflects a high 
risk of developing primary or endogenous disease, or of reinfection followed by exogenous 
disease. 
Data from these studies also suggest that the risks of developing disease decrease with 
the time since initial 'infection'. The greatest proportion of individuals who developed 
disease (i. e. 41%) did so during the first year of the trial, corresponding to an annual risk 
of 12.2 per 1,000. This dropped to 3.1 per 1,000 per year for the following two years and 
was about 1.6 per 1,000 per year during the sixth and seventh years. These data do not 
provide reliable insight into the magnitude of the decrease in the risk of developing disease 
with time since infection, given that the time of conversion to tuberculin-positivity for these 
individuals could not be established. Hence these results are not directly comparable to 
those from the UK MRC BCG study. 
1.2.1.3 Follow-up studies from the pre-chemotherapy era 
Several follow-up studies during the pre-chemotherapy era attempted to quantify the risks 
of developing disease following 'infection'. The reliability of the results from these studies is 
restricted, given that most considered only small populations, usually consisting of univer- 
sity or medical students, and generally had short durations of follow-up. These studies are 
reviewed by Styblo [6] and are not described here. Two of the more extensive studies during 
the pre-chemotherapy era which followed up individuals for over ten years and attempted 
to estimate these risks of developing disease according to both age and time since infection 
are described below. 
Oslo Public Health Service, 1929-1944 
A study of Meyer in 1949 followed up 889 'converters' to tuberculin-positivity found by 
the Oslo Public Ilealth Service during the period 1929-1944 (46]. These individuals were 
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Table 1.4: Summary of the age-specific cumulative risks of developing pulmonary tuber- 
culosis following conversion to tuberculin- positivity, as found by the follow-up study of 
patients during the period 1929-1944 through the Oslo Public Health Services [46]. 
Age at Number of Total who Cumulative risks 
4conversion' 'converters' ultimately of developing 
(years) developed disease disease 
0-3 58 0 
4-12 342 4 2.4 
13-19 242 26 12.4 
20+ 247 19 9.3 
identified through either routine annual medical examinations of schoolchildren, or through 
tenvironmental and industrial investigations'. The definition of conversion depended on the 
test used (i. e. 5mm induration for Mantoux test with 1mg tuberculin or "3mm induration 
and 4mm rubor" for the Pirquet test) and hence was not identical for all individuals. 
The cumulative risks of developing pulmonary tuberculosis according to the age at 'con- 
version' during the 17 years of follow-up found by the survey are summarized in Table 1.4. 
This shows that individuals who 'converted' when aged 4-12 years faced a cumulative risk 
of about 2.4%, as compared with about 12.4% for 'converters' aged 13-19 years. 
These risks of developing disease following 'conversion' during adolescence exceed those 
found during the UK MRC BCG trial (see Table 1.2). This could reflect either biases in the 
way the follow-up population in Oslo was selected or that a greater proportion of individuals 
developed disease following infection during the pre-chemotherapy era, as compared with 
counterparts thereafter. The latter could be a consequence of 
1. the high risks of infection during the pre-chemotherapy era, which meant that many 
individuals were reinfected and subsequently experienced exogenous disease, and 
2. poor living standards and general health status of the population during the pre- 
chemotherapy era, which predisposed a large proportion of individuals to develop 
disease after infection. 
Given the small numbers of cases found in the follow-up population, the study provides 
only limited information on the risks of developing disease according to the time since 
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'conversion'. For 13-19 year olds, the data suggest the annual risks of developing disease 
were 2-3% during the first four years after 'conversion'. 
Williamson County, Tennessee 1931-1954 
Some insight into the age-dependent risks of developing disease is provided by a major 
study of families of contacts of 828 tuberculosis cases notified to Williamson County (Ten- 
nessee) Health Department during the period 1931-1954 [47]. This study was undertaken in 
Tennessee as a result of its high tuberculosis mortality rates for both white and non-white 
individuals, as compared with those in the rest of the US. As part of this study, 3,446 white 
individuals (1,778 males and 1,668 females) and 768 non-white individuals (384 males and 
384 females) were followed up for up to 24 years. 
Twenty two years after the start of the study, Zeldberg et al [48] analysed the time 
interval between exposure (as measured by the estimated onset of 'cough' of the case first 
notified to the County Health Department) and disease of 733 children of white, sputum- 
positive tuberculous cases. Figure 1.6 summarizes the cumulative risks of developing disease 
according to the age at first exposure, as found by the study. These results suggest that 
the cumulative risks of developing disease following 'exposure' at age 5-14 years were lower 
than those for other age groups (e. g. about 12%, as compared with 20% for individuals 
aged over 15 years). These estimates seem high, given that the degree of exposure varied 
between individuals and hence only a fraction of the exposed individuals had probably been 
infected. 
The reliability of these results is unclear, given that they were based on small numbers 
of cases and the size of the follow-up population in each age group was not provided in the 
original report. A further limitation is that there are no data on when or even whether the 
'exposed' individuals had converted to tuberculin sensitivity. The high risk of developing 
disease observed soon after exposure for individuals aged over 15 years, for example, could 
reflect a greater prevalence of infection, as compared that in other age groups. It is also 
impossible to make any inferences about whether the disease individuals developed was pri- 
mary, endogenous or exogenous in origin, given that the subsequent exposure of individuals 
to tuberculosis is not provided. 
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Figure 1.6: Cumulative risks of developing tuberculosis for 733 children of white sputum- 
positive cases, according to age at first 'exposure', as found by the Williamson County 
tuberculosis study during the period 1931-1954 [48]. Numbers in brackets denote the total 
number of cases observed among the individuals followed-up. 
Reproduced from Zeidbery et al [48]. 
1.2.1.4 Estimates of the risks of developing endogenous or exogenous disease 
There have been few direct observational studies of the risk of developing endogenous disease 
and no studies examining the risks of exogenous disease after reinfection. 
Estimates of the risk of developing endogenous disease have been inferred in the past 
by observing the incidence of disease among tu berculi n- positive individuals in an area with 
a low risk of infection. Styblo [6], for example, observed that the incidence of sputum- 
positive pulmonary disease among 65-74 year olds and those aged over 75 years in the 
Netherlands was about 10 and 20 per 100,000 respectively during the period 1971-73 (when 
the risk of infection was low), and concluded that this reflected the risk of developing 
endogenous disease, given that most individuals in this age range were probably infected 
and few were reinfected, given the low risks of infection during the period. While this is a 
realistic assumption, it is complicated by the fact that many older individuals do not mount 
a response to tuberculin at all. This either implies that they have never been infected or 
else that they have lost the sensitivity they had earlier in life (see section 1.1). 
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Similar estimates of the risks of developing endogenous disease were derived by Hor- 
witz et al [49], who followed up for 12 years 286,250 tuberculin reactors (6mm or more 
induration to 10TU) aged over 15 years identified during the period 1950-1952 during BCG 
vaccination campaigns in Denmark. 
In areas with a high risk of infection, the incidence rates among individuals are generally 
high and do not reflect the risks of endogenous disease, given that some of the disease is 
attributable to reinfection and exogenous disease. 
This is illustrated by the fact the during community chemoprophylaxis trials in Green- 
land during the 1950s, the incidence of disease among initially tu berculi n- positive individ- 
uals during the 6 years of follow-up was about 82 per 1000 followed up (45]. This was over 
two and half times greater than that found among tuberculin-positive individuals during 
the US Public Health Service trials during 10 years of follow up (see Table 1.3). Inferences 
as to the magnitude of the risk of reinfection and of subsequent exogenous disease are com- 
plicated by the fact that we have to account for both the age and time since infection in 
the corresponding study populations. 
1.2.1.5 Conclusions 
In interpreting. the results from these studies, it is important to recognize that they are 
influenced by a number of factors, such as the type of test and criterion used to determine 
tuberculin-positivity, the efficiency and duration of follow-up, and the definitions used to 
describe a tuberculosis case. 
Two consistent features nevertheless emerge from these studies, namely that the risk of 
developing disease depends on both: 
1. the age of individuals considered, and appears to be greater among adults than for 
children. This result is consistent with age-specific patterns in mortality rates among 
birth cohorts during the pre-chemotherapy era (see section 1.1). 
2. The degree of tuberculin sensitivity. Individuals with a small amount of tuberculin 
sensitivity at the start of follow-up in the above studies faced lower risks of develo- 
ping disease, than did individuals who 'converted' to tuberculi n- positivity. Assuming 
that this weak tuberculin sensitivity is attributable to infection with M. tuberculosis, 
this suggests that infection might confer some protection against disease many years 
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thereafter 4. 
The studies also suggest that the risk of developing disease among tuberculin-positive 
individuals in populations with a high risk of infection, exceed those for comparable indi- 
viduals in populations with low risk of infection. Whilst this difference may be attributable 
to differences in the environmental, genetic and social factors in the populations, which 
may be associated with high risks of infection, the fact that some of the disease may be 
attributable to exogenous reinfection should not be ignored. 
Given these observations, we conclude that both age and reinfection are important 
factors underlying the disease incidence, and should be included in a model if we are to 
provide a realistic representation of past trends in tuberculosis in England and Wales. 
"Note that weak tuberculin sensitivity may also be attributable to infection with environmental mycobac- 
teria - see section 1.1. 
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1.2.2 Studies of the transmission of M. tuberculosis 
The basic and net reproduction numbers are two of the most important parameters un- 
derlying the dynamics of any infectious disease, as they describe the number of secondary 
infectious cases which will result from one infectious case under given circumstances. More 
formally, the basic reproduction number is defined as: 
'the average number of secondary infectious cases resulting from the introduc- 
tion of a typical infectious case during its entire infectious period, in a [totally] 
susceptible population' [50,51]. 
The net reproduction number can be defined analogously as: 
'the average number of secondary infectious cases resulting from each infectious 
case during its entire infectious period, in a given population'. 
The definitions and interpretation of both the basic and net reproduction numbers are 
complicated for tuberculosis, given that individuals face age-dependent risks of developing 
'primary', 'endogenous' and 'exogenous', and that even reinfected individuals can be con- 
sidered 'susceptible' to tuberculosis, given that reinfection can occur. These issues will be 
discussed in detail in Chapter 5. 
A basic or net reproduction number greater than 1 for a given infection implies that one 
infectious case leads, on average, to more than one subsequent infectious cases and that the 
infection will persist in the population in the absence of control or intervention. This logic 
was implicitly recognized by Frost as early as 1937 [2]: 
"It is necessary only that the rate of transmission be held permanently below 
the level at which a given number of infection-spreading (i. e. open) cases succeed 
in establishing an equivalent number to carry on the succession. If, in succes- 
sive periods of time, the number of infectious hosts is continuously reduced, 
the end result of this diminishing ratio, if continued long enough, must be the 
extermination of the tubercle bacillus. " - 
The dramatic decline in tuberculosis which has been observed in developed countries 
since the 1850s, suggests that the net reproduction number has been less than unity over 
this period. This decline has been attributed to various factors (e. g. reduced crowding or 
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increased resistance to developing disease), but the effect of these factors on the basic re- 
production number of tuberculosis is unclear. Reduced crowding, associated with improved 
socio-economic conditions, for example, infers a reduction in transmission, and hence a 
reduction in the basic and net reproduction numbers. 
There has been only one published study of the basic reproduction number for tubercu- 
losis [9], using a model in a hypothetical population without age-structure. This is described 
in greater detail in section 1.3. Until now, no study has attempted even to define the net 
reproduction number for tuberculosis. Instead, some researchers in the past have attempted 
to estimate a statistic which is related to the reproduction numbers, namely the average 
number of new infections resulting from a single infectious (smear- positive) case. For dis- 
eases in which all infected individuals develop disease, this measure would be identical to 
the net reproduction number. These estimates are reviewed below. 
In practice, such measures represent only average values and are subject to a large degree 
of variability. Some insight into the extent of this variability and its determining factors is 
provided by documented reports of outbreaks of tuberculosis. Examples of such outbreaks 
are described below. 
Average number of new infections per smear-positive case 
The earliest attempt at estimating the average number of new infections resulting from a 
smear-positive individual was that of Styblo [52], who defined a "contagious parameter", 
given by the ratio between the annual risk of infection and the prevalence of smear-positive 
cases. This "contagious parameter" was first obtained for the period 1921-1937 for the 
Netherlands, which has detailed information on the annual risk of infection since 1911 from 
tuberculin survey data, but no pre-chemotherapy data on the prevalence of smear-positive 
cases. Styblo first estimated the latter for the period 1921-1937 by assuming that it was 
four times the mortality rate of all forms of tuberculosis in the general population. This 
implicitly assumed that 
1. The prevalence of smear-positive cases in the general population was twice the corre- 
sponding incidence (i. e. that cases are infectious for two years), and 
2. The incidence of smear-positive disease was twice the mortality rate from all forms of 
tuberculosis in the general population. 
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Using this approach, Styblo estimated that each smear-positive case in the Netherlands 
infected on average 13-14 individuals in a given year during the period 1921-1937. The 
main shortcoming of these estimates was that the relationship between the mortality rate 
of all forms of tuberculosis and the prevalence of smear-positive cases is more complicated 
than that assumed, given that the risks of developing disease are age-dependent and the 
fact that the age-distribution of smear-positive cases in the general population has changed 
over time. 
Styblo obtained similar values for the 'contagious parameter' in Uganda and Lesotho 
using estimates for the annual risk of infection in 1960 and the prevalence of smear-positive 
cases estimated from surveys in 1957 and 1958. The latter were based on small numbers 
of cases, which restricts their reliability. By assuming that each infectious case is infectious 
for 2 years in developing countries and infects 10 others in a given year, Styblo estimated 
that, on average, each smear-positive case leads to 20 new infections. 
These analyses were extended by Styblo [53] and then by Murray et al [54], who cor- 
related the annual risk of infection to the incidence of smear-positive disease by linear 
regression. This used estimates of the incidence of smear-positive disease for the Nether- 
lands from the pre-chemotherapy era (derived using mortality data, as above), and WHO 
tuberculosis prevalence survey data from 13 African countries during the late 1950s. These 
included Nigeria, Bechuanaland and Somaliland, where the annual risks of infection were 
estimated to be over 4%, over 5% and about 8% respectively. 
The analyses of Murray et al indicated that each 1% risk of infection corresponded to 
an incidence of 49 smear-positive cases per. 100,000 general population (95% Cl: 39 to 59 
per 100,000). As pointed out by Rieder [15], these results may be unreliable, given that the 
authors could not account for variance in sample size, and, where sufficient data were not 
available, just assumed that the smear-positive disease incidence was half the prevalence, 
which was perhaps too simplistic. The estimates of Murray et at imply that each smear- 
positive case infects on average about 20 individuals in a given year. This is roughly twice 
the estimate derived by Styblo earlier. 
1.2.2.2 Overview of outbreak literature 
Much of the older literature on factors determining the size of an outbreak, as defined by 
the number of new infections and/or secondary cases found, was reviewed by Lincoln in 
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1965 [55], who reviewed 109 outbreaks in 12 countries from both before and during the 
chemotherapy era. To some extent, documented reports of outbreaks provide an overesti- 
mate of the number of new infections and/or secondary infectious cases which can result 
from a given typical infectious case, as only the remarkable ones are generally reported. 
There have been few outbreaks in which it has been possible to estimate reliably the 
number of new infections resulting from an infectious source, given that the tuberculin 
sensitivity status of individuals prior to exposure is often not known. This is complicated 
in many instances by the fact that the outbreak is identified at a late stage, when there 
are several cases of (infectious) pulmonary tuberculosis, and it is impossible to identify a 
unique source of infection. 
A famous outbreak in a Danish school during 1943 described by Ilyge [56] is exceptional, 
in that several weeks prior to the outbreak (December 1942), 105 pupils out of 368 had been 
tested and found tuberculin-negative (Ma, ntoux, 100TU). During January-February 1943, 
70 of these had converted to tuberculin-positivity, with 41 developing lesions detectable 
by X-ray. In this instance, there had been only one source case (a physics teacher) and 
transmission had occured over a 2-month period in 2 blacked-out basement teaching rooms 
with no ventilation, one of which also served as an air-raid shelter. 
Most of the outbreaks reviewed by Lincoln occurred among young adults or schoolchil- 
dren. In these instances, children were rarely sources of infection. - This reflects the rarity 
of infectious pulmonary disease among children, as compared with its frequency among 
adults. Whilst outbreaks must have occurred among older adults, they were less likely to 
be recognized as such, given the high infection prevalence among adults during the period 
reviewed. More recently, however, with a lower infection prevalence among adults, there 
have been several documented outbreaks involving adult exposure to smear-positive cases. 
Kline (57] documented one such outbreak during the 1990s, in which the source case was 
a homeless individual who spent most of his infectious period (approximately 6 months) at 
a neighbourhood bar in Minneapolis. In total, he was estimated to have infected 41 out of 
a possible 97 contacts (though this could be an overestimate, as only 8 of these were known 
to be tuberculin-negative before the outbreak). 
Reports of outbreaks provide only limited information on the number of (sputum- 
Positive) cases resulting from each infectious source, as exposed individuals are rarely fol- 
lowed up over a sufficiently long period of time. The outbreak documented by Hyge [56] 
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involved a very long follow-up of up to 12 years. Before the advent of DNA fingerprinting, 
even when individuals were followed up for long time-periods, it was typically impossible to 
determine whether or not a disease episode resulted from an initial infection or a subsequent 
reinfection. 
The main factor in determining the number of secondary (infectious) cases resulting 
from a given source is the age of those exposed. All the exposed individuals in the outbreak 
documented by Hyge (56] were aged 14-18 years, and therefore faced high risks of developing 
disease. As a result, a large number (14) of cases of pulmonary tuberculosis occurred among 
those presumed to have been infected by the source, with 8 doing so within a year of 
exposure. It is unclear exactly how many of these cases were sputum-positive, as 8 had 
a documented positive gastric lavage, all were defined as having 'post-primary pulmonary 
tuberculosis', but 8 involved cavitation. 
Similarly, adults comprised most of those exposed to the infectious source in the Min- 
neapolis bar [57], and in total, 14 active tuberculosis cases developed among the contacts 
within of 2-3 years. At least eight of these cases had been infected/reinfected by the source 
case, as determined by identical RFLP patterns. It is not known whether this large number 
of secondary (sputum-positive) cases was a consequence of an increased susceptibility to 
infection and subsequent disease among heavy alcohol users in the bar, or the high risks of 
developing (spu tu m- positive) disease following initial infection or reinfection in adult life. 
The number of secondary cases resulting from a given infectious source also depends 
on the prior tuberculin sensitivity status of exposed individuals, given the different risks of 
developing disease after first infection or of reinfection followed by subsequent disease. There 
have been few documented outbreaks in which exposed individuals developed exogenous 
disease. One famous exception involved homeless individuals in a shelter in Boston during 
the 1980s, in which one index case lead to 7 cases of exogenous disease, as determined by 
the similarity between phage-types and drug-resistance patterns [21]. 
Since the 1950s, the number of smear-positive cases resulting from an infectious source 
has also depended on whether exposed individuals received chemoprophylaxis after expo- 
sure. In an outbreak in 1974 in Corinth (Mississippi) [58], one adolescent source case led to 
4 other pulmonary cases within 2 years of exposure, as determined by the similarity between 
phage types and drug-sensitivity patterns; 2 of these cases had been prescribed isoniazid at 
the time of exposure, but uptake had been irregular. 
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The total number of secondary cases resulting from a given infectious source also depends 
on whether he/she has several (infectious) disease episodes and the number of individuals 
infected during each of these periods of infectiousness. The index case in the outbreak 
in the Boston shelter [21] had been treated for culture-positive tuberculosis at least once 
before the outbreak, but it is not known how many individuals had been infected during 
the earlier disease episode. 
More recently, there have been several outbreaks involving multi-drug resistant organ- 
isms. Most of these have been among HIV-positive individuals and involved either hospi- 
talized patients [22,23,42,59] or prison inmates [30,43], who have different mixing patterns 
from individuals in the general population. In practice, the number of secondary (infec- 
tious) cases resulting from an infectious source in an IIIV-positive population depends on 
many factors, such as the stage in the IIIV-infection at which infection with M. tubercu- 
losis is acquired. Those who develop tuberculosis early in the course of HIV-infection, for 
example, are more likely to be smear-positive as compared with those doing so with a low 
CD4+ T lymphocyte count [60]., Several of these outbreaks have been remarkable in demon- 
strating the rapid development of disease among IIIV-positive individuals. In the outbreak 
documented by Coronado et al [23], for example, three IIIV-positive individuals developed 
multi-drug resistant disease, with identical RFLP patterns, within 5 months of exposure to 
the index case. 
1.2.2.3 Concluding remark 
Overall, we see that the number of infections and secondary infectious cases resulting from a 
given infectious source in the outbreak setting are subject to a large degree of variability, and 
it is difficult to make generalizations as to the magnitude of the basic or net reproduction 
numbers for tuberculosis on the basis of such data. 
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1.3 Models for tuberculosis 
Models for tuberculosis fall into several categories, of which transmission models comprise 
the largest group. These describe the disease process in a population by modelling the 
transitions of individuals between at least three different epidemiological states, namely: 
1. Those not yet infected with the tubercle bacillus, 
2. Those infected, but who have not yet developed an infectious form of disease, 
3. Infectious cases. 
Possible transitions between these groups of individuals are illustrated schematically 
in Figure 1.7. In this simple model, infectious cases may recover and experience further 
disease. 
Uninfected I P, P, Infectious I Infected ', -i 
Recovered 
Figure 1.7: Schematic diagram showing the structure of simple models of the transmission 
dynamics for M. tuberculosis. 
Models of the transmission dynamics of M. tuberculosis have generally used the term 
tsusceptible' to describe individuals who have not yet been infected with the tubercle bacil- 
lus. This term should be used with caution when considering the natural history of tuber- 
culosis, given that even infected individuals can be 'susceptible', as reinfection can occur. 
As we see below, the models published by other authors ignored the effect of reinfection 
on the transmission dynamics of M. tuberculosis, and hence assume that only uninfected 
individuals are 'susceptible'. 
In most transmission models, the rate at which 'susceptible' individuals become in- 
fected is a function of the prevalence of infectious individuals, according to the mass action 
principle, first postulated by Hamer [61]. Where the endemicity of infectious pulmonary 
tuberculosis is high, as in some developing countries today or in developed countries at the 
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beginning of this century, the implicit assumption of homogenous mixing between infectious 
and 'susceptible' individuals may be realistic. This is not the case in populations with a low 
prevalence of infectious pulmonary tuberculosis, since transmission is likely to be confined 
to certain high risk groups, in which the risk of infection greatly exceeds the average. 
Transmission models can be categorized according to whether they consider a population 
with or without any age-structure i. e. whether or not transitions between the epidemiological 
groups are age-dependent. One of the drawbacks of age-structured models is that more data 
or assumptions are required to specify the characteristics of the population, as compared 
with models without age-structure. Published examples of these two categories of models 
are reviewed below. 
A second and smaller group of models for tuberculosis comprises those developed for 
parameter estimation [7,62]. These follow a statistical approach, and are generally simpler 
than transmission models. These are discussed in section 1.3.2. 
1.3.1 Transmission models for tuberculosis 
1.3.1.1 Models considering populations without age-structure 
The first and simplest model for the transmission dynamics of M. tuberculosis in a pop- 
ulation without age-structure was produced by Waaler et at in 1962 [63]. This consisted 
of four difference equations and modelled the transitions between 'susceptible' (defined as 
uninfected), infected and infectious individuals. The structure of the model was the same 
as that shown in Figure 1.7, except that recovered individuals returned to the infected 
category and faced the same risks of developing disease as did other infected individuals. 
The initial parameters of the model population were defined using data from a survey 
carried out during the period 1951-1955 in South India (64]. The model was used to predict 
the incidence of infectious pulmonary tuberculosis over 20 years, with either no intervention, 
or with a case-finding and treatment programme or with BCG vaccination. This model was 
designed only to illustrate the potential contribution of modelling approaches for evaluating 
different control programmes for tuberculosis. 
Models produced by Azuma in 1975 [65], Hock and Loy in 1981 [66] and Trefny and 
Heidova in 1982 [67] had the same structure as the model of Waaler [63], and made long-term 
predictions of the incidence of 'bacteriologically confirmed' cases in Japan from 1953 [65], 
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in Singapore from 1975 [66] and in the Czech republic from 1949 [67]. All these models 
were simplistic and their main weakness was that they assumed all infected individuals 
experienced the same unchanging risk of developing disease over the entire period simulated. 
This was given by the ratio between the crude incidence of infectious pulmonary tuberculosis 
and the prevalence of infection in the population at the start of the period, estimated using 
survey data. 
Given the complex natural history of tuberculosis, the average risk of developing disease 
in a population is a function of the individual risks of developing 'primary' and 'endogenous' 
disease and of reinfection, followed by 'exogenous' disease, and the number of individuals 
experiencing each form. These depend most importantly on the age distribution of individ- 
uals at risk of developing each of these disease forms and the annual risk of infection. Since 
neither of these factors remains at a constant level over a long-term period, the predictions 
from the early models are unlikely to have been reliable. It is also interesting to note the 
different annual risks of developing disease estimated for these models using survey data, 
namely 0.85% for South India, 0.05% for Japan, 0.1% for Singapore and 0.14% for the Czech 
Republic. 
Subsequent variants of Waaler's basic model partially remedied this problem regarding 
unchanging risks of developing disease (e. g. ReVelle et al [68] and Chorba and Sanders (69]). 
The model of ReVelle et al, for example, which explored the effect of combinations of control 
strategies (BCG vaccination, chemoprophylaxis) on the disease incidence in a developing 
country setting, subdivided infected individuals into those with high and low risks of develo- 
ping disease, according to whether or not they had received chemoprophylaxis. Additionally, 
diseased individuals recovered either naturally or after treatment, and faced different risks 
of developing disease from those who had yet to develop disease. 
The model of Chorba and Sanders in 1971 [69] was similar to that of ReVelle et at, 
except that it broke the infected category down still further into those with a recent or 
a more distant infection. The latter were at a high or a low risk of developing disease 
according to whether or not they had pulmonary lesions. The structure of the model is 
illustrated in Figure 1.8. This model explored the effects of vaccination or administering 
chemoprophylaxis on the incidence of disease in the US during the period 1967-1987 and 
assessed the costs and benefits of screening for infection in high and low infection prevalence 
areas. 
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Figure 1.8: Schematic diagram showing the structure of the model produced by Chorba 
and Sanders in 1971 [69]. 
The model of Chorba and Sanders was the first to include a separate (disease) state 
consisting of individuals with pulmonary lesions. The model of Joesoef et al in 1989 [70] 
similarly assumed that infected individuals developed pulmonary lesions before developing 
bacillary diseas6. The structure of this model is shown in Figure 1.9. Whilst this is a realistic 
assumption, it requires reliable data on the prevalence of radiological cases, which is often 
difficult to acquire. Joesoef et al also assumed that vaccinated individuals faced unchanging 
risks, of developing pulmonary lesions (see Figure 1.9), which, in practice, should have been 
a function of the annual risk of infection. The model of Joesoef et al made projections 
of the incidence of cases with active pulmonary lesions and bacillary disease in Indonesia 
during the period 1983-2003, and investigated the cost-effectiveness of different treatment 
strategies. 
More recently, models have been developed by Schulzer et al [71,72] and Heymann [73] 
to assess the impact of the HIV epidemic on the tuberculosis situation in Africa. These 
describe only adult populations (15-49 year olds), and assume that parameters do not vary 
between different age groups in this age band. Hence these models also fall into the category 
of non-age-structured models. 
In the model of Schulzer et al, first published in 1992 [71] and presented in greater detail 
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Figure 1.9: Schematic diagram showing the structure of the model produced by Joesoef 
in 1989 [70]. 
in 1994 [72], individuals could develop either smear-positive or smear-negative disease, and 
the risk of doing so depended on the time since first infection. Thus 5% of IIIV-negative 
individuals, for example, developed disease during the first year after infection, 2% during 
the second year, 0.5% during the third year etc. The risk of developing disease among 
HIV-positive individuals was assumed to be about 8 times greater than that among IIIV- 
negative individuals during each year after infection. This corresponded to a 42.1% risk 
among HIV-positive individuals during the first year after infection (which is very high). A 
further drawback of this model was that they did not consider the role of reinfection, which 
may well play an important role in the epidemiology of tuberculosis in developing countries. 
Schulzer et al assumed that any increase in the annual risk of infection occurred as 
a consequence of new smear-positive cases among HIV-positive individuals, and neglected 
the contribution from new smear-positive cases among HIV-negative individuals. They also 
assumed that an annual risk of infection of 1% corresponds to a smear-positive incidence 
of roughly 50 per 100,000, which is based on a result from linear regression analyses of 
incidence and infection risk data from both developing and developed countries [34,53,54]. 
The results from this regression analysis are themselves controversial [15] (see section 1.2-2). 
The model predicted that with an annual risk of tuberculous infection of 1%, a tubercu- 
lous infection prevalence of 45% and a 2% prevalence of IIIV infection in 1989, there would 
be a 68% increase in the number of new cases of smear-positive tuberculosis among adults 
by the year 2000. The model also considered the effect of HIV infection on the incidence 
of tuberculosis among drug users in Vancouver. This found that with an annual risk of 
infection of 0.01%, a 10% prevalence of tuberculous infection, and HIV infection prevalence 
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of 3.6%, a 21-fold increase in the incidence of smear-positive cases would occur between 
1995 and 2000. 
The model of Heymann in, 1993 [73] used a Markov chain formulation. This catego- 
rized HIV-positive and negative individuals into those susceptible to tuberculous infection, 
those recently infected, those infected for more than 2 years and those with 'active' tuber- 
culosis. HIV-positive individuals had higher risks of developing disease, as compared with 
HIV-negative individuals. The objective of this model was to assess the impact of chemopro- 
phylaxis and treatment on tuberculosis mortality in Africa. However, it did not incorporate 
disease through exogenous reinfection and it did not distinguish between smear-positive and 
smear-negative forms, which restricted the validity of the conclusions. 
The most recently published model of the transmission dynamics of M. tuberculosis, 
that of Blower et al [9], also considered a population without age-structure. This catego- 
rized individuals into those who were 'susceptible' (defined here as uninfected'individuals), 
'latently infected', infectious or non-infectious cases, and those who were recovered. 0-30% 
of individuals were assumed to develop disease within a year I of infection and reinfection 
was not incorporated. This model differed from those described thus far as it did not model 
the tuberculosis dynamics in any specific population and instead explored the long-term 
dynamics of disease. 
The authors simulated an epidemic following the introduction of one infectious individual 
into an uninfected population, and found that the incidence of infectious cases initially 
increased, peaked and then stabilized at an equilibrium level within 31 to 7,524 years, 
assuming that all conditions remained constant. 
Blower et al concluded that tuberculosis epidemics have slow intrinsic dynamics and 
suggest that the decline in tuberculosis over the past century in developed countries reflects 
the natural decline in a long epidemic. This interpretation of the decline in tuberculosis 
was also postulated by Grigg in 1958, who proposed that the incidence of tuberculosis first 
increased during the 1600s in developed countries [74]. 
The main shortcoming of this model was that it oversimplified the natural history of 
tuberculosis by neglecting to consider an age-structured population and the contribution of 
disease following reinfection. 
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1.3.1.2 Models with age-structured populations 
The first model to consider an age-structured population was produced by Brogger in 
1967 [75]. The population was stratified into single year age bands for those aged under 15 
years and into 5 year age bands for 15-89 year olds. The model was similar in structure to 
that of Joesoef et al, in that individuals first entered an intermediary stage containing those 
with pulmonary lesions, before developing infectious pulmonary disease. Brogger did not 
distinguish between 'primary', 'endogenous' and 'exogenous' forms of disease and assumed 
that the risk of developing disease was age dependent but independent from the time since 
first infection. The structure of the model is shown in Figure 1.10. This model explored the 
effects of BCG vaccination, case-finding and chemotherapy in Thailand, using data from 
the national survey carried out during the period 1960-1963. 
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Figure 1.10: Schematic diagram showing the structure of the model produced by Brogger 
in 1967 [75]. 
The framework for a more realistic age-structured model was produced by Waaler in 
1968 [76]. This extended Brogger's work and Waaler's earlier model (63]. The population 
was stratified into 5 year age groups. Individuals faced different risks of developing disease 
according to whether they had been infected for more or less than 5 years, and could develop 
either smear-positive or smear-negative disease. This was the first model to distinguish 
between primary and post-primary disease. The overall structure of the model is illustrated 
in Figure 1.11. In this theoretical framework, Waaler allowed post-primary disease to occur 
either through endogenous reactivation or exogenous reinfection. 
The model was first applied to evaluate the cost-effectiveness of BCG vaccination and its 
effect on the long-term incidence of disease in a country with a low annual risk of infection, 
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Figure 1.11: Schematic diagram showing the structure of the age-structured model pro- 
duced by Waaler in 1968 (76]. 
similar to Norway during the 1970s [77-79]. The effect of BCG vaccination in a region 
similar to rural South India, was also explored [80). This analysis was based using data 
from the longitudinal 5-year survey of tuberculosis carried out in Bangalore during the 
period 1961-66 [251. 
In both applications, Waaler allowed individuals to develop disease only through en- 
dogenous reactivation. This was a reasonable assumption to make for Norway, given its low 
risk of infection during the 1970s. The situation in Bangalore, however, was vastly different, 
with a high annual risk of infection (1-2%), and with much disease among infected individ- 
uals probably occurring through exogenous reinfection. This led to unreliable conclusions 
from the model, namely that with a vaccine efficacy of 30% and an annual coverage of 66% 
among 0-20 year olds, the incidence of bacillary cases would decrease to less than one third 
of its initial level within 40 years. Since then, studies have also shown that the effects of 
BCG vaccination are unpredictable and may be temporary (81]. 
Waaler also provided a method for assessing the impact of different control programmes 
in a population by defining a 'TB problem' as the 'cumulative sum, over all future years 
of man-years of tuberculosis experienced by a community' [76]. Waaler later refined this 
definition to assign different weights for cases occurring many years or shortly after the 
start of a control programme [82]. This measure was used by Azuma [65] and Hock and 
Loy [66] to assess the relative impact of different combinations of treatment efficiency and 
BCG vaccination on the tuberculosis situation in Japan and Singapore respectively. 
WhIlst this is a useful measure of a 'TB problem', it depends on assumptions in the 
model, i. e. whether all infected individuals experience the same risk of developing disease, 
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irrespective of their age and the time since infection, and whether individuals can develop 
disease through both exogenous reinfection and endogenous reactivation. 
The most recent age-structured model of the transmission dynamics of A tuberculosis, 
which also used data from the longitudinal survey in Bangalore, was produced by Bal- 
asangameshwara et al in 1992 [83]. This divided the population into broader age-bands 
than used by Waaler [76] (i. e. into 0-4,5-14,15-34,35-54 and >55 year olds). The risks 
of developing disease were assumed to be constant over time and thus Balasangameshwara 
et al did not distinguish between exogenous and endogenous disease forms. The model 
explored the effect of alternative coverage levels of active case-finding and treatment on the 
prevalence of smear and/or cultu re- positive cases over a 50 year time period. 
1.3.2 Models for parameter estimation 
Styblo et al first used a model-based approach to estimate the annual risk of infection in 
the Netherlands since 1911 [62]. This relied on two data sets, namely: 
1.4 tuberculin surveys (using the von Pirquet test) of 0-14 year old children who were 
not home contacts of tuberculosis cases, which were carried out by the Amsterdam 
Chest Clinic during the periods 1925-1927,1933-1935,1938-1940 and 1946-1948, and 
2. routine tuberculin sensitivit surveys among Dutch military recruits, aged about 191 y2 
years, during the period 1956-1966. Individuals were considered infected if they re- 
sponded with an induration of 8mm or more to a Mantoux test of 1TU of RT23. 
BCG was not used as a routine general control strategy in the Netherlands, and so the 
survey data provided a reliable indication of the prevalence of 'infection' in these age groups. 
The data sets were analyzed separately using the same approach. 
Considering the prevalence surveys among Dutch military recruits, Styblo et al first 
estimated the average annual risk of infection experienced by each cohort during its lifetime. 
These were assumed to be the actual risks experienced in some year during the cohort's 
lifetime, and were found to decrease at a constant rate. These risks were then extrapolated 
back and assigned to particular years by fitting the expected prevalence of infection to the 
prevalence of tuberculin sensitivity obtained at each survey. Combining these results with 
those from the survey among children in Amsterdam, Styblo et al found that the annual 
risk of infection declined at about 5.5% pa until 1940 and at about 13% thereafter. The 
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faster decline after 1940 was attributed to the enforced pasteurization of milk during the 
Second World War. Sutherland et al subsequently extended these analyses to estimate the 
risks of infection until 1979 in the Netherlands [84]. 
Styblo et al discussed some of the problems with this analysis, such as the reliability 
of the von Pirquet method used for detecting tuberculous infection among children in Am- 
sterdam and possible age-specific fluctuations in the annual risk of infection. A further 
problem with the analysis is that the data sets were analyzed independently. In estimating 
the prevalence of infection among recruits tested in 1956, (who were born in 1937) Styblo et 
at did not use the annual risks of infection estimated using the surveys of school-children in 
Amsterdam, for the period 1937-1940. This would not have substantially altered the risk 
estimates obtained. 
The work of Styblo et at constituted the first attempt at quantifying past trends in 
transmission of tubercle bacilli in any country, and represents an extremely important con- 
tribution to tuberculosis epidemiology. 
Sutherland et at used these estimates of the annual risk of infection to estimate the 
individual risks of developing 'primary', 'endogenous' and 'exogenous' disease among 15-69 
year olds during the period 1951-1970 in the Netherlands [7]. In the first version of the 
model, presenteLd in 1975 [85], Sutherland et at assumed that individuals faced 
1. a constant annual risk rl of developing ('primary') disease during the first five years 
after infection, 
2. an annual risk r2 of developing ('endogenous') disease more than 5 years after first 
infection, and in the absence of reinfection, and 
3. a constant annual risk r3 of developing ('exogenous') disease during the first five years 
after reinfection, for those who had experienced an initial infection more than 5 years 
beforehand. 
These risks were assumed to be identical for all age groups throughout the time period 
considered. Sutherland et al expressed the expected incidence of disease for each age group 
and for each year as the sum of the corresponding incidence of 'primary', 'endogenous' and 
texogenous' diseases. These were given by the product of 
1. The population in each age group at risk of developing the given disease form, Xi, X2 
and X3, estimated using the annual risks of infection derived by Styblo et al, and 
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2. The individual risks of developing disease, rl, r2 and r3. 
This yielded a system of 220 linear equations in rl, r2, and r3, for the expected incidence 
of disease in each 5-year age group between 1951 and 1970. Multiple regression techniques 
were used to estimate the risks rl, r2, and r3, by fitting the expected incidence to the 
corresponding notification rates of respiratory disease in males and females (separately) in 
the Netherlands. 
These produced the following annual risks of developing respiratory disease in 15-69 
year old males: 
1.5.01% per annum during the five years after first infection, 
2.1.91% per annum during the first five years after reinfection, 
3.0.0253% per annurn following a distant primary infection with no reinfection. 
This corresponds to a risk of 23% and 9% of developing 'primary' and 'exogenous, 
diseases during the first five years after first infection and reinfection respectively. The 
risk of developing primary disease appears high, compared with a risk of developing disease 
of about 10% during a ten year period for those who 'converted' to tuberculin sensitivity 
during the UK MRC BCG trial (see section 1.2.1.1). 
Sutherland et al also considered the effect of modifying the assumptions in the basic 
model on the disease risk estimates, e. g. assuming an initial infection conferred complete, 
partial or no immunity against subsequent reinfection, or that individuals infected for more 
than 25 years without subsequent reinfection faced no risk of developing endogenous dis- 
ease. Further refinements documented in a TSRU (Tuberculosis Surveillance Research Unit) 
working paper in 1975 [86] show the effects of assuming age-dependent risks of infection and 
a declining risk of developing disease during the first ten years after first infection. Some of 
the main findings were summarized by Sutherland in 1982 [7]. 
Although each of these were realistic extensions of the basic model, they were not 
incorporated simultaneously, and better fits were obtained only by assuming age-dependent 
risks of infection. 
The chief shortcoming of this approach for estimating risks of developing disease, is that 
it does not account for the prior disease status of individuals, nor their recovery time, which 
means that the individuals at risk of developing each form of disease are only crudely defined. 
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Those infected for less than five years, for example, comprise those at risk of developing 
'primary' disease - this definition encompasses individuals who had been infected for 3 
years, for example, and had developed disease during the previous year, and who in practice 
would have been recovering. A further problem relates to the use of the time since infection 
for defining individuals at risk of developing exogenous and endogenous disease. We discuss 
this in greater detail section 3.1.1. 
Krishnamurthy and Chaudhuri [87] used a similar approach to that of Sutherland et 
al [7] to estimate the risks of developing endogenous and exogenous smear/cultu re- positive 
disease among 'infected' individuals in South India. They used data from the 5-year longi- 
tudinal tuberculosis survey carried out during the period 1961-1966 in Bangalore [25]. This 
fitted the expected incidence of smear/culture-positive disease among individuals considered 
infected (10+mm induration to 1TU PPD RT23) to the observed incidence during two time 
periods and yielded estimates of 6.55% and 0.21% for the risks of developing exogenous and 
endogenous disease during one and a half years. 
It is difficult to interpret these disease risk estimates, given that they are based only 
on 2 data points, and that those in the infected category included individuals with signs of 
active disease, as diagnosed by X-ray. 
Schulzer et al [88] employed a similar approach to estimate the risk of uninfected in- 
dividuals developing drug-sensitive or drug-resistant disease during a five-year period in 
Korea. This used data from tuberculosis surveys carried out at 5-year intervals during the 
period 1961-1982, which provided information on drug-resistant and drug-sensitive cases 
which had emerged, or had remained prevalent between surveys in the population. 
Schulzer et al assumed that new drug-sensitive/resistant cases developed as a conse- 
quence of mixing between uninfected individuals and those drug-sensitive/resistant at the 
preceding survey. The corresponding combined risk of infection and of developing disease 
of the uninfected individual depended on the duration of time during which the case had 
been prevalent and his/her drug-sensitivity. 
Whilst this is a realistic assumption, Schulzer et al neglected the age of uninfected 
individuals at risk of infection and disease, and did not consider the effect of reinfection on 
the emergence of new cases. 
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1.3.3 Conclusions 
The objectives of most of the models of the transmission dynamics described in this section 
were to forecast the likely incidence of tuberculosis under various settings and thereby to 
assess the potential impact of different control programmes. Their main shortcoming was 
that they oversimplified the basic natural history of tuberculosis and were overambitious 
in their aims. Only three transmission models [75,76,83], for example, considered the 
dynamics in age-structured populations, and only the statistical models of Sutherland et 
al [7] and Krishnamurthy and Chaudhuri [87) considered the effect of reinfection on the 
disease incidence. As we saw in section 1.2.1, both age and reinfection are important in 
determining the risks of developing disease experienced. 
Intuitively, before we can assess the likely impact of a given intervention on the tuber- 
culosis situation in a given setting, it is necessary to understand how different factors, such 
as age, the different risks of developing 'primary', 'endogenous' and 'exogenous' disease and 
trends in the risks of infection determine the dynamics underlying the disease incidence. 
This has been the objective of the work described in this thesis. 
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Chapter 2 
Epidemiology of tuberculosis in 
England and Wales data sources 
and trends 
2.1 Mortality rates 
Age and cause-specific mortality rates were first published in England and Wales in 1838. 
These have been published in the Annual Report of the Registrar General for England and 
Wales until 1974 and in the OPCS Monitor thereafter. The numbers of deaths by age, 
sex and cause by single year since 1901 are also available in electronic form from OPCS as 
'historic data' files. 
From 1847 until 1901, mortality rates among 0-24 and 25-74 year olds were stratified 
into 5 and 10 year age bands respectively, and those among individuals aged over 75 years 
were combined into a single age band. Since 1901, the rates have been stratified into smaller 
age bands. 
Published mortality rates distinguished between 4 forms of tuberculosis until 1901, 
namely 'Pulmonary tuberculosis and phthisis (not otherwise defined)', 'Tuberculous menin- 
gitis', 'Tuberculous peritonitis, tabes mesenterica' and 'Other tuberculous diseases'. Tuber- 
culosis mortality rates from 1901 have been classified using the 'International Classification 
of Disease' codes (ICD codes), which have since undergone nine revisions. During the pe- 
riods 1901-1910 and 1940-1949,9 and 15 ICD codes respectively were used to categorize 
68 
400 
cý 300 
C) 
C) 
CD 
cx 
';; 200 
cz 
4- 
cz 
I-- 
oloo 
2 
1840 1860 1880 1900 1920 1940 1960 1980 2000 
Year 
Figure 2.1: Mortality rates from respiratory tuberculosis in males in England and Wales 
during the period 1847-1990. (Age-standardized to the 1901 male population. ) 
tuberculosis deaths, as compared with the 47 currently in use. 
Figure 2.1 summarizes the annual mortality rates from respiratory tuberculosis in males 
between 1847 and 1990, which have been age-standardized to the population in 1901. This 
shows that the mortality rate in England and Wales began to decline at least as early 
as the mid 1850s, despite the absence of effective treatment or vaccination. The peaks in 
mortality rates during the periods 1914-1918 and 1940-44 reflect increased mortality during 
the two World Wars. The dramatic decline in the mortality rate after 1950 occurred as a 
consequence of the introduction of specific anti mycobacterials for treating tuberculosis (see 
section 1.1)_ 
The corresponding mortality rates within individual age groups during the period 1850- 
1990 are summarized in Figure 2.2. These declined within each age group in a similar 
way to the mortality rates in the general population (see Figure 2.1), with sharp increases, 
especially among 15-24 and 25-34 year olds during the two World Wars. This excess 
mortality among young adults during the two World Wars is attributable to at least two 
factors. 
First, the rates refer to the civilian population only. This comprised a greater proportion 
of individuals with high risks of developing disease than during peacetime, since 'healthier' 
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individuals were conscripted into the army. 
Second, some deaths which occurred in or after combat, or as a consequence of desertion 
could well have been deliberately misdiagnosed as tuberculosis. This would have affected 
the mortality rates among young adults, given that they composed most of the military 
force. 
Figure 2.2 shows that throughout the time period considered, 0-14 year olds experienced 
lower mortality rates than did any other age group. The mortality rates also declined 
more rapidly for these individuals than for older individuals. This is seen more easily in 
Figure 2.3, which plots the age-specific mortality rates on a log scale. The reasons behind 
this are complicated and relate to the decline in the risk of infection and how it determined 
the age at initial infection. We return to this issue in greater detail in section 3.4.2. 
The decline in the risk of infection also led to changes in the age-specific pattern in the 
mortality rates when plotted by year and birth cohort. This is illustrated in Figure 2.4a, 
which plots the mortality rates by year for the period 1881-1935. For all the years shown, 
the age-specific mortality rates increased from adolescence to peak at about 40-50 years 
of age. The pattern changed during the first half of the 20th century, with relatively less 
decline among young adults than those of middle age. When these rates are plotted by 
cohort (Figure ?. 4b), the peak in mortality shifts from individuals aged 30-35 years for the 
early cohorts (born 1881-1890), to young adult life for those born after 1901. 
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Figure 2.4: Age-specific mortality rates from respiratory tuberculosis in males in England 
and Wales during the period 1881-1950, plotted by year and birth cohort. 
These figures are identical to those on page 30 in section 1.1. They have been reproduced here for 
convenience. 
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2.2 Notifications of Miberculosis 
2.2.1 Data sources and case definitions 
Respiratory and non-respiratory tuberculosis became notifiable in England and Wales in 
1912 and 1913 respectively. Until 1954, notifications were recorded on annual returns sub- 
mitted by local authorities to the Ministry of Health and the figures were published in the 
Annual Reports of the Ministry of Health. Since 1954, weekly and quarterly returns of 
notifications of tuberculosis have been sent by Medical Officers of Health to the General 
Register Office. The figures from quarterly returns have been included in the Registrar 
General's Statistical Review of England and Wales; from 1974, these have been published 
in the OPCS MB2 Monitor Series. 
Published notifications were not stratified by age and sex until 1938 and, until 1954, 
differentiated only between respiratory and non-respiratory forms of tuberculosis. Since 
1954, notifications have distinguished between tuberculous meningitis/CNS, respiratory and 
non-respiratory forms. 
Several changes in disease classification were introduced in 1982 as a result of ambiguities 
found during a national survey of tuberculosis notifications in 1978/9 [89,90]. The main 
changes are summarized below and are discussed in greater detail in the Report of the Joint 
Tuberculosis Committee of the British Thoracic Association (91]. 
1. Since 1982, notified cases with lesions in a respiratory and another site have been 
included in the totals of both respiratory tuberculosis and of 'other forms'. Until 1982, 
such cases were classified as having respiratory tuberculosis only, although official 
guidelines (OPCS 1974) stated that cases involving meningitis and CNS should have 
priority over "other forms", whilst "other forms" should have priority over "respiratory 
tuberculosis". 
2. Medical officers of health now have to state whether a tuberculous case has: 
(a) pulmonary lesions (with or without mediastinal nodes or pleural effusion or both), 
(b) mediastinal nodes or pleural effusion, or both, without a pulmonary lesion, 
(c) meningitis or CNS or both, 
(d) other forms alone, 
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(e) more than one of the above. 
All sites of involvement have to be specified if possible. Prior to this, there were no 
guidelines indicating whether individuals with isolated mediastinal lymphadenopathy 
or pleural effusion or both, should be included in the "respiratory tuberculosis" or 
"other form of tuberculosis" categories. 
3. Since 1982, all individuals with no evidence of disease but notified because they were 
taking chemoprophylaxis are excluded from published notifications. The 1978/9 sur- 
vey found that individuals taking chernoprophylaxis comprised about 3% of all noti- 
fications. 
4. Cases notified after death are now included in the published notifications; the policy 
was ambiguous until 1982, although the intention was that they should be reported 
separately from those notified whilst alive. 
There have been only two studies estimating the degree of undernotification. The first 
survey [92] reviewed all pathology reports between 1981 and 1984 at the Pathology de- 
partment at Edinburgh university, and found that of the 69 firmly diagnosed tuberculosis 
cases, 26 (40%) had not been notified. About a third of the 62 treated cases also escaped 
notification. 
The second survey reviewed all patients presenting at the London Chest Hospital or the 
Royal London group of hospitals in the East End of London, between January 1985 and 
December 1989 [93]. Information was available for 580 patients (95% of all cases), of whom 
426 (73%) had been notified, as compared with 177 out of 205 (84%) of smear-positive 
cases. 
In contrast with practice in England and Wales, microbiologists in Scotland have a 
statutory duty to notify all positive bacteriological results, which should compensate for 
any failure to notify by clinicians. Hence the lower estimate of the level of undernotification 
for Scotland is surprising. 
2.2.2 Trends in notifications 
Figure 2.5 compares the crude notification rates of respiratory tuberculosis in England 
and Wales until 1990 with the corresponding mortality rates. The latter differ from those 
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Figure 2.5: Crude annual mortality and notification rates (non-age standardized) of res- 
piratory tuberculosis in England and Wales between 1901 and 1990. 
shown in Figure 2.1 since the rates are not age-standardized: published notifications were 
not published by age and sex until 1938 (see page 74). 
In addition -to 
the obvious increase during the First World War, this shows that the 
notification rates increased in both 1923 and 1938 whereas the mortality rates declined 
throughout the time period considered. The increase in 1923 reflects a change in the regis- 
tration of tuberculosis cases: after 1923, the published notifications included cases identified 
from death certificates and other sources, which had not always been formally notified be- 
fore this time. The increase in 1938, just before the start of the Second World War, is 
attributable to improved case detection, as civilians were mobilized into the army and all 
conscripts were examined for signs of tuberculosis. 
Case detection improved further during the 1940s and throughout the 1950s after the 
introduction of mass miniature radiography into the civilian population in 1943. This is 
reflected in Figure 2.6, which compares the age-specific notifications of respiratory tubercu- 
losis in males in the general population in England and Wales during the period 1938-1989 
agaýinst the corresponding mortality rates. This shows that for most age groups, the noti- 
fication rates first decreased during the late 1940s/early 1950s, whereas the corresponding 
mortality rates had been declining at least since 1850. Case detection improved relatively 
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Figure 2.6: Published age-specific notification and mortality rates of respiratory tubercu- 
losis in males in England and Wales during the period 1930-1989. 
Note that published notifications for 45-64 year olds were first broken down into those for 45-54 and 
55-64 year olds after 1965. Hence the mortality data for 45-64 year olds in this figure are stratified 
differently from those in Figure 2.4. 
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slowly for individuals aged over 60 years, as indicated by the fact that the notifications first 
exceeded the mortality rates after 1950 and started to decline during the 1960s. 
The most rapid decline in the notification rates during the 1950s occurred among 15-24 
year olds (see Figure 2.6). This is a consequence of two factors. First, BCG vaccination 
of tu berculin- negative 13 year olds was introduced in 1954 in England and Wales, which 
protected 84% of adolescents against tuberculosis during the first five years following vac- 
cination in the UK MRC BCG trial [38]. Second, the introduction of chemotherapy in 
1950 (see section 2.3) accelerated the decline in the annual risk of infection in England and 
Wales, and led to a reduction in the incidence of 'primary' disease in all age groups. This 
particularly affected notifications in adolescents, since they faced high risks of developing 
disease after infection and a greater proportion of their disease was probably 'primary' in 
origin, as compared with that in older individuals. This issue is discussed in greater detail 
in section 3.4.2. 
The decline in notifications in most age groups in the general population slowed down 
during the 1960s at the same time as immigration increased from regions with higher tu- 
berculosis disease prevalence, in particular, the Indian subcontinent (ISC). Routine noti- 
fications are not broken down by ethnic group and the extent of the contribution from 
immigrants was not known until a national survey of tuberculosis notifications was carried 
out between February and April in 1965 [94]. Further surveys of tuberculosis notifications 
were carried out during 4 months in 1971 and over 6 months during the period 1978-9, 
in 1983,1988 and 1993 [89,95-98]. Two nationwide tuberculosis surveys had been carried 
out earlier during the period 1955-56 and in 1963, but these focussed on the prevalence 
of drug-resistance among patients treated for bacteriologically-confirmed disease in chest 
clinics [99,100]. 
The relative contribution of the ISC to notifications of respiratory and non-respiratory 
tuberculosis found by the surveys are summarized in Table 2.1. This shows that 10% of 
all tuberculosis notifications (380 out of 3,806) in 1965 came from the ISC population. 
The contribution varied by type of disease, with the ISC constituting 21% and 5% of the 
notifications of non-respiratory and respiratory forms respectively in 1965. By 1971t 45% 
and 18% of notifications of non-respiratory and respiratory tuberculosis respectively came 
from the ISC population, as compared with 57% and 33% by 1988. 
The ISC population constituted a small proportion of the general population in these 
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Table 2.1: Summary of notification rates of all forms, respiratory and non-respiratory 
forms of tuberculosis in the general population in England and Wales during the period 
1965-1988, together with the relative contribution from the ISC population. 
Year All forms Respiratoryt Non-respiratoryt 
Notif rate % from Notif rate % from Notif rate % from 
(per 100,000) ISC (per 100,000) ISC (per 100,000) ISC 
1965 31.87 10 27.6 5 4.3 21 
1971 22.4 24 18.2 18 4.3 45 
1978/9 16.4 35 12.7 31 4.9 52 
1983 12.0 37 9.1 32 4.0 52 
1988 8.4 39 6.9 33 3.0 57 
Data compiled from OPCS publications (see section 2.2.1) and from reports from the national 
surveys [89,94-97]. 
Ilnclude notifications involving both respiratory and non-respiratory sites. 
Note also that notifications after 1978/9 are for England only; prior to this, they refer to England 
and Wales. 
years (under 2% and about 3% of that in 1978/9 and 1988 respectively) and, given their 
large contribution to the reported tuberculosis incidence in England and Wales, had higher 
notification rates than the white ethnic group. This is illustrated in Table 2.2, which 
summarizes the crude notification rates of all forms of tuberculosis for the ISC and white 
ethnic groups found in each survey. This shows that the notification rates were about 178 
and 6.9 per 100,000 in 1983 in the Indian and white ethnic populations respectively. This 
corresponds to a difference by a factor of 38. By 1988 the notification rates in these two 
populations differed by a factor of about 28. 
Springett et al performed separate analyses of the notifications of all forms of tuberculosis 
in the white ethnic group between the period 1953 and 1983 and estimated the rate of decline 
in individual age groups [101]. 1953 was selected as the starting point since it predated both 
the large-scale immigration from the Caribbean and the Indian subcontinent to England 
and Wales, and the introduction of BCG vaccination of tuberculin-negative 13 year olds. 
This implicitly assumed that the age-specific notifications for the general population in 1953 
approximated those in the white ethnic group. Results from a similar comparison between 
the corresponding notifications between 1978/9 and 1988 are provided in the report of the 
national survey in 1988 [97]. The average annual declines for each age group and for each 
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Table 2.2: Crude annual notification rates (per 100,000) of all forms of tuberculosis in the 
white, Indian and Pakistani ethnic groups found during the national surveys of notifications 
between 1965 and 1988 in England and Wales. 
Year White 
Ethnic groupt 
Indian Pakistani 
1965 27.6 324.0 684.0 
1971 15.6 414.0 840.0 
1978/9 9.4 354.0 353.0 
1983 6.9 178.0 169.0 
1988 4.7 134.6 100.5 
I determined by an individual's place of birth for surveys in 1965 and 1971; by individual's place 
of birth and that of his/her parents for subsequent surveys. Population estimates: for 1965 and 
1971 - from censuses carried out in 1961 and in 1971 respectively; for 1978/9 - from a National 
Dwelling and Housing Survey in 1978; for 1983 and 1988 - on the basis of Labour Force Surveys 
in these years. 
period are summarized in Table 2.3. 
This shows that the fastest decrease in the notification rate occurred among 15-24 year 
olds during the period 1953-1965. This is consistent with findings in this age group in 
the general population (see page 78). The fastest decline among 25-34 year olds occurred 
during the period 1965-1971. This is attributable to the introduction of BCG vaccination 
in 1953: most of those aged 25-34 years in 1965 had not been vaccinated, whilst many of 
their counterparts in 1971 were protected by vaccination. 
In any time period, the rate of decline in the notifications was slowest for those aged 
over 65 years. Most individuals in this age range had been infected much earlier in life 
and hence were at risk only of developing endogenous disease or of reinfection followed by 
exogenous disease. Given the low risk of infection at this time, much of the disease among 
these individuals was probably attributable to endogenous reactivation. Hence the slow 
decline in the notification rates among those aged over 65 years reflects the gradual change 
in the corresponding prevalence of infection. This is discussed by Springett (102]. 
45-54 and 55-64 year Olds experienced the most rapid declines in the notification 
rates during the period 1978/9-1983. As pointed out by Springett et at [1011, most Of 
these individuals experienced rigorous tuberculosis examinations during the war years, and 
chemotherapy was available from the 1950s. This suggests that relatively few of these indi- 
viduals had undetected and untreated lesions and hence were at risk of relapse later on in 
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Table 2.3: Average annual decline in the notifications of all forms of tuberculosis by age 
in white males in England and Wales between 1953 and 1988, as estimated by Springett et 
al [101] and MRC [97] 
Age group Average annual decline (% pa) 
(years) 1953-1965 1965-1971 1971-1978/9 1978/9-1983 1978/9-1988 
0-14 13.7 8.7 8.4 6.2 7.2 
15-24 15.3 10.1 10.4 8.3 13.8 
25-34 10.8 13.4 7.3 6.3 9.9 
35-44 8.4 9.4 9.6 7.5 7.5 
45-54 7.9 9.8 5.9 12.3 8.0 
55-64 6.4 9.3 2.9 12.4 10.5 
65 and over 3.7 6.0 1.7 3.8 3.7 
life. This argument may be justified, given that the rate of decline in the notification rate 
in this age group remained high between 1983 and 1988. 
2.2.3 Discussion 
Results from the national surveys suggest that tuberculosis notifications in England and 
Wales since 1965 had been influenced by contributions from the immigrant population. 
Given that immigrants experienced different risks of infection from individuals born in the 
UK, any analysis of the transmission dynamics of tuberculosis has either to take this into 
account or just consider one ethnic group. For this reason, this thesis analyses tuberculosis 
only in the white ethnic group. Given gender differences in the epidemiology of tuberculosis 
(see page 29), we further restrict our analyses to white ethnic males. 
The analyses of Springett et al were carried out on notifications of all forms of tuberculo- 
sis. Notifications of respiratory tuberculosis are more relevant for studying the transmission 
dynamics of Al. tuberculosis, since only aý small proportion of extrapulmonary forms are 
infectious (see section 1.1). The survey in 1988 provides the only data on respiratory tu- 
berculosis for the white ethnic population, and hence the notification rates for earlier years 
have to be estimated from those of all forms of tuberculosis. 
Reasonable approximations can be derived by assuming that notifications of respiratory 
tuberculosis declined from their level in 1953 at the same rate as those of all forms of 
tuberculosis, summarized in Table 2.3. The estimates derived in this way are compared 
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Figure 2.7: Comparison between age-specific notification rates of respiratory tuberculosis 
in males in the general population in England and Wales and those estimated for the white 
ethnic group, assuming that they declined from their level in 1953 at the rates given in 
Table 2.3. 
Note that notification rates for 45-54 and 55-64 year olds in 1953 (denoted by +) were assumed to 
be 95% of those of all forms of tuberculosis, given in Springett et al [101] (see page 83). 
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against the corresponding notifications in the general population in Figure 2.71. Note that 
tuberculosis notification rates for 45-54 and 55-64 year olds in the general population were 
not officially published until 1965- see also Figure 2.6. The notification rates of respiratory 
tuberculosis for these age groups in 1953 were derived by assuming that they constituted 
95% of those of all forms of tuberculosis. The notification rates for the latter are provided 
by Springett et al [101]. This assumption is reasonable, given that respiratory tuberculosis 
comprised 95% of notifications of all forms of tuberculosis for 45-64 year olds in 1953. 
Figure 2.7 shows that the difference between the notification rates among white ethnic 
males and those in the general population was greatest among 15-24 and 25-34 year olds 
after the mid 1960s, and was smaller for older individuals. This suggests that notifications 
in the general population among individuals aged over 55 years after 1965 accurately reflect 
those in the white ethnic group. 
'The method used to generate these data was validated by comparing the notification rates estimated 
for 1988 against those from the national survey in this year, obtained directly from Dr J Watson and Mr A 
Charlett at CDSC. The notification rates derived using this method differed by upto 0.7 cases per 100,000 
for each age group from those in the national surveys. 
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2.3 Annual risk of infection 
2.3.1 Pre-chemotherapy era 
There are few data on the annual risk of infection in England and Wales during the pre- 
chemotherapy era. The national survey of tuberculin sensitivity carried out during the 
period 1949-1950 [103] provided the first indication of the nationwide prevalence of tuber- 
culous infection. This covered 22 urban and rural areas and a population of 94,2215-20 year 
olds. Individuals were considered tuberculin-positive if they responded with an induration 
of 5mm. or more to tuberculin jelly (equivalent to an intradermal test with 10TU) or to a 
Mantoux test with 100TU of Old Tuberculin (0.1ml of 1/100 dilution). 
Figure 2.8 shows the age-specific percentage of tu berculin- positive males found in the 
south urban, northern urban and in rural areas in England. About 30% of 11-12 year old 
males in south urban England were considered tuberculin-positive, as compared with about 
44% of those in rural areas. Rural areas also had the highest prevalence of tuberculin- 
positive males/individuals in other age groups. These differences reflect regional variations 
in the interpretation of tuberculin reactions, and the greater prevalence of infection with 
Al. bovis in rural areas, as compared with urban areas. The latter has been attributed to 
the greater consumption of raw milk from non-attested cattle in rrural areas 
[103]. 
The annual age-specific incidence of infection during the survey was estimated by taking 
the ratio between the prevalence of tu berculi n- negative individuals in adjacent 2-year age 
groups (e. g. 5-6 year olds and 7-8 year olds), who were tested simultaneously [103]. This 
estimate did not account for the effects of tuberculin boosting and reversion in tested 
individuals, and implicitly assumed that the prevalence of infection in a given age group 
did not change over time, which is unrealistic. Hence the estimates of the risks of infection 
obtained (e. g. 5% and 15% for 17-18 year old males in rural and urban areas respectively 
and about 4% for 5-6 year olds in both areas) probably overestimated the true values. 
Styblo et al [62] found that tuberculous meningitis mortality rates among 0-4 year olds 
provide a reliable indication of the annual risk of infection during the pre-chemotherapY era. 
Tuberculous meningitis is a severe extrapulmonary form of tuberculous disease, affecting the 
central nervous system (CNS) [10]. The time interval between infection and disease onset is 
approximately 3 months [11] and without treatment, its case fatality approaches 100% (see 
section 1.1). Tuberculous meningitis was responsible for 48-62% of all tuberculosis deaths 
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Figure 2.8: Age-specific prevalence of tuberculin- positive males in England and Wales, as 
found by the national tuberculin survey during the period 1949-50 [103]. 
among 0-4 year olds in the Netherlands between 1905 and 1940 [104]. Styblo et al [62] 
found that the tuberculous meningitis mortality rate in 0-4 year olds during the period 
1920-1949 in the Netherlands was roughly 1% of the corresponding annual risk of infection, 
and depended on prevailing social conditions. During a harsh famine in 1945, for example, 
the ratio between the two increased to 2%. This relationship implies that if individuals 
experience identical risks of infection in a given year, irrespective of age, then 1% of 0-4 
year olds who become infected with the tubercle bacillus develop tuberculous meningitis 
and die if not treated. 
A similar correlation between the annual risk of infection and tuberculous meningitis 
mortality rates existed in Sweden between 1925 and 1935 [105]. The two did not correlate 
as well thereafter as a result of specific control measures aimed at reducing exposure of 
infants to infection in the community (e. g. case isolation, BCG vaccination of children in 
tuberculous homes and the compulsory pasteurization of milk for consumption by 1939). 
These measures accelerated the decline in tuberculous meningitis mortality rates, but had 
a lesser effect on the risk of infection. 
Figure 2.9 summarizes the tuberculous meningitis mortality rates among 0-4 year old 
males in England and Wales during the period 1860-1957. Before 1920, deaths from tuber- 
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Figure 2.9: Mortality rates from tuberculous meningitis in 0-4 year old males in England 
and Wales during the period 1860-1957. 
culous meningitis were classified separately from other deaths. After 1920, published tu- 
berculous meningitis deaths were grouped with other deaths from tuberculosis of the CNS. 
Given that tuberculous meningitis is the commonest form of tuberculosis of the CNS [10], 
the two classifications should be comparable and there is no apparent discontinuity in the 
trend in mortality before and after 1920. 
Figure 2.9 shows that the tuberculous meningitis mortality rate declined steadily until 
1950, peaking slightly during the two World Wars. Similar increases in mortality rates from 
other forms of tuberculosis in other age groups in England and Wales were also observed 
during these time periods (see section 2.1). Regression analyses of the mortality rate during 
the period 1901-1950 show that it declined by 4.0% pa (95% Cl [3.8,4.2]) and by about 2% 
pa before this. Application of the 1% correspondence between the tuberculous meningitis 
mortality rate and the annual risk of infection implies that the latter was about 14% in 
1901, declined to about 6% in 1920 and reached 2% in 1949. This estimate for 1949 is lower 
than that obtained from the national tuberculin survey during the period 1949-50, and is 
perhaps more realistic. 
This risk of infection for 1901 (i. e. 14%) seems extremely high and exceeds the level 
found in several developing countries in recent years (see e. g. [25,26]). Similarly high risks 
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of infection (11%) were estimated for the Netherlands for 1911 on the basis of data on the 
prevalence of tuberculin sensitivity among schoolchildren and military recruits [62]. Even 
higher risks of infection (25%) were estimated among Eskimos in Alaska the 1950s (see 
section 1.1). This suggests that the high risk estimated for England and Wales in 1901 is 
not unrealistic. 
As we have seen, tuberculous meningitis mortality data can only be used to infer the 
annual risk of infection in the absence of treatment and hence, after 1950, alternative 
measures are required to estimate the risk of infection. 
2.3.2 Chemotherapy era - after 1950 
The second national tuberculin survey was carried out during the period 1971-1973, and 
given wide-spread coverage of BCG vaccination of 13 year olds since 1954 (see section 2.4), 
covered only 6 and 13 year olds [106]. The latter were tested prior to vaccination. The 
survey covered 29 local health authorities and tested 24,221 children with two Mantoux 
tests, using 5TU of human PPD and 5TU of Battey PPD. Individuals reacting with an 
induration of 8mm or more to human PPD were considered tuberculin-positive2. 
Of 8,699 unvaccinated 6 year olds in the "UK national group" (children who, together 
with their parents, were born in the UK), 0.31% were tu berculi n- positive, as compared with 
1.14% of the 11,519 children tested at age 13 years. Christie and Sutherland estimated from 
these data that the annual risk of infection in the UK national group had been about 0.18% 
(CI 0.13-0.24) in 19GO, and 0.089% (CI 0.06-0.12) and 0.045% (CI 0.03-0.06) in 1965 and 
1970 respectively [106]. This corresponded to an decline of about 13% pa, which is similar 
to that seen in the Netherlands during this time (see section 1.3.2) [84]. 
Estimates of the risk of infection for other ethnic groups were slightly higher, but more 
unreliable and difficult to interpret, given that they were based on a small sample size (e. g. 
a total of 303 children born in the UK but belonging to the Asian and African group). 
Given the high tuberculous meningitis case fatality rate during the pre-chemotherapy 
era, notification rates in an efficient disease notification system should directly reflect the 
level of the mortality rates, and hence the level of the annual risk of infection, if treatment 
2 The report points out that the definition of tuberculin-positivity also depended on the type of induration 
resulting from human PPD and the diameter of induration to Battey PPD, but further details have never 
been published. 
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Figure 2.10: Comparison between mortality rates of tuberculous meningitis in 0-4 year 
old males in England and Wales until 1957 and the corresponding notification rates from 
1954. 
not been available. 
Figure 2.10 summarizes the notification rates of tuberculous meningitis in England and 
Wales among 6-4 year olds after 1954, together with the mortality rates until 1957. This 
shows that the notification rate declined more rapidly during the 1950s than the corre- 
sponding mortality rate before 1950. This is attributable to three factors: 
1. deficiencies in the notification system, which meant that a proportion of tuberculous 
meningitis cases were never reported, 
2. a genuinely faster decline in the annual risk of infection after 1950, as a consequence 
of the introduction of chemotherapy, which reduced dramatically the prevalence of 
sources of infection by shortening the duration of infectiousness of infectious pul- 
monary cases, and 
3. BCG vaccination of contacts of infectious cases introduced in 1949. Its protection 
against tuberculous meningitis among infants is estimated at 65-95% [107], and hence 
notifications among 0-4 year olds after 1950 exclude those who perhaps would have 
developed disease before the introduction of BCG vaccination. 
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This suggests that tuberculous meningitis notification rates are not directly comparable 
to corresponding mortality rates in 0-4 year olds before 1950. Hence the decline in tuber- 
culous meningitis notification rates during the 1950s probably slightly overestimates the 
actual decline in the annual risk of infection. 
It is difficult to interpret the slow rate of decline in the tuberculous meningitis notifica- 
tion rates after the mid 1960s, as there are few cases both in the white ethnic group and in 
the immigrant population. This suggests that notification rates of tuberculous meningitis 
in England and Wales after the mid 1960s cannot provide reliable estimates of the true level 
of the annual risk of infection. However, tuberculous meningitis notifications until this time 
provide a useful indication that the annual risk of infection declined at a faster rate after 
1950, as compared with that before this time. 
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2.4 BCG vaccination data 
Table 2.4 summarizes the main events relating to BCG vaccination in England and Wales 
since 1949. These events are discussed in greater detail below. 
BCG vaccination was first officially introduced in England and Wales in 1949. Coverage 
was initially restricted to individuals considered to be at high risk (i. e. medical students, 
nurses, and contacts of infectious pulmonary cases), and was extended to tu berculin- negative 
13 year olds in 1954, with the aim of preventing high morbidity rates during adolescence and 
early adult life. In 1959, vaccination was extended to cover children aged over 14 years who 
were still at school, students at further educational establishments, and children below age 
13 years. The last amendment enabled entire school classes to be vaccinated simultaneously, 
rather than in stages. 
The vaccination policy varies between regions in England and Wales. A survey of all 
district health authorities in 1984 found that most (184 out of 201) were vaccinating 11-14 
year olds, and 5 had stopped routine vaccination of schoolchildren altogether. Table 2.5 
summarizes the age groups covered in these authorities. According to the most recent 
survey [108] 15 health authorities had stopped vaccinating schoolchildren by 1990, a further 
13 were reviewing their policy and the remaining 169 questioned were routinely vaccinating 
10-14 year olds. 
A summary of the total numbers of individuals vaccinated under the schools and contacts 
scheme has been published annually in the Chief Medical Officer's Report to the Government 
until the 1980s. These data have also been published in the Digest of Health Statistics 
for 1970-1972. The most detailed data are published in the "Health and Personal Social 
Services Statistics for England and Wales" from 1972. These are broken down according to 
the number of individuals skin tested, found to be tu berculi n- positive, tuberculin negative, 
and the number vaccinated under both the schools and contacts schemes. These data are 
not broken down by age, although most of those vaccinated under the schools scheme were 
aged 13 years at least until 1959. From 1974, this detalled breakdown is provided only for 
England. 
Since its introduction, vaccination coverage of schoolchildren increased gradually. In 
1954,42,735 children were vaccinated, as compared with 443,236 children in 1959. Estimates 
suggest that by 1962, about 60% of each cohort had been vaccinated, rising to about 
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Table 2.4: Summary of the main events in the history of BCG vaccination in England and 
Wales. 
Year Event 
1949 Introduction of vaccination (fluid vaccine from State Serum institute, Copen- 
hagen) of individuals at high risk, i. e. hospital nursing staff, medical students 
(by special arrangement with the Ministry) and contacts of infectious pul- 
monary cases. Total vaccinated: 1,000 (P-. half were nursing staff, the rest 
contacts) - 
1950 MRC BCG trial of adolescents started. 
1953 Ministerial approval for vaccination of children towards year preceding 14th 
birthday. LHAs to apply to government for permission to introduce vacci- 
nation in schools under their jurisdiction. Parental consent also required. 
1954 First year of vaccination among schoolchildren - 43,765 children vaccinated. 
2 LIIAs granted permission to vaccinate diabetic schoolchildren outside the 
official age range. 
1956 Trials of British freeze-dried vaccine begun. Initial results from MRC trial 
confirms protection for the first 2 and a half years. 
1958 2 vaccines in use: freeze-dried and Copenhagen. Advantage of free-dried 
vaccine - can be stored for longer. 
1959 Vaccination extended to children aged over 14 years still at school and stu- 
dents of FE establishments, and those aged under 13 years. 
1965 Immigrants of school age and newly arrived adults to be tuberculin tested 
and vaccinated if necessary. 
1972-1983 5 LHAs suspend vaccination of schoolchildren (2 in 1972, one each in 1977, 
1980 and 1983). 
1983-1900 11 more LHAs suspend vaccination; 1 MIA reverses suspension made during 
1972-1983. 
1985 Joint Committee on Vaccination and Immunization (JCVI) recommends vac- 
cination to be discontinued in 1990 if decline in notifications continues. 
1990 JCV1 recommends BCG vaccination to continue until results from national 
survey in 1993 available. 
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Table 2.5: Summary of BCG vaccination policy in 201 districts in England and Wales in 
1984, as found by Miller et al [109]. 
Number of 
districts Policy 
Schools scheme: 
184 11-14 years (mainly 13 year olds) 
8 10-11 years 
1 5-13 years 
2 5 years 
1 newborn, school entrants and 13 year olds 
Neonates: 
98 neonatal contacts and/or immigrants 
9 all neonates 
88 no routine vaccination of neonates 
6 neonatal vaccination under consideration 
70% by 1970 and has remained constant at 75% since then [110]. It is likely that the 
corresponding proportions for tuberculin-negative individuals in each cohort are slightly 
greater; breakdowns for these individuals are not published. 
Data on the proportion of individuals found to be tuberculin-positive prior to testing are 
difficult to interpret and cannot be used to estimate the annual risk of infection for several 
reasons. First, the definition of a positive reaction varies between regions and according 
to the test used. Second, the proportion of individuals found to be 'tu berculi n- positive' 
under either the schools or contacts scheme are not broken down by age - an increasing 
proportion of individuals tested under the former after 1960 were aged 10-24 years. Third, 
many individuals tested after 1960 were from the immigrant population, who faced different 
risks of infections earlier in life. For reference, Figure 2.11 summarizes the prevalence of 
tuberculin sensitivity found among individuals tested under the schools scheme. This shows 
that the combination of the above factors led to a prevalence of tuberculin sensitivity which 
was far in excess of that found among 13 year olds during the national tuberculin survey 
during the period 1971-1973 [106] (see section 2.3.2), indicating that the data are unreliable. 
Data on the efficacy of BCG vaccination among adolescents in England and Wales is 
provided by the UK MRC BCG trial during the 1950s. This found that among 13,598 
individuals who were vaccinated with BCG, 84% were protected during the first 5 years, 
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Figure 2.11: Prevalence of tuberculin sensitivity among school children and students tested 
as part of the national BCG vaccination scheme. 
and 69% and 59% during the following 2 five year periods [38]. Estimates of the efficacy 
thereafter are unreliable, as there were only 5 cases in the unvaccinated group, and 6 among 
those vaccinated. This corresponds to an overall vaccine efficacy of about 77% during follow- 
up. 
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Chapter 3 
Development and evaluation of a 
model for tuberculosis - TBDYN3 
3.1 Formulation of TBDYN3 
3.1.1 Definitions of 'primary' and 'post-primary' disease 
Transmission models typically describe a disease process in a population by modelling the 
transitions of individuals between different states, i. e. those susceptible to infection, those 
infected (but not diseased) and those who are diseased (see section 1.3). 
The model of the transmission dynamics of M. tuberculosis presented here, called TB- 
DYN31, considers an age-structured population, and subdivides the states so as to reflect 
the different risks of developing disease according to time since infection and reinfection. 
TBDYN3 extends the work of Sutherland et al (7], who were the first to estimate the rela- 
tive contribution of 'primary', 'endogenous' and 'exogenous' forms to the disease incidence 
in any country (see section 1.3.2). Before describing the structure and assumptions of TB- 
DYN3, we first discuss how the risks of developing disease differ between individuals and 
how they relate to the definitions of primary, endogenous and exogenous disease. 
Tuberculous disease is conventionally defined as either 'primary' (occurring during the 
first five years after infection) or 'post-primary' (occurring more than five years after infec- 
'Originally, the name TBDYN3 reflected the model's status as the third stage in an evolution. The 
name now reflects the fact that it describes the dynamics of tuberculosis, and assumes that there are three 
mechanisms through which individuals can develop disease. 
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tion) [16] (see section 1.1). These formal definitions stem from Holm in 1969 [16], although 
the clinical distinction between the two forms is often unclear in practice. Post-primary 
tuberculosis is generally associated with disease in the upper part of the lung [111] and 
cavitation [112], for example, but both can also occur shortly after initial infection. Post- 
primary tuberculosis is thought to occur either through endogenous reactivation or after 
exogenous reinfection [16], and Holm defined exogenous disease as disease occurring within 
five years of reinfection. These definitions, and the analyses of Sutherland et al on the risks 
of developing disease, reflect the views that 
1. individuals experience an initial high risk of developing (primary) disease after infec- 
tion, which then falls to a lower unchanging risk of endogenous reactivation after a 
few years, and 
2. reactivation and reinfection are generally rare during the first few years after infection. 
The formal definitions of 'primary', 'endogenous' and 'exogenous' disease lead to several 
inconsistencies when considering individuals who experience two or more disease episodes 
within five years of initial infection or reinfection. Both episodes experienced by an individ- 
ual who develops disease during the first and fifth years after initial infection, for example, 
would be defined as 'primary' in origin, although the risk of developing the second episode 
could well have differed from that of someone who was still at risk of developing their first 
(primary) episode during the fifth year after infection. On this basis, the second disease 
episode within five years of infection might also be defined as endogenous in origin, if the 
individual did not experience any reinfection, and exogenous otherwise. 
The situation is equally complicated for an individual who develops disease within a year 
of reinfection, but recovers and experiences disease again two years thereafter (i. e. within 
five years of reinfection) without having experienced further reinfection. The second disease 
episode could be defined as 'endogenous reactivation of the reinfection event', but, by the 
definition of Holm [16], would be defined as exogenous disease. 
, 
The conventional definition of post-primary disease implies that reinfection cannot occur 
within five years of infection. It is likely that reinfection can occur at any time, although it 
may be less likely than initial infection once an individual has mounted an immune response 
to M. tuberculosis antigens. The effect of reinfection on the disease risk whilst an individual 
is still at a high risk of developing disease from the preceding infection or reinfection event, 
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is unclear. It is also unclear whether the first (primary) disease episode within 5 years 
of initial infection among individuals who have also been reinfected can be attributed to 
bacilli from the initial infection, from the subsequent reinfection or from both infection and 
reinfection events. This issue becomes important when considering the incubation period, 
serial interval and basic and net reproduction numbers for tuberculosis. 
From these perspectives, it is unrealistic to apply the same 5-year cut-off criterion, used 
for defining 'primary', 'endogenous' and 'exogenous' forms to distinguish between different 
risks of developing disease. It is preferable to assume reinfection can also occur less than 
five years after initial infection and that the disease risks experienced differ according to 
whether individuals are at risk of developing their first primary episode, endogenous or 
exogenous disease, where 
1. exogenous disease is redefined as the first disease episode within five years of 
reinfection, and 
2. the definition of endogenous disease (by convention, disease occurring five or more 
years after initial infection or most recent reinfection) is extended to include disease 
occurring within five years of infection or reinfection, if an individual has 
already experienced disease but no further reinfection in the meantime. 
The disease states modelled in TBDYN3 reflect these assumptions concerning the dif- 
ferent risks of developing disease, and are described fully below. 
3.1.2 General structure of TBDYN3 
Figure 3.1 shows the overall structure of TBDYN3, in terms of the transitions between 
the individual disease states. Following the discussion in section 2.2, we will restrict our 
analyses to respiratory forms of tuberculosis in the white ethnic male population in England 
and Wales. 
Diseased individuals are divided into three categories: those experiencing their first 
primary episode (P), endogenous disease (E,,, ), or exogenous disease (E., ), where endogenous 
and exogenous disease are as defined by points 1 and 2 above. 
Similarly, TBDYN3 separates infected individuals into three categories, which reflect 
those at risk of developing each form of disease, namely: 
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Figure 3.1: Schematic diagra m showing the overall structure of the TBDYN3 model. 
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1. Those in the (recently) infected class (I), defined to be at risk of developing their first 
primary episode, 
2. Those in the 'latent' class (L), defined to be at risk of developing endogenous disease 
or of being reinfected, and 
3. Those in the (recently) reinfected class (1), defined to be at risk of exogenous disease. 
Individuals first enter the 'latent' class either five years after initial infection in the 
absence of any disease, or after recovering from their first primary episode. Similarly, they 
return to the 'latent' class after recovering from endogenous or exogenous disease, or five 
years after reinfection in the absence of any disease in the meantime. 
It is recognized that in reality, individuals can probably be reinfected at any time (see 
section 3.1.1). For simplicity, we assume that individuals cannot be reinfected whilst they 
are experiencing disease, or whilst they are at an already high risk of developing their 
first primary episode or exogenous disease (i. e. whilst in the infected or reinfected classes 
respectively). Individuals reinfected whilst in the 'latent' class enter the reinfected class R, 
where the risk of developing exogenous disease behaves analogously to the risk of developing 
the first primary episode after initial infection. 
Two further states are included in TBDYN3: those uninfected (i. e. 'susceptible' to first 
infection), U, and those protected by BCG vaccination (V). It is assumed that all individ- 
uals are born susceptible, and that once infected, they retain infection for life. Individuals 
effectively vaccinated (determined by the vaccine coverage and the vaccine efficacy) are as- 
sumed to be protected for life. The effects of these assumptions on model predictions are 
discussed in section 3.3.3. 
Appendix A. 1 summarizes the partial differential equations describing the general for- 
mulation of TBDYN3. Table 3.1 summarizes the names and definitions of the individual 
disease states. Table 3.2 summarizes the transition variables between these states, which 
are discussed in greater detail below. 
3.1.3 Transitions between disease states 
The parameter i(t) determines the rate at which uninfected or 'latent' individuals become 
infected or reinfected respectively. This depends only the time t and is not defined here 
in terms of the contact between uninfected and 'infectious' individuals. This assumption 
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Table 3.1: Definitions of class variables used in TBDYN3 
Variable name Definition 
B(t) Number of live births at time t. 
U (a, t) Number of uninfected individuals of age a at time t. 
V (a, t) Number of individuals of age a at time t who are protected by BCG 
vaccination. 
I (a, t, s) Number of individuals of age a at time t who have been infected for 
time s (: 5 5 years) without having yet developed disease. 
P (a, t, Number of individuals of age a experiencing their first primary episode 
at time t, who have been diseased for time h. 
L (a, t) Number of individuals of age a at time t in the 'latent' class i. e. those 
who have either just recovered from their first primary episode, or who 
have been infected for more than five years. 
1, (a, t, s) Number of individuals of age a at time t, who have been reinfected for 
time s (5 5 years) and who have not yet developed exogenous disease. 
E-- (a, t, Number of individuals of age a with exogenous disease at time t, who 
have been diseased for time h. 
E,, (a, t, Number of individuals of age a who have endogenous disease at time t, 
who have been diseased for time ý. 
is modified in Chapter 5, when we consider the net and basic reproduction numbers for 
tuberculosis. The model assumes homogeneous mixing between individuals, an assumption 
which is probably more appropriate for the early part of this century in England and Wales, 
when the risks of infection were high, than for recent years. The risk of infection may in 
fact vary slightly with the age of individuals, but the extent and nature of this variation is 
unclear [113]. 
In reality, the infection rate for uninfected individuals probably exceeds the reinfection 
rate for those in the 'latent' class (see section 3.1.1). There are no empirical estimates of the 
magnitude of the difference, and so we assume, as a first approximation, that the infection 
and reinfection rates are identical. 
Individuals in the infected class I develop their first primary disease episode at a rate of 
dp(a, s), which depends on the age at infection and declines with time since infection. The 
rate in each year following first infection is a factor of dp(a, 0) (i. e. the rate immediately 
after first infection). Approximate values for these factors (relative rates) were obtained 
from the estimated 'relative risks' of developing disease in each year following tuberculin 
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Table 3.2: Definitions of transition variables used in TBDYN3. 
Variable name Definition 
Rate at which uninfected and 'latent' individuals become infected and 
reinfected respectively at time t. 
v (a, t) Proportion of uninfected individuals of age a who have been immunized 
at time t. 
dp (a, s) Rate at which individuals infected at age a who have been infected for 
time s develop their first primary disease episode. 
r (a, t, Rate at which individuals of age a at time t recover from their first 
primary episode, exogenous and endogenous disease, at time h after 
disease onset. 
kL(s) Rate at which individuals who have been infected or reinfected for time S 
without developing disease move into the 'latent' class. kL(S) =-- 0 if 
0<s<5 andoofor s=5 years. 
d.,, (a, s) Rate at which individuals reinfected at age a, who have been reinfected 
for time s develop exogenous disease. 
d,, (a) Rate at which 'latent' individuals of age a develop endogenous disease. 
d+ (a) Relative contribution of sputum-positive forms to the disease incidence 
among individuals of age a. 
tn+ (t 19) Mortality rate of among sputum-positive cases at time t and time A 
since disease onset. 
(a, t) Mortality rate of sputum-negative and non-diseased individuals in the 
general population of age a at time t. 
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Figure 3.2: Approximate risks of developing the first primary disease episode, relative to 
those experienced during the first year after infection, as estimated from the distribution 
of the time interval between 'tuberculin conversion' and disease onset of those who were 
tuberculin-negative at the start of the UK MRC BCG trial [29]. 
conversion among those who were tuberculin-negative at the start of the UK MRC BCG 
trial [29], as shown in Figure 3.2. The 'relative risk' for a given year after 'conversion' is 
assumed to be the ratio between 
1. the proportion of the total disease incidence among initially tuberculin-negative indi- 
viduals which occurred in that year following 'conversion, and 
2. the corresponding proportion which occurred during the first year after 'conversion'. 
The estimates provide only a rough indication of the magnitude of the actual 'relative risks'; 
these could not be estimated more accurately given that the date of tuberculin 'conversion' 
was not established for almost half of the initially tuberculin-negative individuals who de- 
veloped disease in the UK MRC trial (see section 1.2.1.1). The data from the trial were 
not stratified according to the type of disease individuals developed in each year following 
tconversion', and hence we assume that similar estimates for the 'relative risks' would be 
obtained for respiratory forms alone. 
According to the approach employed here, the rate at which infected individuals develop 
101 
1 
isý 
mwo CL 
Figure 3.3: Relationship between the risk of developing the first primary disease episode 
and the age at infection assumed in TBDYN3. 
The relationships (a) between the risk of developing exogenous disease and the age at reinfection, 
and (b) between the risk of developing endogenous disease and the current age of an individual are 
assumed to be analogous. 
disease immediately after infection (dp(a, 0)) defines the rate during the following five years. 
dp(a, 0) is assumed to depend on the age at infection in the manner shown in Figure 3.3 
(i. e. constant for those infected when aged 0-10 years, increasing linearly to age 20 years, 
and con'stant thereafter). This formulation means that the rate at which individuals in- 
fected between the ages 10 and 20 years develop disease immediately after infection can be 
expressed in terms of that for 0-10 year olds (dp(10,0)) and individuals aged over 20 years 
(dp(20,0))2. 
The assumed increase between the ages 10 and 20 years in the rate at which individuals 
develop disease is consistent with observed age-specific patterns in mortality rates among 
cohorts during the pre-chemotherapy era (see section 1.1). Reasons for the decreasing risks 
of developing disease according to time since 'conversion' found during the UK MRC BCG 
trial were discussed in section 1.2.1.1. 
The number of individuals experiencing their first primary episode when aged a at time t 
2 dp(a, 0) = 
(dp(20,0) - dp(10,0» a+ 2dp(10,0) - dp(20,0) for 10 <a< 20. 10 
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Age at infection (years) 
and at time s following initial infection is given by the product of the number of individuals 
in the infected class of age a at time t who have been infected for time s (I(a, t, s)), and the 
corresponding rate at which they develop disease, dp(a - s, s). Summing over the possible 
values for s for individuals in the infected class 1 (0 <s< 5), the total number of new cases 
experiencing their first primary episode at age a at time t is given by the integral term in 
equation A. 4 in Appendix A. 1. 
Individuals in the reinfected class R experience exogenous disease at a rate d,, (a, s). This 
is assumed to depend on the age at reinfection and on the time since reinfection in the same 
way as that at which dp (a, s) depends on the age at and the time since first infection (see 
Figures 3.2 and 3.3). This is intuitively reasonable, although there are in fact no empirical 
data indicating whether the risk of exogenous disease is a function of age or time since 
reinfection. Equation A. 7 in Appendix A. 1 describes the rate of change in the incidence of 
exogenous disease with age and time. 
Individuals in the 'latent' class develop endogenous disease at a rate d,, (a), which is 
assumed to depend only on their current age, as shown in Figure 3.3. In reality, this 
probably increases even after age 20 years, but the extent and nature of this increase is not 
clear from the available data (see section 1.2.1.4). 
A proportion d+(a) of all diseased individuals is assumed to be sputum-positive, which 
depends only on their age and not on whether they are experiencing their first primary 
episode, endogenous or exogenous disease. We use data from Norway from the time period 
1951-1968 (see section 1-1) to estimate d+(a). These values are illustrated in Figure 3.4. 
On this basis, it was assumed that 10%, 65% and 85% of respiratory disease among 0-10, 
20 and 90 year olds respectively was sputum-positive, and that the proportions increased 
linearly between these age groups. 
Individuals are assumed to be diseased for two years, unless they die in the mean- 
time. The mortality rate experienced depends on their sputum status. Individuals who are 
sputum-negative face a mortality rate m,, (a, t), which is identical to that of other individuals 
of the same age in the general population. Sputum-positive cases ýre assumed to face a mor- 
tality rate m+ (t, ý), which depends only on time t and the time since they developed disease 
(9), and not on their age. Until 1950,35% and 23% of sputum-positive cases are assumed 
to die during the first and second years after they develop disease, which is equivalent to an 
overall case-fatality rate of 50%. This is consistent with estimates of the overall case-fatality 
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Figure 3.4: Summary of the relative contribution of sputum-positive disease to age-specific 
notifications of pulmonary tuberculosis in males in Norway during the period 1951-1969, 
together with the corresponding values assumed by TBDYN3 (d+(a)). 
rates from follow-up studies during the pre-chemotherapy era (see section 1.1), and from a 
longitudinal study of the natural history of tuberculosis in South India during the period 
1961-1966 [25]. The ratio between the case-fatality rate for sputum-positive cases in the 
first and second years after disease onset is assumed to be constant throughout the time 
period considered (i. e. 35/23 ; -ý1.4). 
The overall case-fatality rate for sputum-positive cases is assumed to decline steadily 
after 1950, reaching 30% and 25% by 1953 and 1956 respectively. This is held constant 
until 1976, and is assumed to be identical to the mortality rate in the general population 
thereafter. These assumptions are consistent with findings from follow-up studies of treated 
patients after 1950 in England and Wales [40,41] (see section 1.1), although it is recognized 
that the assumed case-fatality for sputum-positive cases after 1976 may be slightly low. 
3.1.4 Incidence of disease 
The total number of individuals of age a at time t (N(a, t)) in the population is given by the 
sum of individuals in each of the disease states. The total number of incident cases of age a 
at time t (C(a, t)) is given by the sum of new cases experiencing their first primary episode 
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(P(a, t, 0)) and endogenous and exogenous disease (E,, (a, t, 0) and E,., (a, t, 0) respectively): 
C (a, t) = P(a, t, 0) + E,, (a, t, 0) + E.., (a, t, 0) 
Each of these depend on the past disease history of individuals born at time t-a, and are 
functions of the age-specific rates at which individuals develop the first primary episode, 
endogenous and exogenous disease. These, in turn are functions of the rates among 10 and 
20 year olds (Idp(10,0), dp(20,0)}, {d,, (10), d,, (20)} and {d,, (10,0), d.,, (20,0)} (see footnote 
on page 102), denoted by Ap, An and d respectively. 
The incidence rate of disease in individuals of age a at time t, Y (a, t; Ap,, d,, d) is given 
by: 
(a, t; Ap, A., d. ) =C 
(a, t; dp, d., d. ) 
N (a, t) 
(3.2) 
and the corresponding incidence in specific age groups (e. g. 5-14 year olds) at time t is 
therefore given by: 
Y(a5-14, t; Ap, A,,, d) 
C(a5-141 Upi An 
t-dx) (3.3) 
N(a5-14, t) 
E 14 a=5C(a, t; Ap, A.,, d) (3.4) 
E14 
5N (a, t) 
Hence we see that for given input data on the incidence of infection, the age and time- 
specific mortality rate, and the numbers of live births and vaccinations, only the parameters 
Ap, & and d are required to describe the disease incidence for a given age group and for 
a given year. By their definition, these parameters also determine the relative contribution 
of endogenous and exogenous forms to the age and time-specific disease incidence. In this 
chapter, we first derive estimates of these parameters, and explore how they determined age 
and time-specific patterns in the overall disease incidence since 1900 in England and Wales. 
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3.2 Methods and input data 
3.2.1 Input data 
To describe fully the disease incidence among individuals aged 0-100 years since 1900 in 
England and Wales, TBDYN3 uses the following input data: 
1. Annual age and time-specific mortality rates for sputum-negative and non- 
diseased individuals, mg (a, t). Age and time-specific mortality rates for all individ- 
uals in the general population are provided on an annual basis since 1841 by the UK 
Government Actuary's Department. The corresponding mortality rates for sputum- 
negative and non-diseased individuals were derived from these data by taking away 
the deaths among sputum-positive individuals, which were estimated using TBDYN3. 
2. Annual number of live births, B(t). These are available from OPCS publications 
also since 1841. 
3. The annual risk of infection, i(t). Following the discussion in section 2.3, the 
annual risk of infection was assumed to be 14% in 1901, declining at 4% pa until 
1950, and at 13% pa thereafter. We assume the annual risk of infection declined at 
2% pa between 1880 and 1900, and was constant before this. The rate of decline from 
1880 is consistent with that found for tuberculous meningitis mortality rates among 
0-4 year olds (see section 2.3), although it implies that the annual risk of infection 
was extremely high at 22% in 1880. 
4. BCG vaccination data. It is assumed that most of the individuals vaccinated in 
England and Wales were aged 13 years (see section 2.4). The actual numbers of 
individuals vaccinated under the schools scheme from 1954 until 1960 were used in 
TBDYN3, as published in the Chief Medical Officer's Report [110]. These data are 
not stratified by sex and hence males are assumed to have comprised 50% of all those 
vaccinated. From 1960, it is assumed that 80% of uninfected 13 year olds males were 
vaccinated each year. The vaccine efficacy is assumed to be 77% which is consistent 
with corresponding estimates from the UK MRC BCG trial during the 1950s [38] (see 
section 2.4). 
The mortality and births estimates were extrapolated back from 1841 to 1800, so that 
the transmission dynamics could be considered among all individuals from 1900. 
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3.2.2 Estimating the age-specific risks of developing disease 
The system of partial differential equations in Appendix A. 1 was first reduced to a set 
of ordinary differential equations following individual cohorts from birth throughout their 
lifetime. These equations were programmed in 'C', using time-steps of 1 year, using the 
Euler method - this meant that the continuous time transition rates could be replaced by 
annual transition risks, and hence yearly data on the number of births, age and time-specific 
mortality, vaccination and the risk of infection, provided in their original format, could be 
used 3. 
The risks of developing the first primary, endogenous and exogenous disease for 0-10 
year olds and individuals aged over 20 years (Ap, d,, and A. ) were estimated by fitting 
model predictions of the disease incidence to age-specific notification data for white ethnic 
males, available for the period 1953-1988 (see section 2.2). The annual risk of infection 
can be estimated reliably on the basis of tuberculous meningitis mortality data only since 
1901 (see section 2.3). Hence the fitting was restricted to notification data only among 
individuals born since then, illustrated in Figure 3.5. The notifications for 55-64 and 65-74 
year olds are those in the general population, since they closely correspond to those in the 
white ethnic population (see section 2.2). In total, the fitting was based on 252 notification 
data points. 
Best-fitting estimates for the 6 parameters, {dp(10,0), dp(20,0)}, {dn(10), dn(20)} and 
{d., (10,0), d.., (20,0)} were obtained by finding a minimum sum of squares of the differ- 
ences between the incidence predicted by the model and the notification rates shown in 
Figure 3.5, using the Levenburg-Marquardt method [114]. This uses an iterative approach, - 
and converges to a minimum sum of squares using 
a set of starting parameter estimates, and 
2. expressions for the partial derivative of the expected age and time-specific disease 
incidence with respect to each of the six parameters. 
The latter determines only the speed at which the procedure converges to a minimum 
31t is generally more conventional to use Runge-Kutta or Bulirsch-Stoer methods to solve ordinary dif- 
ferential equations [114]. These methods are less convenient than the Euler method for implementing the 
equations in TBDYN3, given that they require input data (i. e. mortality rates and numbers of births) 
representing continuous-time, rather than discrete-time, transitions. 
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Figure 3.5: Estimated age-specific notification rates of respiratory tuberculosis in white 
ethnic males used to derive the risks of developing disease by TBDYN3. These notification 
rates were estimated from data on all forms of tuberculosis in white ethnic males during the 
national surveys. See section 2.2 for further details. We restrict the fitting to data points 
corresponding to individuals born since 1901. 
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sum of squares, and does not affect the best-fitting parameter values themselves. Hence, 
given that these partial derivatives cannot be expressed analytically in terms of the 6 pa- 
rameters, realistic approximations were used (see Appendix A. 2). 
The function of the sum of squares of the difference between the expected incidence 
and the actual notifications may have several (local) minima, which correspond to different 
sets of parameter values. Iterative procedures, such as the Levenburg-Marquardt method, 
sometimes converge to such local minima, depending on the set of starting parameter values 
used. To compensate for this problem, the fitting process was repeated several times starting 
from different sets of parameter values. The best-fitting parameter values were considered 
to be those yielding the overall minimum sum of squares. 
3.2.3 Sensitivity analyses of parameter estimates 
Formal standard errors for the parameter values derived using TBDYN3 cannot be obtained 
easily. For general (non-)linear models, standard errors on fitted parameter values can be 
obtained from the covariance matrix of the converged estimates if 
1. the (notification) data points used in the fitting procedure are independent and iden- 
tically distributed and 
2. the differences between the estimated incidence and the notifications used are normally 
distributed [115]. 
The notification rates of respiratory tuberculosis for white ethnic males used in the 
fitting procedure were estimated by assuming that they declined from their level in 1953 at 
the same rate as those of all forms of tuberculosis (see section 2.2), as estimated from data 
from the national tuberculosis surveys [97,101]. Hence the notification rate of respiratory 
tuberculosis used for a given year is determined by that in both the preceding year and in 
1953, and also by the magnitude of the notification rates of all forms of tuberculosis found 
during the survey years. The estimated notification rates used in the fitting procedure are 
therefore not independent and identically distributed and hence the first condition above is 
not satisfied for the parameters estimated using TBDYN3. On this basis, formal standard 
errors for the parameter estimates cannot be derived using the corresponding covariance 
matrix. 
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It is likely that the notification rates of all forms of tuberculosis during the national 
surveys were themselves subject to some random variability, which would have influenced 
the magnitude of the estimated notification rates of respiratory tuberculosis for white ethnic 
males. This could have led to slightly different estimated risks of developing tuberculosis 
from those obtained using the original data. This only applies to the notifications used for 
0-54 year olds, as those used for older individuals are assumed to approximate notifications 
in the general population (see section 2.2.3). 
To explore the sensitivity of the disease risk estimates to the magnitude of the notifica- 
tion rates, the fitting procedure was repeated on 50 other simulated data sets of notifications 
of respiratory tuberculosis among white ethnic males, which could have been derived from 
the notifications of all forms of tuberculosis from the national surveys, if the numbers of 
cases during the survey years had been subject to some random variability. This variability 
in the number of cases of all forms of tuberculosis during the survey years was assumed to 
follow a Poisson distribution4 with a mean given by the 'observed' numbers of cases. Hence 
the notification rates of respiratory tuberculosis obtained by assuming that the numbers 
of cases of all forms of tuberculosis followed a Poisson distribution during the survey years 
represent the plausible range in which the true notification rates would be expected to lie. 
We provide further details of the method used to generate the data sets in Appendix A. 3, 
and Figure A. 1 summarizes the 95% range of the notification rates of respiratory tuberculosis 
covered by the simulated notification data sets. 
3.2.4 Application to Dutch data 
Estimates of the age-specific risks of developing disease were also obtained using data from 
the Netherlands for comparison against 6ose obtained by Sutherland et al [7]. 
Sutherland et al based their estimates of the disease risks on notifications of respiratory 
tuberculosis among 15-69 year olds during the period 1951-1970. The analyses using TB- 
DYN3 were based on the same notifications, but covering the age groups 0-69 years, among 
individuals born since 1892, as birth and mortality data (obtained from the Dutch Cen- 
tral Statistics bureau) are available only since this year. The notifications were generously 
provided by Dr. K. Styblo at the International Union Against Tuberculosis. Following the 
assumptions of Sutherland et al (7], the annual risk of infection was taken to be 18% in 
4This distribution is generally used to model random variability in 'count' data [1161 
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1892, declining by 2.5% pa until 1911, at 4% pa until 1940 and at 13% pa thereafter. 
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3.3 Estimates of the risks of developing disease 
3.3.1 Results 
Table 3.3 summarizes the best-fitting estimates of the risks of developing disease obtained, 
together with the corresponding values for 15 year olds. Figure 3.6 compares the resulting 
age-specific incidence of disease against the notification data used in the fitting procedure. 
Table 3.3: Best-estimates of the risks of developing disease (to 3 significant figures (sf)), 
as derived using TBDYN3 by fitting to notifications in white ethnic males in England 
and Wales. Values for the first primary and exogenous disease episodes refer to the risk 
during the first year after infection and reinfection respectively and the cumulative risks 
experienced during the first five years after infection /reinfection. 
Risks (% pa) 
Age (years) First primary Endogenous Exogenous 
1st year Cumulative 1st year Cumulative 
(1st 5 yrs) (1st 5 yrs) 
0-10 2.42 3.96 1.39xlO-" 3.69 6.00 
15 5.59 9.01 0.0144 4.38 7.10 
> 20 8.76 14-0 0.0288 5.07 8.19 
Table 3.3 shows that about 4% of 0-10 year olds were estimated to develop disease 
within 5 years of infection, as compared with about 14% of those infected when aged over 
20 years. This higher risk of developing disease following infection during young adult life, 
as compared with that in childhood, is consistent with patterns in age-specific mortality 
rates seen among birth cohorts during the pre-chemotherapy era (see section 1.1). 
The risks of developing the first primary episode among individuals aged over 15 years 
slightly exceeds those estimated from the UK MRC trial, which found that 6.9% and 5.5% 
of individuals developed disease within 10 years of 'conversion' to tuberculin-positivity at 
age 14-15 and 16 years respectively (see section 1.2.1.1). This suggests that TBDYN3 may 
slightly underestimate the population considered to be at risk of developing the first primary 
episode, and hence the estimated risk of developing the first primary episode has to exceed 
that found during the MRC trial to attain the notification rate. Such an overestimate 
could be a consequence of the simplifying assumptions incorporated into TBDYN3 (e. g. 
that vaccination confers full protection against infection for 77% of individuals, and that 
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Figure 3.6: Comparison between the incidence of respiratory tuberculosis in 0-74 year old 
males estimated using TBDYN3 for England and Wales, and the notifications used in the 
fitting process. 
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the risk of infection depends only on the calendar year and not on the age of an individual). 
The effect of these simplifications on the magnitude of the parameter estimates obtained is 
discussed in detail in section 3.3.3. 
Figure 3.6 suggests that the overall fit of model predictions to the disease incidence 
was good, although, for most age groups, TBDYN3 underestimated the given notification 
rate during the early 1950s. This could again be a consequence of simplifying assumptions 
incorporated in TBDYN3. Sutherland et al [7] also found that the fit of their model to the 
Dutch data was worse for the early 1950s. 
The estimated risk of endogenous disease among individuals aged over 20 years is of a 
similar order of magnitude to that derived by Styblo, [6] and Horwitz [49] for the Netherlands 
and Denmark respectively (see section 1.2.1.4). For individuals aged over 20 years, the risk 
of developing the first primary episode exceed both the risks of developing endogenous and 
exogenous disease. Sutherland et al [7] obtained similar findings for the Netherlands. This 
is consistent with results from observational studies in developed countries, which found a 
lower disease incidence among individuals with weakly tuberculin-positive reactions than 
among tu berculi n- negative individuals (see section 1.2.1). 
The estimates for the risks of developing endogenous and exogenous disease among 0-10 
year olds are baýsed on fewer data points than the corresponding risk of developing the first 
primary episode, and hence, are less reliable. This stems from the assumption in TBDYN3 
that individuals can first develop endogenous and exogenous disease either five years after 
infection or after recovering from the first primary episode. This constrains 3 year olds to be 
the youngest at risk of developing these forms of disease, whereas individuals can develop a 
first primary episode at any age. This may explain the higher estimated risk of developing 
exogenous disease, as compared with that of developing the first primary episode, for 0-10 
year olds. 
3.3.2 Sensitivity analyses 
Table 3.4 summarizes the range of parameter estimates derived by repeating the fitting 
procedure on the 50 simulated data sets described in section 3.2.3. 
Considering the risk of developing the first primary episode during the first year after 
infection at age 0-10 years, this shows that 95% of the parameters obtained were within 
the range 2.18-2.58%, whereas the risk estimated using the original data set was 2.42%. 
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Table 3.4: Summary of the disease risk estimates obtained by repeating the fitting proce- 
dure on 50 simulated notification data sets, derived by sampling the numbers of notifications 
from the national tuberculosis surveys from the Poisson distribution. Values for the risks 
of developing the first primary and exogenous disease refer to those experienced during the 
first year after infection/reinfection respectively. 
Age Simulated data 
Parameter group, Original Mean Lower Median Upper 
(years) data 95% 95% 
.................. First Primary 0-10 2.42 2.40 2.17 2.41 ................... 2.58 
Episode >20 8.76 8.55 7.96 8.64 9.05 
Endogenous 0-10 1.39X10-7 9.55X10-7 2.36xlO-' 1.23X10-5 9.06 X 10-4 
>20 0.0288 0.0295 0.0287 0.0296 0.0304 
Exogenous 0-10 3.69 5.15 3.33 4.68 8.52 
>20 5.07 5.07 4.79 5.06 5.28 
Similarly, the estimated risks of developing the first primary episode, endogenous and ex- 
ogenous disease for individuals aged over 20 years using the original data set compare well 
against the 95% range of those derived using the simulated data. 
This 95% range is not equivalent to a 95% confidence interval - on the basis of these 
results, for example, it is not possible to say with 95% certainty that the true risk of 
developing disease would lie in the given interval for the given set of assumptions. At best, 
the 95% range can be interpreted as 
"the range in which 95% of parameter estimates would lie, given that the 'true' 
notification rates of respiratory tuberculosis were in a given (realistic) interval". 
Table 3.4 shows that the risks of developing endogenous and exogenous disease for 
individuals aged 0-10 years are relatively insensitive to the level of the notification rates, 
and hence are less reliable than the other disease risk estimates. 95% of the estimates for 
the risks of developing exogenous disease ranged between 3.33% and 8.52%. This range 
overlaps the range of values obtained for the risks of developing exogenous disease among 
individuals aged 20 years. 
The risk of developing endogenous disease for 0-10 year olds also lies in a broad range, 
with the upper and lower 95th percentiles differing by a factor of 104, although the absolute 
magnitude of the risk is small, relative to the other disease risk estimates. 
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These results are consistent with the fact that estimates of the risks of developing en- 
dogenous and exogenous disease among individuals aged 0-10 years are based on fewer data, 
as compared with those for other age groups (see section 3.3.1). 
Overall, this suggests that 
1. the estimated risks of developing the first primary episode for all age groups and those 
of developing endogenous and exogenous disease for individuals aged over 20 years 
are relatively insensitive to slight variation in the notification rates of respiratory 
tuberculosis and 
2. of all the parameter estimates, the risks of developing endogenous and exogenous 
disease among 0-10 year olds are the least reliable. 
At best, TBDYN3 represents a simplification of a complex disease process, and thus the 
estimates for the risks of developing disease are valid only for the set of assumptions incorpo- 
rated. The extent to which they reflect the 'true' risks of developing disease experienced in 
England and Wales since 1953 depends on how closely the simplifications approximate the 
true processes involved. These simplifications and their possible effects on the best-fitting 
parameter estimates are discussed in the next section. 
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Table 3.5: Comparison between the best-fitting values for the risks (to 3sf) of developing 
the first primary episode and endogenous disease derived assuming individuals cannot be 
reinfected, and the values obtained by including reinfection (original TBDYN3 model). 
Risks of the first primary episode and exogenous disease refer to those experienced during 
the first year after infection/reinfection respectively. 
Risks (% pa Sum of 
Assumption Age 1st squares 
(years) primary Endogenous Exogenous 
No exogenous 0-10 2.58 5.72x10-7 
disease 15 8.09 0.0206 
> 20 13.6 0.0411 - 25517 
Original 0-10 2.42 1.39 x 10-7 3.69 
TBDYN3 15 5.59 0.0144 4.38 
20 8.76 0.0288 5.07 5232 
3.3.3 Effect of simplifications on the disease risk estimates obtained 
3.3.3.1 Relevance of reinfection disease 
The relative frequency of endogenous and exogenous disease is controversial (see section 1- 1), 
and most of the disease in developed countries in recent years among older individuals is 
attributed to endogenous reactivation [6]. 
The importance of reinfection in determining the observed disease incidence was explored 
by repeating the fitting procedure assuming that no reinfection, and hence no exogenous 
disease could occur. Table 3.5 summarizes resulting disease risk estimates, together with the 
goodness of fit, as given by the sum of squares of the differences between the predicted inci- 
dence and the notification rate used. The estimates derived using the original assumptions 
are also shown. 
This shows that the estimated risks of developing the first primary episode and endoge- 
nous disease for all age groups are appreciably greater when it is assumed that individuals 
cannot experience exogenous disease, as compared with those derived assuming the con- 
verse, and the. fit to the data is considerably worse. This is illustrated in Figure 3.7, which 
compares model predictions of the disease incidence against the notifications used. The fit 
is especially poor for 45-54 year olds, for whorn'the model falls to match the decline in the 
disease incidence between 1955 and 1970. For younger individuals, the effect of excluding 
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reinfection from TBDYN3 on the fit to notification rates is smaller. 
Given the high risks of infection before 1950, most 45-54 year olds during the period 
1955-1970 must have already been infected. Hence it is, unlikely that the reduction in the 
notification rates among these individuals is attributable to a decline in the incidence of 
first primary episodes. If it is assumed that 45-54 year olds could not have been reinfected, 
then the rapid decline in the notification rate could only have occurred as a consequence of 
a dramatic reduction in the risk of developing endogenous disease over time, which seems 
unrealistic. This suggests that to attain a realistic fit to the notifications rates especially 
for 45-54 year olds for the given set of assumptions, reinfection has to be included into 
TBDYN3. 
3.3.3.2 Effect of age-independent risks of infection 
Some studies have suggested that the risk of infection increases with age, although the 
magnitude of the increase is not clear [113). TBDYN3 assumes that the risk of infection 
depends only on the calendar year and not on the age of an individual, and hence may 
misrepresent the prevalence of infection and the size of the population at risk of developing 
disease in given age groups and years. To explore this question, the prevalence of infection 
predicted by TBDYN3 was compared against data from the national tuberculin surveys in 
1949 and during the period 1971-1973 [103,106] (see section 2.3). 
Figure 3.8 compares the expected prevalence of infection among 0-50 year olds in 1949 
used by TBDYN3, against the prevalence of tuberculin sensitivity found during the national 
tuberculin survey during the period 1949-1950 (103]. The two agree well for 5-16 year 
olds from south urban areas, although TBDYN3 may overestimate slightly the infection 
prevalence among 5-8 year olds. The prevalence of tuberculin sensitivity in southern urban 
areas probably more accurately reflected actual trends in the annual risk of infection with 
M. tuberculosis than did that in rural and north urban areas, as an appreciable proportion 
of tuberculin sensitivity was attributable to infection with M. bovis in the latter areas (see 
section 2.3). 
The prevalence of infection predicted by TBDYN3 for individuals aged over 18 years, 
underestimates the corresponding prevalence of tuberculin sensitivity found in south urban 
areas during the survey. This is consistent with results from other studies (113], which 
suggests that the risk of tuberculous or other mycobacterial infection increased slightly 
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Figure 3.8: Comparison between the expected age-specific prevalence of infection in Eng- 
land and Wales in 1949, as used in TBDYN3 and the prevalence of tuberculin sensitivity 
in south urban, north urban and rural England, as found during the national tuberculin 
survey during the period 1949-1950 [103]. 
during adolescence. 
The high risk of infection during the early 1900s (e. g. 14% in 1901) leads to an estimated 
prevalence of infection approaching 100% among 50 year olds in 1949 (see Figure 3.8). It is 
difficult to determine whether such high estimates for the risk and prevalence of infection are 
realistic. Tuberculin surveys in South India during the period 1961-1966 [25], for example, 
found a lower prevalence of tuberculin sensitivity among those aged over 55 years, than for 
45-54 year olds. It is unclear whether this reflected genuine differences in the prevalence of 
infection or a greater tuberculin reversion rate among those aged over 55 years, as compared 
with that among 45-54 year olds. Surveys carried out among Eskimos during the late 1950s, 
on the other'hand, found that all adults were sensitive to tuberculin [117] (induration of 
8mm or more to 1 TU PPD-S), corresponding to an annual risk of infection of about 25%. 
This suggests that in extreme circumstances, a prevalence of infection approaching 100% is 
not impossible. 
The national tuberculin survey during the period 1971-1973 found that the prevalence 
of tuberculin sensitivity among 6 and 13 year olds in the "UK national" group was about 
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0.31% and 1.14% respectively [106] (see section 2.3). These estimates are slightly lower 
than the expected prevalence of infection used by TBDYN3 for 1972, namely 0.89% and 
3.2%. However, the differences between the two are difficult to interpret given the absence 
of tuberculin sensitivity data among other age groups. 
Overall, this suggests that TBDYN3 slightly overestimates the risk of infection among 
young children, and hence overestimates the proportion of these individuals who are at risk 
of disease, although the size of this overestimate is probably too small to affect substantially 
the corresponding disea-se risk estimates. 
TBDYN3 also slightly underestimates the prevalence of infection among young adults 
during the early 1950s, and probably overestimates that among individuals aged over 40 
years. Given that the risks of developing disease are assumed to be identical for all individ- 
uals aged over 20 years, it is likely that the net effect of the under- and the overestimates in 
the risk of infection among young adults and those aged over 40 years respectively on the 
estimated risks of developing disease is small. 
3.3.3.3 Vaccine efficacy 
TBDYN3 probably underestimates the proportion of the population at risk of first infection 
and of subsequent disease by assuming that vaccination confers solid immunity against 
infection for 77% of individuals. This may be unrealistic, given that the UK MRC BCG 
trial found that the vaccine efficacy declined over time (see section 2.4). The assumption 
could have led to an overestimate in the risk of developing the first primary episode, and 
would have affected the estimated risks of developing endogenous and exogenous disease, 
given that the parameter values are correlated (e. g. a high risk of developing the first primary 
episode may require a lower risk of developing endogenous or exogenous disease to attain 
the required notification rate). 
The effect of this assumption on the parameter estimates was explored by repeating the 
fitting procedure by deliberately overestimating the population at risk of developing the first 
primary episode by assuming a zero vaccine efficacy. Whilst this is unrealistic, it yields a 
lower bound on the risk of developing the first primary episode, had a waning vaccine efficacy 
been incorporated into TBDYN3. Table 3.6 summarizes the corresponding parameter values 
obtained and Figure 3.9 compares the resulting age-specific disease incidence against the 
corresponding notification data. 
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Table 3.6: Comparison between the best-fitting values for the risks (to 3sf) of develo- 
ping the first primary episode and endogenous disease derived assuming vaccination confers 
no protection against infection, and the values obtained by assuming 77% of individuals 
are protected from infection for life (original TBDYN3 model). Risks of the first primary 
episode and exogenous disease refer to those experienced during the first year after infec- 
tion/reinfection respectively. 
Risks (% pa Sum of 
Assumption Age 1st Squares 
(years) primary Endogenous Exogenous 
0% vaccine efficacy 0-10 2.25 1.81 x 10-9 9.36 
15 5.00 0.0146 7.33 
> 20 7.75 0.0293 5.30 5823 
Original 0-10 2.42 1.39X 10-7 3.69 
TBDYN3 15 5.59 0.0144 4.38 
> 20 8.76 0.0288 5.07 5232 
As expected, the fit to the notification data is worsened by assuming a zero vaccine 
efficacy. The assumption leads to only slightly higher estimates for the risks of developing 
endogenous and exogenous disease among individuals aged over 20 years, and to slightly 
lower risks of developing the first primary episode for all age groups, as compared with 
those derived using the original assumption. This suggests that these disease risk estimates 
are not greatly sensitive to the assumptions regarding vaccine efficacy. 
Note also that even though we have assumed that only 13 year olds have been vaccinated 
since 1954, the assumption of a zero vaccine efficacy leads to different disease risks even for 
0-10 year olds. This follows from the facts that 
1. we carried out the fitting procedure with this assumption considering all age groups, 
and 
2. the risks of developing disease among 10-20 year olds (and hence among vaccinated 
individuals) are a function of those for 0-10 year olds and individuals aged over 20 
years (see footnote on page 102). 
Table 3.6 also shows that the risk of developing exogenous disease for 0-10 year olds esti- 
mated by assuming a zero vaccine efficacy exceeds that derived for individuals aged over 20 
years. This follows from the fact that this parameter is correspondingly less reliable (see 
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sections 3.3.1 and 3.3.2). 
3.3.3.4 Mixing patterns 
TBDYN3 also assumes that both the risks of first infection and reinfection are indepen- 
dent from mixing patterns in the population. High risks of infection or reinfection among 
individuals in a given age group may in fact be associated with high risks of developing 
disease. 
As mixing patterns changed over time, the relative contribution to the disease incidence 
from individuals at high infection and disease risk must also have increased, and hence 
the overall 'observed' risks of developing disease must have changed. The magnitude of 
this change is unclear. Given that the risks of developing disease obtained lead to a good 
fit to the notification data throughout the time period considered, this suggests that the 
assumption of random mixing is not excessively simplistic. 
3.3.3.5 Concluding remarks 
Overall, we see that the simplifications incorporated into TBDYN3 have not greatly affected 
the estimates of the risks of developing disease obtained. This suggests that the assumptions 
incorporated into TBDYN3 are sufficient to provide a realistic representation of the basic 
tuberculosis situation in England and Wales. Intuitively, identical risks of developing the 
first primary episode, endogenous and exogenous disease should be obtained if TBDYN3 
were to be applied to data from other developed countries. We explore this question in the 
next section, in which we present results obtained from applying TBDYN3 to data from 
the Netherlands. This also provides the opportunity to compare the results from the model 
of Sutherland et at (7] with those of TBDYN3. 
3.3.4 Disease risk estimates for the Netherlands 
Table 3.7 compares the parameter values obtained for the Netherlands using TBDYN3 
against those obtained by Sutherland et at [7]. Sutherland et at assumed that the risks of 
developing 'primary' and 'exogenous' disease were constant during the first five years after 
infection. Hence the cumulative risks of developing these disease forms within five years of 
infection and reinfection are best compared against those from TBDYN3. For reference, 
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Table 3.7: Comparison between the risks (to 3sf) of developing the first primary episode, 
endogenous and exogenous disease derived with TBDYN3 for the Netherlands, and the 
corresponding risks derived by Sutherland et al [7]. Values for the risks of developing the 
first primary episode and exogenous disease refer to the cumulative risks experienced during 
the first five years after infection/reinfection. 
Model Age Risks (% pa ) 
& data used (years) 'Primary' Endogenous Exogenous 
TBDYN3 - Netherlands 0-10 12.3 4.17X10-7 19.8 
15 22.0 0.0106 15.2 
20 31.1 0.0213 10.5 
Sutherland et al [7] 15-69 22.9 0.025 9.19 
TBDYN3 -E&W 0-10 
15 
3.96 
9.01 
1.39X10-7 
0.0144 
6.00 
7.10 
20 14.0 0.0288 8.19 
Figures A. 2 and A. 2 summarize compare model predictions of the disease incidence for the 
Netherlands, against the notifications used. 
This shows that the slightly more flexible assumptions regarding the natural history of 
tuberculosis incorporated into TBDYN3, as compared with those used by Sutherland et al 
led to relatively small differences between the risks of developing endogenous and exogenous 
disease among adults. The corresponding risk of developing the first primary episode derived 
using TBDYN3, on the other hand, is almost one and a half times greater than that derived 
by Sutherland et aL The magnitude of this risk is unrealistically high and exceeds even the 
disease risk estimates found from observational studies during the pre-chemotherapy era 
(see section 1.2.1). 
Table 3.7 shows that the risks of developing endogenous and exogenous disease among 
Dutch adults derived using TBDYN3 compare well against those for England and Wales. 
The age-specific risks of developing the first primary episode are over two times greater 
than those for England and Wales, and the estimated risk of developing exogenous disease 
decreases between the ages 10 and 20 years in the Netherlands. There are no obvious 
biological reasons for these differences between the two countries. Insight into why such 
differences occurred can be obtained by comparing the annual risk of infection and the 
notification rates in the Netherlands with those for England and Wales. 
As shown in Figure 3.10, the annual risk of infection during the period 1951-1970 was 
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Figure 3.10: Comparison between the estimated annual risk of infection in the Netherlands 
and that in England and Wales during the period 1901-1990. 
lower for the Netherlands than for England and Wales. A smaller proportion of the Dutch 
population had therefore been newly infected or reinfected and was eligible to develop the 
first primary episode or exogenous disease, as compared with that in England and Wales. 
This implies that if the risks of developing the first primary episode and exogenous disease 
were identical for the two countries, the age-specific disease incidence in the Netherlands 
should have been lower than that for England and Wales, after correcting for individuals 
protected by BCG vaccination in England and Wales. 
As shown in Figure 3.11, the notification rates in the Netherlands were lower than those 
for England and Wales only among individuals aged over 25 years. The notifications among 
0-4 and 15-24 year olds were similar in the two countries, whilst those for 5-14 year olds in 
the Netherlands exceeded those in England and Wales. Given that BCG vaccination was 
not routinely used in the Netherlands, a greater proportion of 5-14 and 15-24 years olds in 
England and Wales were protected from developing disease, as compared with those in the 
Netherlands. This accounts for the 'unexpected' similarity in the notifications in these age 
groups between the two countries. However, even though BCG vaccination was incorporated 
into TBDYN3 for England and Wales, the fitting procedure resulted in different estimates 
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Figure 3.11: Comparison between notification rates of respiratory tuberculosis in males 
in the Netherlands during the period 1951-1970 and those estimated from survey data (see 
section 2.2) among white ethnic males in England and Wales. 
Notification data supplied by Dr. K. Styblo at the International Union against Tuberculosis 
Note: Notifications shown in the 65+ year olds category for the Netherlands correspond to those of 
65-69 year olds. Notifications for England and Wales in this age groups correspond to those in the 
general population. 
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for the risks of developing the first primary episode for the two countries. 
Other factors may also account for the unexpected similarity between the notification 
rates among 0-4 and 15-24 year olds in the Netherlands and England and Wales, and the 
high rates for 5-14 year olds, such as differences in the notification efficiency, degree of 
overnotification, or case definitions. These factors would have affected the notification rates 
in older age groups in a similar way, and this would have resulted in widely different values 
for the risks of developing endogenous and exogenous disease obtained for individuals aged 
over 20 years in the Netherlands and England and Wales. 
These differences could also be attributable to other biological differences between the 
two countries, such as the extent of crowding, infection with M. bovis or other mycobacteria. 
Alternatively, this suggests that the annual risk of infection in the Netherlands was actually 
higher than that estimated, or the increase in the risk of infection with age was greater 
than that for England and Wales. The most likely explanation is that the parameter values 
obtained for the Netherlands are based on a smaller data set as compared with those in 
England and Wales, and as a consequence, are less robust. 
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3.4 Discussion and implications for past trends in the age- 
specific incidence of disease 
3.4.1 Discussion 
In spite of simplifying assumptions incorporated into TBDYN3, the parameter estimates 
obtained are of a realistic order of magnitude. The risk of developing the first primary 
episode among adolescents compares well against the risk estimates from the UK MRC 
BCG trial, and the risk of developing endogenous disease among adults is similar to those 
derived by Styblo [6] and Horwitz [49] for the Netherlands and Denmark respectively (see 
section 1.2.1.4). 
Both the risks of developing endogenous and exogenous disease exceed the risk of de- 
veloping the first primary episode for individuals aged over 20 years. This suggests that 
initial infection may confer some protection against subsequent disease or reinfection. This 
finding is consistent with results from observational studies in developed countries, which 
found a lower disease incidence among individuals with weakly tuberculin-positive reactions 
than among t uberculin- negative individuals (see section 1.2.1). 
The risk of developing exogenous disease can be interpreted as a combined risk of rein- 
fection and of developing subsequent disease, since it is assumed that the risks of reinfection 
and infection are identical. It is likely that the risk of reinfection is in fact lower than that 
of first infection (see section 3.1.1), which suggests that the risk of developing exogenous 
disease could be greater than that obtained, and perhaps exceeds that of developing the first 
primary episode. This is not unrealistic, given that the immune response must already be 
low, by definition, for reinfection to occur, which could increase the likelihood of subsequent 
disease. 
It is likely that the risks of developing disease also depend on the type of disease consid- 
ered (e. g. pulmonary, as opposed to extrapulmonary). The relationship between tuberculous 
meningitis mortality rates and the annual risk of infection during the prechernotherapy era 
suggests that about 1% of 0-4 year olds develop tuberculous meningitis after infection (see 
section 2.3). This risk estimate is about 4 times smaller than that estimated for respira- 
tory tuberculosis for 0-4 year olds (see table 3.3), even though the corresponding mortality 
rates from tuberculous meningitis exceeded those of respiratory tuberculosis until 1957 (see 
Figure 3.12). A similar comparison between the notification rates after 1953 of the two 
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Figure 3.12: Comparison between tuberculous meningitis and respiratory tuberculosis 
mortality rates among 0-4 year old males in England and Wales during the period 1860- 
1957. 
Note that the tuberculous meningitis and respiratory tuberculosis mortality rates declined at the 
same rate. This results from the fact that disease among 0-4 year olds is attributable to recent 
infection, and hence the mortality rates reflect the trend in the annual risk of infection. 
forms of disease suggests that the morbidity from tuberculous meningitis was lower than 
that for respiratory tuberculosis for 0-4 year olds (see Figure 3.13). This shows that the 
case-fatality rates must have been considerably lower for respiratory tuberculosis than for 
tuberculous meningitis. 
It is unclear whether similar disease risks estimates would be obtained if TBDYN3 were 
to be applied to data from developing countries. During the BCG trial in South India during 
the 1970s [26], for example, where the risk of infection was in the range 2-6%, the average 
annual risk of disease was about 21,55 and 192 per 100,000 during follow-up for individuals 
with tuberculin reactions measuring 0-7mm, 8-11mm and 12-15mm respectively. This 
suggests that 
1. if it is assumed that individuals in South India face identical risks of infection as of re- 
infection, then the risk of developing endogenous and exogenous disease in South India 
must have been greater than that estimated for England and Wales, or alternatively 
2. if it is assumed that the risks of developing endogenous and exogenous disease are 
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Figure 3.13: Comparison between tuberculous meningitis and respiratory tuberculosis 
mortality rates among 0-4 year old males in England and Wales until 1957, and the corre- 
sponding notification rates in the general population from 1953. 
identical to those in England and Wales, then the risk of reinfection in South India 
must exceed that of first infection, 
The situation is further complicated in South India, given that there is high prevalence of 
infection with atypical mycobacteria, as compared with that in England and Wales, which 
may impart some protection against disease [26]. Overall, this suggests that the results 
obtained for developed countries cannot be easily extrapolated to developing countries, and 
that the transmission dynamics in the two should be analyzed separately. 
As it stands, the model formulated in this chapter provides a sound framework with 
which to explore the transmission dynamics of M. tuberculosis. We explore the implications 
for past trends in the age and time-dependent disease incidence in the next section. 
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3.4.2 Implications for age-specific patterns in the disease incidence pre- 
dicted by TBDYN3 
Figure 3.14 summarizes the age-specific incidence of disease among 2-70 year olds since 
1900 predicted with TBDYN3 using the best-fitting parameter values. This also shows 
the relative contribution of disease attributable to first primary episodes, exogenous and 
endogenous disease. The corresponding incidence of disease after 1950 is shown in greater 
detail in Figure 3.15. 
These indicate that much of the disease experienced by individuals aged over 10 years 
at least until 1940 was attributable to exogenous disease. This is intuitively reasonable, 
given the high annual risk of infection, and hence the high prevalence of infection predicted 
for these years. 
Figure 3.14 shows that the predicted incidence of first primary episodes particularly for 
20 and 30 year olds increased between 1900 and 1950. This is attributable to an increase 
in the incidence of first infections occurring during this time in these age groups, which, 
paradoxically, was a consequence of the decline in the annual risk of infection. During 
the early 1900s, for example, only a small proportion of individuals aged over 20 years 
experienced initial infection, since most had been infected early in life. By the 1920s, 
however, a greater proportion of 20 years olds had escaped infection, as compared with 
their counterparts during the early 1900s, since the annual risk of infection during their 
childhood was considerably lower. Styblo predicted similar increases in the incidence of 
infection among adults for the Netherlands after 1911 [6). 
As a result of this increase in the incidence of first primary episodes, the rate of decline 
in the overall disease incidence among adolescents and young adults was slower than that 
for younger individuals. This also resulted in a slower decline in the corresponding observed 
mortality rates for adolescents, as compared with those among infants and young children 
(see section 2.1). 
Figure 3.14 shows that the decline in the predicted incidence of disease in all age groups 
accelerated in 1950. This is attributable to the rapid decline in the annual risk of infection 
after 1950 (associated with improvements in case-finding and treatment - see section 2.3), 
which led to a dramatic reduction in the incidence of first primary episodes and exogenous 
disease. This translated into an equally dramatic decline in the overall notification rates of 
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Figure 3.14: Estimated age-specific incidence of respiratory tuberculosis since 1900 in Eng- 
land and Wales attributable to first primary episodes, exogenous and endogenous disease, 
as predicted using TBDYN3 using the best-fitting parameter values. 
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respiratory tuberculosis for all age groups (see Figure 3.15). 
Figure 3.16 compares the disease incidence predicted using TBDYN3 for given years 
during the period 1901-1950, against the corresponding mortality rates. This shows that 
the overall pattern in the age-specific disease incidence predicted using TBDYN3 is con- 
sistent with that seen in the mortality rates (i. e. low for 0-10 year olds, increasing during 
adolescence and remaining consistently high thereafter). Figure 3.17 compares the overall 
disease incidence rates of respiratory tuberculosis predicted by TBDYN3 against the cor- 
responding published and predicted mortality rates. This shows that the predicted and 
the observed mortality rates compare well for all years, and for most age groups, except 
the elderly. For these individuals, model predictions of the mortality rates exceeded those 
published for most years. This is attributable to at least two factors: 
1. problems with case- recognition among elderly individuals, which meant that many 
deaths attributable to tuberculosis were not recognized as such, and 
2. a large proportion of individuals with tuberculosis in older age groups could have also 
died from causes other than tuberculosis (i. e. the issue of 'competing mortality'), and 
hence would not have contributed to the overall tuberculosis mortality rates. 
The relative contribution of endogenous, exogenous and first primary episodes to the 
age-specific incidence of disease after 1950 predicted using TBDYN3 is shown in Figure 3.18. 
The corresponding disease incidence assuming no individuals had been vaccinated is given by 
the dotted line. This shows that overall, the pattern in the age specific incidence predicted 
using TBDYN3 agrees well with that in the notification rates. The peak in the disease 
incidence for young adults in 1955, for example, is consistent with a similar peak in the 
notification rates. Similarly, the absence of a peak in young adult life in later years predicted 
using TBDYN3 is also confirmed by the notification data. 
Another perspective on the validity of the results from TBDYN3 may be obtained from 
Figure 3.19, which compares the incidence and mortality rates of disease among cohorts 
born during the period 1901-1935 predicted using TBDYN3 against the corresponding 
mortality rates from respiratory tuberculosis in England and Wales. The similarity between 
the published and the predicted mortality rates for young adults is particularly striking, 
especially for cohorts born during the periods 1901-1910 and 1911-1915. 
Figure 3.19 shows that the peak in mortality rate shifted from 30-35 year olds for 
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Figure 3.16: Comparison between the incidence of respiratory tuberculosis attributable 
to first primary episodes, exogenous and endogenous disease for males during the period 
1901-1950 in England and Wales, as predicted using TBDYN3 and the corresponding male 
mortality rates. 
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the 1881-1890 birth cohort to young adult life for individuals born after 1901, whereas 
TBDYN3 predicts that the peak occurred at age 20 years for each birth cohort. This is 
largely attributable to the fact that individuals born during the period 1881-1890 were aged 
30-40 years during the First World War, when they faced high case-fatality rates: TBDYN3 
assumes that, until 1950, the case-fatality rate is independent from the calendar year. A 
similar argument can be applied to explain analogous differences between the published and 
predicted mortality rates for the cohort born during the period 1891-1900. 
Overall, we see that the assumptions incorporated into TBDYN3 lead to realistic pat- 
terns in the age and time-specific disease incidence and mortality rates for both the pre- 
chemotherapy and the chemotherapy eras. We explore the implications of these assumptions 
for the definitions and interpretation of the incubation period, serial interval and basic and 
net reproduction numbers for tuberculosis in the following chapters. 
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Chapter 4 
The incubation period, serial 
interval and lifetime risks of 
developing tuberculosis 
4.1 Definitions and relevance 
The incubation period of an infectious disease is defined as the time interval between infe-c- 
tion and disease onset. For many common infectious diseases, such as measles, mumps and 
rubella, most infected individuals subsequently develop disease and the incubation period 
is short (measured in days). Moreover, such infections induce a permanent solid immunity 
and hence the single disease episode experienced is attributable the initial infection event. 
The definition of an incubation period for tuberculosis is complicated, given that indi- 
viduals can be reinfected and may then experience exogenous disease within a few years 
of reinfection, or may reactivate many years thereafter as a consequence of the reinfection 
event. Because of this, the time interval since initial infection might be used as the basis to a 
definition of the incubation period for tuberculosis, but would not be ideal, as the beginning 
(initial infection)-and terminal (disease) events might not even be causally linked. 
For tuberculosis, and for other infections in which individuals can develop disease fol- 
lowing reinfection, such as herpes varicella-zoster [118], the incubation period may better 
be defined as: 
The time interval between infection or reinfection and the disease 
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episode which occurs as a result of that infect ion /reinfect ion event. 
The serial interval, also known as the "generation time" [119], was first defined by 
Hope-Simpson in 1948 [120] as the time interval between successive cases in a chain of 
transmission. It is equivalent to the incubation period if the onset of infectiousness and 
disease coincide and if the duration of infectiousness is relatively short. 
For tuberculosis, since not all disease is infectious, the serial interval may best be 
defined as: 
The time interval between the clinical onsets of infectious pulmonary 
disease in successive cases in the chain of transmission. 
By the above logic, it is equivalent to the incubation period of infectious pulmonary 
disease if the duration of infectiousness is short. This is complicated by the fact that disease 
may arise in different ways, as either the first primary episode, reactivation or reinfection 
disease. The mechanisms underlying all these processes must be considered in evaluating 
both the serial interval, and incubation period for AL tuberculosis. 
The incubation period of tuberculosis can be derived either prospectively as: 
the distribution of the time interval until the first disease episode as a result of 
an infection/reinfection event among individuals of a given age in a given year, 
or retrospectively as: 
the distribution of the time interval since the infection or reinfection event caus- 
ing disease among individuals with disease onset at a given age in a given year. 
Serial intervals can be derived analogously. 
For many communicable diseases, such prospective and retrospective analyses would 
yield identical distributions, irrespective of the age groups or the time period considered. 
This is not the case for tuberculosis, because of the three different mechanisms underlying 
disease, and their dependence on the age at infection and on the annual risk of infection. A 
few general comments will serve to point out the complexity of the incubation period and 
serial interval concepts as they apply to tuberculosis. 
First, the incubation period (and serial interval) of tuberculosis may be very long, as 
long as a lifetime. Because of this, its frequency distribution will be a function not only 
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of the age at which infection/reinfection occurs, but also the time period, both of which 
determine the subsequent mortality experience of infected individuals. 
Second, the distributions of both the incubation period and serial interval of tuberculosis 
will also depend on the magnitude and trend in the annual risk of infection, irrespective 
of the age group considered. Some individuals who succumb to exogenous disease would 
not have developed disease at all if they had 'escaped reinfection, and if they had been at 
risk only of endogenous reactivation. A higher annual risk of infection therefore implies 
a shorter time from infection to disease than in conditions characterized by a low risk of 
infection. This implies an inverse relationship between the annual risk of infection and the 
average duration of both the incubation period and serial interval. 
Third, another complication arises because of the age-dependence of tuberculosis patho- 
genesis. As indicated in section 1.1, infectious pulmonary disease is rare, and non-infectious 
forms are comparatively common, in children under the age of 15 years. Many years may 
elapse before an individual infected in childhood develops infectious pulmonary disease 
through either exogenous reinfection or endogenous reactivation. For this reason, a high 
annual risk of infection may be associated with much infection in early childhood but with 
long average serial intervals. 
A different situation arises if the annual infection risks are low, and most individuals 
escape infection until after childhood. Adolescents and young adults experience high risks of 
developing disease, given infection, and much of their disease is sputum-positive. Therefore, 
if an individual becomes infected after childhood, and infects another adolescent or young 
adult, the serial interval can be relatively short, measured in months or a few years. In 
this instance, the serial interval will approximate the incubation period. This last point 
raises an even more difficult issue, that of the pattern of infection transmission within and 
between different age groups. 
We thus see that the definitions of the incubation period and serial interval are compli- 
cated for tuberculosis. A greater understanding of the relationship between the incubation 
period and the serial interval should help to clarify age-specific patterns and trends in 
tuberculosis in different populations. 
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4.2 Methods 
4.2.1 Definition of a 'causal infection /reinfection' event 
TBDYN3 has been adapted to analyze the distributions of the incubation period both 
4 retrospectively' and 'prospectively', as defined below. Retrospective analyses considered 
the frequency distributions of time intervals from the 
1. initial infection event to onset of the current disease episode for (diseased) indi- 
viduals of a given age in a given year, and 
2. "causal" infection or reinfection event to onset of the current disease episode 
for (diseased) individuals of a given age in a given year, 
Prospective analyses of the incubation period considered the distribution of the time 
interval between first infection at a given age a and time t and 
1. The first episode of respiratory disease, and 
2. The first episode of sputum-positive disease. 
These two distributions were broken down according to whether the first disease episode 
was attributable- to the initial infection event, or to subsequent reinfection. 
Before describing the methods used to derive these distributions, we must first clarify 
how TBDYN3 defines a causal infection or reinfection event for individuals experiencing a 
first primary episode, endogenous or exogenous disease. 
TBDYN3 assumes that individuals cannot experience reinfection if they are currently 
experiencing disease, or if they are already at (high) risk of developing their first primary 
episode or exogenous disease (see section 3.1.2). For simplicity, it is assumed that a given 
disease episode is attributable to the most recent infection or reinfection event. It is rec- 
ognized that in reality, disease among reinfected individuals could be attributable to bacilli 
from 
1. both the infection and reinfection events together, 
2. only from the reinfection event, or 
3. only from the initial infection or a more distant reinfection event 
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(see section 3.1.1). 
The situation is less complicated for individuals experiencing endogenous disease - 
TBDYN3 attributes such disease to the most recent infection or reinfection event. 
4.2.2 Retrospective analyses of the incubation period/serial interval 
4.2.2.1 Distribution of time intervals since initial infection 
TBDYN3 assumes that a proportion d+(a) of the disease incidence among individuals of 
age a is sputum-positive irrespective of the time t, irrespective of whether they are ex- 
periencing their first primary, endogenous or exogenous disease, or whether it constitutes 
their first or a subsequent episode (see section 3.1.3). As a result of this assumption, the 
distributions of the time interval since initial infection for individuals diseased at a given 
age at a given time do not depend on whether we stratify the individuals according to their 
sputum status. This follows from the following argument: 
The distribution of the time interval since first infection of individuals experiencing onset 
of respiratory tuberculosis at age a at time t, Di (a, t, s), is given by 
Di (a, t, s) 
Di (a, t, s) for 0<s<a 
0 Di (a, t, s) 
where Di (a, t, s) denotes the number of individuals with all forms of respiratory disease of 
age a at time t who had been infected s years previously (i. e. when aged a- 'S years at 
time t- s). The denominator in this expression is the total number of individuals of age a 
with respiratory disease at time t. 
The number of individuals experiencing sputum-positive disease of age a at time t, 
who had been infected s years previously is given by d+ (a) Di (a, t, s). Similarly, the total 
number of individuals experiencing sputum-positive disease of age a at time t is given by 
E, ', 
ýO d+ 
(a) Di (a, t, s). Hence the distribution of the time interval since initial infection for 
individuals experiencing sputum-positive disease at age a at time t is given by: 
Di+ (a, t, s) = 
d+ (a) Di (a, t, s) (4.2) 
E, '=o d+ (a) Di (a, t, s) 
d+ (a) Di (a, t, s) for 0<s <a (4.3) d+ (a) Es=o Di (a, t, s) 
Cancelling out d+(a) from both the numerator and denominator, we see that this ex- 
pression is identical to that for the distribution of the time interval since initial infection 
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for individuals experiencing all forms of respiratory tuberculosis at age a at time t (see 
equation 4.1), as follows: 
Dt(a, t, s) = 
Di (a, t, s) 
0 Di (a, t, s) 
Di(a, t, s) 
(4.4) 
for 0<s<a (4.5) 
The distribution Di (a, t, s) is therefore interpretable as both an 'observed' incubation 
period and serial interval for individuals diseased at a given age and in a given year. ' It 
does not correspond to a 'true' incubation period or serial interval experienced by such 
individuals (see definition in section 4.1), given that a current disease episode is not always 
attributable to the initial infection event. 
We estimated the distributions Di (a, t, s) for individuals diseased at a given age a be- 
tween 1900 and 1990 by first deriving the corresponding Di(a, t, s) for all possible values 
of s, namely between 0 and a years. Hitherto, the disease incidence has not been broken 
down according to the year in which the initial infection event, or the infection/reinfection 
event causing the disease episode occurred, and so TBDYN3 had to be modified slightly to 
derive these estimates. 
TBDYN3 derives the disease incidence in a given age group and year by following co- 
horts since birth and applying the corresponding infection, reinfection and disease risks and 
mortality rates. At any time, individuals in a cohort belong to either the uninfected, 'im- 
mune', infected, 'latent' or reinfected classes, or are diseased with either their first primary 
episode, endogenous or exogenous disease (see section 3.1.2). 
The approach used to derive Di (a, t, s) for all values of s between 0 and a years was iden- 
tical, except that TBDYN3 was restricted to track the disease dynamics only in the group 
of individuals infected at age a-s at time t-s for duration s. As above, individuals in this 
group belong to either the infected, 'latent' or reinfected classes, or are experiencing either 
their first primary episode, endogenous or exogenous disease. Di (a, t, s) is thus given by the 
total number of individuals in the first primary, endogenous and exogenous disease classes 
in the group after time s. The system of differential equations representing the disease 
dynamics in these individuals is analogous to that used to derive the incidence of disease in 
i given cohorts of individuals tracked from birth (see section 3.1.2 and Appendix A-1). 
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4.2.2.2 Distributions of time intervals since the infect ion/ reinfect ion event 
causing a disease episode 
The distribution of the time interval since the infection/reinfection event causing disease 
among individuals of a given age a at time t, Dc (a, t, s) is given by: 
Dic 
Dc , 
(a, t, s) + D, (a, t, s) 
. 
(a, t, s) 
O{Di, (a, t, s)+D,.,,, (a, t, s)} 
for 0<s<a (4.6) 
where Di. (a, t, s) denotes the number of individuals of age a at time t experiencing disease 
as a consequence of an infection event s years previously, and D,.. (a, t, s) denotes the number 
of individuals of age a at time t experiencing disease as a consequence of a reinfection event 
s years previously. The denominator in this expression is the total number of diseased 
individuals of age a at time t, and is therefore identical to that in expression 4.1. 
By an analogous argument to that used in section 4.2.2.1, this distribution does not 
depend on whether we stratify diseased individuals according to their sputum status. The 
distribution D, (a, t, s) is therefore interpretable as both an 'actual' incubation period and 
serial interval for individuals diseased at a given age and in a given year (see definition in 
section 4.1). 
TBDYN3 assumes that the first primary episode and exogenous disease are attributable 
to tubercle bacilli from the initial infection and most recent reinfection events respectively 
(see section 4.2.1). Endogenous disease is attributed to the most recent infection or rein- 
fection event experienced by the individual. 
Di, (a, t, s) therefore corresponds to the number of individuals of age a at time t, who 
were infected s years previously, experiencing either a first primary episode or endogenous 
reactivation of the initial infection, and who therefore have never been reinfected. Sim- 
ilarly, D,., (a, t, s) corresponds to the number of diseased individuals of age a at time t, 
who were reinfected s years previously, experiencing either exogenous disease or endogenous 
reactivation of this reinfection event, and who therefore have not been reinfected further. 
The distribution Dc(a, t, s) was obtained for individuals diseased between 1900 and 
1990 using the same approach as that used in section 4.2.2.1, namely by estimating the 
corresponding Di, (a, t, s) and D,.. (a, t, s) for all possible values of s (i. e. between 0 and 
a years). These were estimated by first deriving the numbers of individuals infected and 
reinfected respectively at age a-s at time t-s, and simulating the disease dynamics 
for duration s in the subset of individuals in these groups who did not experience further 
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reinfection before this time. Individuals in this group belong to either the infected or 
'latent' classes or are experiencing their first primary episode or endogenous disease as a 
consequence of the initial infection. The total number of individuals in the last two disease 
classes after time s gives Di, (a, t, s). 
Individuals reinfected at age a-s at time t-a, on the other hand, belong to either 
the reinfected and 'latent' classes, or are experiencing exogenous or endogenous disease as 
a consequence of the reinfection event at time t-s. The total number of individuals in 
the last two classes in this group after time s gives D,, ja, t, s). The corresponding differ 
ential. equations representing the disease dynamics to derive Di, . 
(a, t, s) (and by extension 
D,., (a, t, s)) are summarized in Appendix B. 1. 
4.2.3 Prospective analyses of the incubation period and serial interval 
4.2.3.1 Extensions to TBDYN3 
In order to derive the distributions of the time interval until the first episode of respiratory 
or sputum-positive disease, individuals infected at a given age and in a particular year must 
in theory be followed up over their entire lives, given that they can develop endogenous 
and exogenous disease many years after an initial infection. The distributions ultimately 
obtained therefore depend on the "definition" of a lifetime. In the context of this work, the 
maximum duration of a lifetime is defined to be 100 years. 
This potentially complicates the derivations of distributions for individuals infected when 
aged 20 years in 1950, for example, since follow-up would have to last until the year 2030, 
when they reach 100 years of age, whereas TBDYN3 has hitherto traced the disease dy- 
namics among individuals only until the year 1990. Truncated distributions of the incuba- 
tion period and serial interval could be obtained, considering the disease dynamics among 
infected individuals only until the year 1990, but this would complicate the comparison 
between distributions among individuals infected at the same age but in different years. 
A truncated distribution for individuals infected when aged 20 years in 1920, for examplet 
would be based on 70 years of follow-up, as compared with 40 years of follow-up for similar 
individuals infected in 1950. 
In order to derive distributions of the time interval until the first respiratory or sputum- 
positive disease episode based on the full maximum 100 years of life for all individuals 
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infected before 1990, TBDYN3 was extended to consider the disease dynamics in England 
and Wales beyond 1990. This required projections for the age and time-specific mortality 
rates and the annual risk of infection into the future. The officially predicted mortality 
rates were obtained from the Government's Actuary's department. In the first instance, it 
was assumed that the decline of 13% pa in the annual risk of infection after 1950 continued 
after 1990, and thus the distributions obtained reflect what would be observed if current 
trends in the risk of infection are maintained. 
4.2.3.2 Lifetime risks and the distribution of the time interval from initial 
infection until the first respiratory or sputum-positive episode 
The distribution of the time interval until the first episode of respiratory tuberculosis for 
individuals first infected at age A at time t denoted by Df (A, t, s), as a function of the time 
since initial infection s is given by 
Df (A, t, s) = 
D, (A + s, t+s, s) for 0<s< 100 -A (4.7) ZIOO-A D, (A + s, t+s, s) =0 a 
where D, (A + s, t+s, s) denotes the number of individuals infected at age A at time t ex- 
periencing their first disease episode after time s (i. e. when aged A+s years at time t+ s) - 
Individuals have a maximum of 100 -A years of life available in which to develop disease, 
given infection at age A. In expression 4.7, DI (A + s, t+s, s) does not stratify first respi- 
ratory episodes according to whether they are attributable to initial infection or subsequent 
reinfection. An analogous expression holds for the distribution of the time interval between 
first infection at age A at time t and the first subsequent sputum-positive episode. 
The denominator in expression 4.7 gives the total number of individuals infected at age 
A at time t who develop at least one respiratory disease episode during their lifetime. Hence 
the ratio between the denominator and the total number of individuals infected at age A at 
time t, I(A, t), gives the overall lifetime risk of developing at least one respiratory disease 
episode given initial infection at age A. 
The distribution of the time intervals until the first respiratory disease episode given 
infection at a particular age, is not directly related to the corresponding distribution consid- 
cring sputum-positive disease. Individuals experiencing their first sputum-positive episode, 
for example, may have already experienced a sputum-negative episode sometime before and 
hence do not contribute to the two distributions simultaneously. 
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These two distributions were derived by estimating the number of individuals experienc- 
ing their first respiratory or sputum-positive episode in each year following infection at age 
A and time t using an analogous approach to that used in section 4.2.2.1. The distributions 
of time intervals until the first respiratory or sputum-positive episode attributable to the 
initial infection (i. e. without further reinfection) were derived similarly. Hence the number 
of individuals infected at age A at time t was first obtained using TBDYN3, and individ- 
uals were followed up until they developed their first respiratory or sputum-positive disease 
episode with or without further reinfection. This involved subdividing the corresponding 
follow-up population into the appropriate disease classes and tracking the transitions be- 
tween them. These disease classes, together with the corresponding follow-up population 
used are summarized in Table 4.1. 
To derive the distribution of time intervals between infection and the first respiratory 
disease episode, as a consequence or otherwise of the initial infection, for example, individ- 
uals infected simultaneously who had not yet experienced disease were followed up. These 
individuals belonged to either the infected, 'latent' and reinfected classes (see row 1(a) in 
Table 4.1). DI (A + s, t+s, s) is therefore given by the total number of individuals entering 
the first primary, endogenous and exogenous disease categories from the infected, 'latent' 
and reinfected ýIasses respectively after time s. 
Similarly, to derive the distribution of the time interval between infection and the first 
sputum-positive episode as a consequence of the initial infection event, individuals infected 
simultaneously who had experienced neither sputum-positive disease nor reinfection were 
followed up. These individuals belong to either the infected or 'latent' classes or are experi- 
encing sputum-negative first primary or endogenous disease (see row 2(b) in Table 4.1). In 
a given year, the total number of individuals experiencing sputum-positive disease for the 
first time as a consequence of the initial infection is given by the total number of individu- 
als entering the sputum-positive first primary and endogenous disease categories from the 
infected and 'latent' classes respectively. 
The lifetime risks of developing respiratory and sputum-positive disease were also ob- 
tained by following up infected individuals until age 100 years, and summing the numbers 
who developed their first respiratory or sputum-positive episode in each year of life. 
150 
G) :i ;j Cd 0 et 0 
r. ' 0 ýC r'n M0E Ei 9) .. 4 -4 Z 9) Cl> Z: CL) A4 tko ho to 
-4. -1 12.0 0 12-4 0 
0 r- -2.. vx -d-D 10 Cd 0= ed 0 1.0 u0 -0 m=w (n 9.1 0 -61 ci "-I w 9--1 wE9.1 E r. :10 ßd bio to 
12.4 0 P. 4 0 
-4.3 -0 4.3 
10 
rn 
10 924 -6.3 
0.6 im. 
1 
10 92 (n 10 R C) CL) Z) 
Q) C. 0 9) 
00> 
ZZ rn 6.1 
vi 
r. .. d 
0Z 
CU 00 (d 0 
.9.. -4 
E r. Ei 
-6.1 
d.. a G) 
(Z *Z to CL) 
CL) 
0 to 6.4 
to 
aw 
0 iz, 0 
-4.3 
"0 x 163 
10 
G) r 
dý 
r V) Mu >ý (n . 
4..? Q) 0) 14-a cj u CL) :14.2 ý. 41 2 4. a 4.. ) tzý 
8 
loä t21 Co 0t =4 b4 -- (0 0 
b--4 0--4 N-4 
tý 
N. -4 
0 
4.1 
«v 9) 
A 
52 0 4-. 0 (n . 6.2 "0 K4 bj ea 
0 0 
-0 0 
tü zi = 
4.2 
9 
C) 0-9 cu tz. 43 u 
c) 04 
-6-9 > e.. ý =3 -4-3 >1 
0 4.3 -2 0 tý 2= U) > r. = 0eZ., - 124 0v 
(G 
10 ý- CZ (n ý. b (4 M s. ce - -0 «ý (0 - -9 0 
ý-w im .- (4 r- > li ce "0 0 s. P-4 di .-Z. - c4 
= Q) ci 
v9s. 41 
20 CL) 
ce 
C. CL) -4. -1 
0 C) 
dv 
0> 
'55 Im. M 4) r. 0. .- Q) e. ) ce 2 4 qm c24 1-- ;2 .- ei 4. 
-4.3 r. 
Z) Q) -4.3 28 b0 0 
0 da di Ei ý *. ) 'Z ý -0 (d 
. 
LD *Z m C, 4 to D c24 "0 c3.10 (L) 
-4.2 
M 41 4 fi ... 0 . -9 4.7 'Z 
e 
-4a 'n .- 
lý (4 
C) 0) 9.4 9.4 (A sý = V-4 0) 9-1 Q) -61 
0 ý.. w ge M 
Nd 
Q 
.5. 
g24 
". i "-i 
ý_w 1.. ý 
z4 
-- 
C-4 c14 
90 
ri 
0 
bO 
0 
t 
E 
151 
4.3 Results 
4.3.1 Retrospective analyses of the incubation period/serial interval 
4.3.1.1 Distributions of time intervals since initial infection 
Figure 4.1 summarizes the distribution of the time interval since first infection of individuals 
who developed disease when aged 20 years during the period 1900-1990, and also shows 
the relative proportion developing their first primary episode, endogenous and exogenous 
disease. 
This shows that only a small proportion (, -o 3%) of diseased 20 year olds in 1900 had 
first been infected during the preceding year, and the greatest proportion (; Zý 25%) had 
first been infected in their first year of life (i. e. 20 years beforehand). Ilence only a small 
proportion of disease among 20 year olds in 1900 constituted first primary episodes and 
most were exogenous in origin. This occurred despite the higher risks of developing disease 
following initial infection in adolescence, as compared with those following reinfection. 
The very small contribution to the disease incidence ftorn 'recently' infected individuals 
follows from the fact that over 95% of 20 year olds in 1900 had already been infected by 
age 19 years, as they were born in 1880, when the annual risk of infection was estimated to 
be high (; ý-, 20%), and declining by about 2% pa (see sections 2.3 and 3.2.1). Hence only a 
small proportion of the cohort was still at risk of infection and of subsequently developing 
their first primary episode in 1900. 
The reasons underlying the large contribution to the disease incidence among 20 year 
olds in 1900 from individuals infected in their first year of life are complicated, and relate 
to the secular decline in the annual risk of infection, and how it determined the age-specific 
prevalence of infection in birth cohorts. By definition, individuals infected for more than 
five years comprise most of the 'latent' class, and face risks of endogenous disease, or of 
reinfection followed by exogenous disease (see section 3.1.2), which are independent of the 
time since initial infection. The proportion of all diseased 20 year olds in any year, who had 
been infected for 20,19,18 etc. years therefore reflects the proportion of the 'latent' class 
who had first been infected 20,19,18 etc. years beforehand, or whilst in their 1st, 2nd, 3rd 
etc. years of life. Given the secular decline in the risk of infection, the greatest proportion 
of any birth cohort was infected in its first year of life, when the risk of infection exceeded 
that in subsequent years. Hence individuals infected in their first year of life constituted a 
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Figure 4.1: Distribution of the time interval sincefirst infection of individuals who devel- 
oped respiratory tuberculosis when aged 20 years during the period 1900-1990, as estimated 
using TBDYN3. 
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infection 
larger proportion of diseased 20 year olds in 1900, as compared with those infected when 
older. 
Between 1900 and 1990, the shape of the distribution of the time interval since initial 
infection changed dramatically. The proportion of disease occurring among individuals in- 
fected during the preceding five years increased, as the contribution of exogenous disease 
to the disease incidence among individuals infected for more than five years decreased. 
Hence by 1990, the disease incidence among individuals infected for more than 5 years 
was attributable largely to endogenous reactivation. Similar changes are seen in the corre- 
sponding distributions considering older individuals diseased in these years (see Figures B-1 
and B. 2 in Appendix B-2). 
These changes are attributable also to the secular decline in the risk of infection, which 
meant that increasing proportions of later cohorts reached adult life without having been 
infected (when they faced high risks of developing the first primary episode), as compared 
with earlier cohorts. The decline in the risk of infection also meant that smaller proportions 
of individuals in the 'latent' class in later cohorts were reinfected and subsequently devel- 
oped exogenous disease, as compared with their counterparts in earlier cohorts. Given the 
shapes of the distributions obtained, we see that it is inappropriate to make general conclu- 
sions about the average time interval since infection of individuals developing disease at 
particular ages and in particular years. 
These distributions were also broken down to reflect the proportions of individuals expe- 
riencing disease for the first, second or subsequent time. Figure 4.2 summarizes the results 
obtained for 20 year olds experiencing disease during the period 1900-1990. 
This suggests that most of the cases in any year who had been infected for more than 
5 years, were experiencing disease for the first time, and only a tiny fraction (not visible 
on the plots) had already experienced two or more episodes. Of the diseased 20 year olds 
in 1900 who had been infected for 20 years (i. e. in their first year of life), about '10% 
were experiencing their second episode, and less than 1% were experiencing their third or 
subsequent episode. For diseased individuals in 1990, the corresponding proportions were 
4% and less than 0.01%. This shows that, overall, diseased individuals in a given year were 
more likely to have experienced a prior episode if they had experienced initial infection early 
in life and early in the century, when the risk of infection was still high. This is intuitively 
reasonable, given that: 
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Figure 4.2: Distribution of the time interval since first infection of individuals who devel- 
oped respiratory tuberculosis when aged 20 years during the period 1900-1990, as estimated 
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1. individuals infected in infancy have more years of life available in which to develop 
several disease episodes before age 20 years, as compared with counterparts infected 
when slightly older, and 
2. individuals first infected during the early 1900s experienced a higher risk of infection, 
and hence a greater proportion were reinfected and experienced exogenous disease, as 
compared with counterparts infected during the 1980s, for example. 
Analogous patterns are seen in the corresponding distributions for 50 and 70 year olds 
diseased during the period 1900-1990 (Figures B. 3 and 4.3 respectively). Of the 70 year 
olds diseased in 1900, who had been infected in their first year of life, for example, only 
about one third were experiencing their second episode, as compared with about 10% of 
their counterparts diseased in 1990. 
4.3.1.2 Distribution of the time interval since the infection/reinfection event 
causing the disease episode 
The distribution of the serial interval, or the time interval since the infection/reinfection 
event causing the current (sputum-positive) disease episode among 20 year olds during the 
period 1900-1990 is shown in Figure 4.4. This complements Figure 4.1, which shows the 
distributions of the time interval since initial infection for these individuals. 
This shows that of the 20 year olds diseased in 1900, almost all bad been reinfected 
during the preceding five years, and were therefore experiencing exogenous disease, whereas 
a negligible proportion was experiencing endogenous reactivation of an earlier infection or 
reinfection. Of those diseased in 1990, on the other hand, about 38% had first been infected 
during the preceding year, and about 8% of disease episodes were attributable to infection 
in the first Year of life. 
The change in the overall shape of the distribution between 1900 and 1990 is attributable 
to the decline in the risk of infection. This meant that later birth cohorts were more likely 
to reach adult life without having been infected (when they faced high risks of developing 
first primary episode if infected), and those who had been infected for many years were less 
likely to be reinfected as compared with earlier cohorts, and mainly developed endogenous 
disease as a consequence of the initial infection. Hence by 1990, diseased 20 year olds were 
either experiencing endogenous reactivation as a consequence of the initial infection event 
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or their first primary episodes after a recent infection. The distribution of the time interval 
since the infection /reinfection event among diseased 20 year olds in 1990, moreover, closely 
resembles that of the time interval since initial infection (see Figure 4.1). 
Similar patterns are also seen in the distributions of the time interval since the infec- 
tion/reinfection event causing the disease episode among 50 and 70 year olds during the 
time period 1900-1990 (see Figures 4.5 and 4.6). For these individuals, a greater propor- 
tion of disease in 1970 and 1990 was also attributable to reactivation of a reinfection event 
more than 5 years previously, as compared with that among diseased 20 year olds in these 
years. This is attributable to the high risks of infection when the corresponding 50 and 70 
year olds were younger. These high infection risks meant that over 60% of 70 year olds in 
1990 infected in their first year of life (in 1920), for example, had also experienced further 
reinfection at least once. 
159 
70 
60 
50 
40 
30 
20 
1c 
CD 
(n 
ca 
CD 
U) 
:5 
V) 
0 
(D 
CD 
"0 
CD 
0) 
cz 
CD 
(D 
CL 
Diseased in 19001 
Diseased in 195 
Diseased in 199 
0 10 20 30 40 50 0 10 20 30 40 
Disease attributable to: 
[:: ]I st primary M Exog Years since (re)infection Reactivation of: [M Infection WReinfection 
50 
Figure 4.5: Distribution of the time interval since the infection or reinfection event causing 
the current (sputum-positive) episode among individuals developing disease when aged 50 
years during the period 1900-1990, as estimated using TBDYN3. Shaded areas denote the 
proportion of individuals experiencing their first primary episode, exogenous disease, or 
reactivation of an earlier infection/reinfection. 
160 
70 
60 
50 
Diseased in 19001 Diseased in 191 
40 
30 
20 
1c 
CD 
Cl) 
as 7 
CD 
6 
C3) 5 
C: 
'a. 4 
0 
3 
CD 2 
"D 
CD 
V) 
co 
(D 
CD 
a- I 
Diseased In 195 
Diseased in 199 
0 10 20 30 40 50 60 70 0 10 20 30 40 50 60 70 
Disease attributable to: 
17-11 st primary M Exog Years since (re)infection Reactivation of: []]] Infection N]Reinfection 
Figure 4.6: Distribution of the time interval since the infect io n/re infect ion event causing 
the current (sputum- positive) episode among individuals developing disease when aged 70 
years during the period 1900-1990, as estimated using TBDYN3. Shaded areas denote the 
proportion of individuals experiencing their first primary episode, exogenous disease, or 
reactivation of an earlier infection /reinfection. 
161 
4.3.2 Prospective analyses of the incubation period and serial interval 
4.3.2.1 Overall lifetime risks of developing respiratory disease and the lob- 
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Figure 4.7: Lifetime risk of developing respiratory tuberculosis for individuals infected at 
different ages dking 1900-1990 in England and Wales, as derived using TBDYN3. 
Figure 4.7 summarizes the lifetime risks of developing respiratory tuberculosis for individuals 
initially infected at different ages during the period 1900-1990, as estimated using TBDYN3. 
According to this prediction, approximately 27% of individuals first infected at age 20 years 
in 1900 developed respiratory tuberculosis at least once in their lifetime, as compared with 
about 16% of their counterparts infected after 1950. For individuals infected in their first 
year of life in 1900 and after 1950, the corresponding lifetime risks were about 17% and 6% 
respectively. 
The overall age and time-specific patterns in these estimated lifetime risks depend on 
several factors, in particular: 
1. The age-specific risks of developing the first primary episode, endogenous and exoge- 
nous disease, 
2. The level and trend in the risk of (re)infection experienced, and 
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served' incubation period 
3. The number of years of life available in which to develop disease following infection 
or reinfection. 
Figure 4.7 shows that, regardless of the age at initial infection, the lifetime risk of deve- 
loping respiratory disease declined between 1900 and 1950 and remained almost unchanged 
thereafter. This decline between 1900 and 1950 was a consequence of the decline in the 
risk of infection, which meant that successive cohorts of individuals infected simultaneously 
were less likely to be reinfected and subsequently experience exogenous disease than their 
predecessors. 
The annual risk of infection was comparatively low after 1950 (e. g. F-4% and 0.4% in 
1950 and 1960 respectively), and hence few individuals first infected during this time also ex- 
perienced reinfection. Most individuals therefore experienced either a first primary episode 
or endogenous disease, if they developed disease at all, as the probability of experiencing 
these forms of disease is insensitive to the level and trend in the risk of (re)Infection. This 
accounts for the small change in the overall age-specific lifetime risks for individuals infected 
after 1950, despite the fact that the decline in the risk of infection accelerated in 1950 from 
4% pa to 13% pa. 
All individuals are assumed to face identical risks of developing their first primary epi- 
sode, endogenous and exogenous disease following infection after age 20 years (see sec- 
tion 3.1.3). Differences between the lifetime risks of developing respiratory tuberculosis for 
20 and 70 year olds first infected during the period 1900-1990 can therefore result only from 
differences in the years of life available in which to develop disease between these two age 
groups. Seventy year olds first infected in 1900, for example, had a lower lifetime risk as 
compared with their twenty year old counterparts, as they had fewer years of life available 
in which to develop disease. 
In contrast, the lifetime risk of developing disease among 20 year olds first infected 
in 1900 was greater than that among corresponding 0-10 year olds. This difference is a 
consequence of the high risk of developing the first primary episode following infection at 
age 20 years (14% - see section 3.3.1), which exceeded even the lifetime risk of developing 
respiratory disease following infection in childhood. 
Figure 4.7 shows that the lifetime risk among 10 year olds infected in 1900 was greater 
than that among younger counterparts, even though they had fewer years of life available in 
which to develop disease. This follows from the fact that TBDYN3 predicts that a greater 
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proportion of 10 year olds developed exogenous disease following infection during the early 
1900s, as compared with younger counterparts, as described below. 
TBDYN3 assumes that the risks of developing the first primary episode, endogenous 
and exogenous disease are identical for 0-10 year olds and first increase after age 10 years. 
Individuals infected in their first year of life in 1900 therefore faced the higher risks of 
developing exogenous disease after 1910 (i. e. when aged over 10 years) when the risk of 
infection was less than 6%. In contrast, 10 year olds first infected in 1900 first experienced 
the high risks of developing exogenous disease when the risks of infection were slightly 
higher. Hence a greater proportion of 10 year olds infected in 1900 were reinfected and 
developed (exogenous) disease, as compared with their counterparts infected in their first 
year of life. 
Given the high risks of infection estimated until 1950, it is likely that most adults during 
the early part of this century were first infected in childhood, and relatively few actually 
experienced the maximum lifetime risks predicted by TBDYN3. This is suggested in Fig- 
ure 4.8, which compares the age-specific lifetime risks of developing respiratory tuberculosis 
shown in Figure 4.7 against the overall lifetime risk weighted by the number of individuals 
infected at each age. 
This shows that the weighted lifetime risk also declined between 1900 and 1950, and, 
until 1920, was of a similar level to the risk among 0-10 year olds. This follows from the 
fact that most new infections during this time period occurred among infants and young 
children. The decline in the risk of infection meant that an increasing proportion of new 
infections occurred among adolescents and adults, who have high lifetime risks of developing 
disease, and hence we see that the decline in the weighted lifetime risk slowed until about 
1950. The increase in the weighted average after 1950 is an artefact of the BCG vaccination 
coverage after 1954 incorporated into TBDYN3. BCG vaccination is assumed to confer full 
protection against infection for 77% of individuals, and hence large proportions of vaccinated 
individuals after 1954 in TBDYN3 do not contribute to the overall weighted average. 
Given the dependence of the lifetime risks of developing disease on both the age at 
infection and the annual risk of infection, these results suggest that the distributions of the 
time interval between initial infection and the first episode of respiratory disease must be 
age and time-dependent. 
This is illustrated in Figure 4.9, which summarizes the distributions of time intervals 
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Figure 4.8: Comparison between the age-specific and overall lifetime risks (weighted by the 
number of individuals experiencing initial infection at each age) of developing respiratory 
tuberculosis for individuals infected during the period 1900-1990 in England and Wales, as 
derived using TBDYN3. 
between initial infection for individuals infected in their first year of life during the period 
1900-1990, and the first episode of respiratory disease. These show the relative contribu- 
tion of first primary, endogenous and exogenous disease to the disease incidence following 
infection. These distributions correspond to the incubation period which would have been 
'observed' among these individuals in practice. They do not correspond to the 'true' incu- 
bation period (defined by the time interval between initial infection/reinfection and the first 
disease episode attributable to this infection/reinfection - see section 4.1), since endogenous 
disease among these individuals can be attributed either to a subsequent reinfection or to 
the initial infection event. 
This shows that, of those infected in 1900 who developed disease sometime thereafter, 
about 23% did so within 5 years, as compared with about 65% and 70% of their counterparts 
infected in 1950 and 1990 respectively. The shapes of the distributions were similar for 
individuals infected in 1970 and in 1990, and most of the disease experienced constituted 
either first primary episodes or endogenous disease. This is consistent with the fact that the 
estimated lifetime risk of developing respiratory disease differed little between individuals 
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Figure 4.9: Distribution of the time interval between first infection and the first episode 
of respiratory disease for individuals infected in their first year of life during the period 
1900-1990, as estimated using TBDYN3. This corresponds to an 'observed incubation 
period'. 
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Figure 4.10: Distribution of the time interval between first infection and the first episode 
of respiratory disease for individuals infected at different ages in 1900, as estimated using 
TBDYN3. This corresponds to an 'observed incubation period'. 
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infected in 1960 and 1990. This follows from the low risk of infection during this time period, 
which meant that few individuals were reinfected and subsequently experienced exogenous 
disease. 
The overall shape of the distribution of the time interval until the first episode of respi- 
ratory disease following infection in infancy after 1950 reflects the high risk of developing 
the first primary episode and the change in the risks of developing endogenous disease ex- 
perienced as the individuals aged (i. e. low for 0-10 year olds, increasing until age 20 years 
and constant thereafter - see section 3.1.3). The proportion developing their first episode 
decreased 60 years after initial infection as a consequence of the high mortality rates, which 
reduced the number of surviving individuals from the initial cohort. 
Most of the disease among individuals infected before 1950 is attributable either to 
a first primary episode or to exogenous disease, although the relative contribution of the 
latter decreased with successive generations of infected individuals whereas that of first 
primary episodes and endogenous disease increased. This is consistent with the decline in 
the estimated lifetime risk of developing respiratory tuberculosis between 1900 and 1950. 
The shapes of the distributions of the time interval until the first respiratory episode 
for individuals infected until 1950 are therefore mainly a function of the size of the risk of 
developing the first primary episode and the secular decline and magnitude of the risk of 
infection. The decline in the risk of infection meant that the proportion of individuals who 
were reinfected and experienced exogenous disease also declined as the time since initial 
infection increased, even when the risks of developing exogenous disease increased, such as 
between the ages 10 and 20 years. This translated into a decline in the overall proportion 
developing respiratory disease as the time since initial infection increased when the risk of 
infection experienced was still high, e. g. for individuals infected in 1900 and 1910. 
This decline in the proportion developing disease as the time since initial infection 
increased is also seen in the corresponding distributions for individuals infected at other 
ages during this time. This is illustrated in Figures 4.10 and BA (Appendix B. 2.2), which 
show these distributions for individuals infected when aged 0-70 years in 1900 and 1930 
respectively. 
Of the individuals who developed disease following initial infection in the first year of life 
in 1900, Figure 4.10 shows that first primary episodes comprised about 23% of the subse- 
quent disease incidence, as compared with about 53% and 85% of that among counterparts 
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infected at age 20 and 70 years respectively. The low contribution for individuals infected in 
their first year of life, as compared with that among 20 and 70 year old counterparts follows 
from the lower risk of developing the first primary episode following infection in infancy, as 
compared with that following infection after age 20 years. The higher contribution of first 
primary episodes to the disease incidence among individuals infected when aged 70 years, 
as compared with that among 20 year old counterparts follows from the facts that 
1.70 year olds had fewer years of life available in which to develop disease, as compared 
with their 20 year old counterparts, and 
2. newly infected 70 year olds are less likely to survive 5 years and to experience en- 
dogenous or exogenous disease, as they faced rapidly increasing mortality rates, as 
compared with their 20 year old counterparts. 
Similar patterns are seen in the corresponding distributions for individuals infected in 
1960 and 1990 (see Figures B. 5 and B. 6 in Appendix B. 2.2). 
4.3.2.2 Overall lifetime risks of developing sputum-positive disease and the 
'observed' serial interval 
Figure 4.11 summarizes the age-specific lifetime risks of developing sputum-posiiive tuber- 
culosis, for individuals infected during the period 1900-1990 in England and Wales. For 
each age at infection considered, these risks are lower than the corresponding lifetime risks 
of developing respiratory tuberculosis (see Figure 4.7), since only an age-dependent fraction 
of all respiratory disease is assumed to be sputum-positive (see Figure 3.4 in section 3.1-3). 
Overall, the temporal and age-specific patterns in the lifetime risks of developing sputum- 
positive disease resemble those found for all respiratory disease. For cacti age at infection 
considered, for example, the estimated lifetime risk of developing sputum-positive disease 
also declined over time and the risks among 20 year olds infected in 1900 exceeded those 
among their 70 year old counterparts. This is consistent with the greater number of years 
of life available for 20 year olds infected in 1900 to become reinfected and subsequently 
develop exogenous disease or develop endogenous disease, as compared with those infected 
when aged 70 years in 1900. 
Whilst individuals aged over twenty years are assumed to face identical risks of develo- 
ping the first primary episode, endogenous and exogenous disease, the probability that this 
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Figure 4.11: Lifetime risk of developing sputum-positive tuberculosis for individuals in- 
fected at different ages during the period 1900-1990 in England and Wales, as derived using 
TBDYN3. 
disease episode is sputum-positive is assumed to increase with age (see Figure 3.4 in sec- 
tion 3.1.3). When the risk of infection is low (e. g. after 1950), this initial high risk following 
infection among 70 year olds exceeds the overall lifetime risk of developing sputum-positive 
disease among younger counterparts. This explains the lower lifetime risks following in- 
fection among 20 year olds after 1940, as compared with that among 70 year olds. In 
contrast, the lifetime risks of developing respiratory disease were found to be consistently 
lower following infection for 70 year olds, as compared with those among 20 year olds (see 
Figure 4.7). 
For reference, Figure 4.12 compares these lifetime risks against the corresponding overall 
lifetime risk, weighted by the number of individuals experiencing initial infection at each 
age. This exhibits very similar temporal patterns to the corresponding weighted lifetime 
risk of developing respiratory tuberculosis, declining until about 1920, and then increasing 
from 1950. 
The differences between the age and time-specific lifetime risks of developing sputum- 
positive tuberculosis and the corresponding risks of respiratory disease, suggest that the 
distributions of the time interval between initial infection and the first sputum-positive 
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Figure 4.12: Comparison between the age-specific and overall lifetime risks (weighted by 
the number of individuals experiencing initial infection at each age) of developing spulum- 
positive tuberculosis for individuals infected during the period 1900-1990 in England and 
Wales, as derived using TBDYN3. 
episode must also differ from those for respiratory disease. 
This is reflected in Figure 4.13, which summarizes the distribution of the time interval 
until the first sputum-positive episode for individuals infected in their first year of life 
during the period 1900-1990. These distributions correspond to the serial interval which 
would have been 'observed' among these individuals in practice. They do not correspond to 
the 'true' serial interval (see definition in section 4.1) since endogenous disease among these 
individuals can be attributed either to the initial infection event or a subsequent reinfection. 
The increase in the risk of developing sputum-positive exogenous disease between the 
ages 10 and 20 years, for example, affects the shape of these distributions for individuals 
who experience high risks of infection. This increase leads to a peak in the proportion of 
individuals experiencing disease during the 20-24th year after infection for those infected 
in infancy before 1950, whereas the greatest proportion of individuals who developed res- 
piratory disease did so during the first five years after infection (see Figure 4.9). 
When the risk of infection is low (e. g. after 1950), the shapes of these distributions 
reflect the relatively high risk of experiencing the first primary sputum-positive episode and 
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Figure 4.13: Distribution of the time interval between first infection and the first episode 
of sputum-positive disease for individuals infected in their first year of life during the period 
1900-1990, as estimated using TBDYN3. This corresponds to an 'observed serial interval'. 
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Figure 4.14: Distribution of the time interval between first infection and the first episode 
of sputum-positive disease for individuals infected at different ages in 1900, as estimated 
using TBDYN3. This corresponds to an 'observed serial interval'. 
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the change in the risks of experiencing sputurn-positive endogenous disease experienced as 
the individuals age. Additionally, the shapes of the distributions are similar to those of the 
distributions considering respiratory tuberculosis (see Figure 4.9), except that the overall 
relative contribution of first primary episodes to the sputum-positive disease incidence is 
slightly lower. For those infected in 1990, for example, first primary episodes comprised 23% 
of the subsequent sputum-positive incidence, and about 70% of the respiratory incidence 
(see Figure 4.9). This follows from the assumption that the risk of a given disease episode 
being sputum-positive increases as individuals age, i. e. as the time since initial infection 
increases. 
Figure 4.14 summarizes the distributions of the time interval since initial infection and 
the first sputum-positive episode for individuals infected when aged 0-70 years in 1900. 
Considering those infected when aged over 20 years, the overall shape of the distributions 
differ only slightly from those considering respiratory tuberculosis (see Figure 4.10), e. g. first 
primary episodes comprise a slightly smaller proportion of the sputum-positive incidence, 
as compared with that of the respiratory incidence. This is consistent with the findings for 
individuals infected in their first year of life discussed above. Similar findings are seen in 
the corresponding distributions considering counterparts infected in 1930,1960 and 1990 
(see Figures B. 7, B. 7 and B. 7 in Appendix B. 2). 
4.3.2.3 Lifetime risks of developing disease attributable to initial infection, and 
the 'true' incubation period and serial interval 
The general conclusions from the analyses of the lifetime risks of developing disease at- 
tributable to the initial infection are similar to those in the previous sections. They are 
included here for documentary thoroughness. 
Figure 4.15 summarizes the lifetime risks of developing respiratory disease attributable 
to the initial infection event for individuals infected when aged 0-70 years during the period 
1900-1990. This refers to the lifetime risk of developing disease without experiencing any 
reinfection in the meantime. This shows that of the individuals infected in their first year 
of life in 1900, about 4% ultimately developed respiratory disease without having been 
reinfected in the meantime, as compared with about 14% of those infected when aged 
20 years. Figure 4.16 summarizes the corresponding risks of developing sputum-positive 
disease. Both also show the overall lifetime risks in each year weighted according to the 
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Figure 4.15: Lifetime risk of developing respiratory tuberculosis attributable to initial 
infection for individuals infected at different ages during 1900-1990 In England and Wales, 
as derived using TBDYN3. 
number of individuals experiencing initial infection at each age. 
These figures show that for all ages at infection considered, the lifetime risks of develo- 
ping sputum-positive or respiratory disease attributable to initial infection increased slightly 
over time. Considering individuals infected in their first year of life in 1900 and after 1950, 
the lifetime risk of developing respiratory disease was about 4% and 6% respectively. This 
paradoxical increase, albeit slight, resulted from the decline in the annual risk of infection, 
which meant that individuals infected after 1950 for example, were more likely to experience 
disease without subsequent reinfection and thus apparently as a consequence of the initial 
infection, as compared with their counterparts infected in 1900. We also see that the decline 
in the, risk of infection, which led to changes in the age distribution of individuals experi- 
encing initial infection, led to increases in the overall weighted lifetime risks of developing 
respiratory and sputum-positive disease over time. 
The overall age-specific patterns in the lifetime risks of developing respiratory tubercu- 
losis attributable to initial infection are identical to those of the overall lifetime risks (see 
Figure 4.7). Given any year of infection, these risks are lowest for individuals infected in 
their first year of life, and are higher for 70 year olds, as compared with those among 20 
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Figure 4.16: Lifetime risk of developing sputum-positive tuberculosis attributable to initial 
infection for individuals infected when aged 0-70 years during 1900-1990 in England and 
Wales, as derived using TBDYN3. 
year old counterparts. The reasons behind these age-specific patterns are identical to those 
explaining the analogous differences in the overall age-specific lifetime risks of developing 
respiratory tuberculosis (see page 163). 
In contrast, the lifetime risks of developing sputum-positive disease attributable to the 
initial infection is estimated to increase with the age at infection, irrespective of the year of 
infection considered. This is consistent with the age-specific patterns in the overall lifetime 
risks of developing sputum-positive disease (see Figure 4.11). These patterns reflect the 
increasing risk (with age) of developing sputum-positive disease immediately after infection, 
which outweighs the overall lifetime risk among younger individuals (see page 170). 
Further insight into these age and time-specific patterns is provided by the distributions 
of the time interval between infection and the first onset of respiratory and sputum-positive 
disease for individuals who developed disease as a consequence of initial infection. These 
are described below. 
Figure 4.17 shows the corresponding distributions considering respiratory tuberculosis 
for individuals infected in their first year of life during the period 1900-1990. These dis- 
tributions reflect the 'true incubation period' for individuals infected at these ages in these 
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years (see definition in section 4.1). 
This shows that of those infected in their first year of life in 1900, who developed 
respiratory disease as a consequence sometime thereafter, about 95% did so during the first 
5 years after infection as compared with about 70% of counterparts infected in 1990. This 
again reflects differences between the risk of infection experienced by these individuals. The 
high risk of infection before 1950, for example, meant that individuals were more likely to 
be reinfected and hence less likely to experience disease attributable to the initial infection 
event more than five years after infection, as compared with counterparts infected after 1950. 
Similar patterns are also seen in the corresponding distributions for individuals infected at 
other ages. For reference, Figures B. 10, B. 11 and B. 12 show these distributions for 0-70 
year old individuals infected in 1900,1960 and in 1990 respectively. 
These figures also show that the distribution of the time interval until the first episode 
of respiratory disease attributable to the initial infection event closely resembles that of the 
'observed incubation period' (see Figure 4.9) for individuals infected after 1950. This is 
consistent with the low level of the risk of infection during this time, which meant that few 
individuals were reinfected and developed disease as a consequence. 
The same general patterns are seen in the corresponding distributions considering sputum- 
positive tuberculosis (i. e. the 'true serial interval' - see definition in section 4.1). This is 
shown in Figure 4.18, which summarizes these distributions for individuals infected in their 
first year of life during the period 1900-1990. We see, for example, that tile proportion who 
developed sputum-positive disease during the first five years after infection was lower for 
those infected in 1900 (80%), as compared with that for individuals infected in 1990 (23%). 
Figure 4.18 also shows that a greater proportion of those who developed sputum-positive 
disease as a consequence did so more than five years after infection, in any year of infection 
as compared with the corresponding individuals who developed respiratory tuberculosis. 
This follows from differences between the risks of developing sputum-positive disease and 
respiratory disease, which were discussed in relation to the distribution of the 'observed' 
serial interval (see section 4.3.2.2). This also holds for the corresponding distributions 
for individuals infected at other ages in other years. These distribution considering 0-70 
year olds infected in 1900,1930, and 1990 are shown in Figures B. 13, B. 14 and B. 15 in 
Appendix B. 2. 
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Figure 4.17: Distribution of the time interval between first infection and the first episode 
of respiratory disease attributable to the initial infection for individuals infected in their first 
year of life during the period 1900-1990, as estimated using TBDYN3. This corresponds to 
an 4actual incubation period'. 
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of sputum-positive disease attributable to the initial infection for individuals infected in their 
first year of life during the period 1900-1990, as estimated using TBDYN3. This corresponds 
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4.3.3 Effects of simplifications on the distributions obtained 
In considering the results, it is important to recognize that TBDYN3 oversimplifies the 
natural history of tuberculosis in several ways. The effect of each of the main simplifications 
is discussed below. 
4.3.3.1 Effect of age-independent risks of infection 
We noted in section 3.3.3 that TBDYN3 oversimplifies the natural history of tuberculosis 
by assuming that the risk of infection is not age-dependent, whereas in reality, it may 
increase slightly during adolescence [113]. In practice, it is likely that the magnitude of 
the increase is too slight to affect substantially the results obtained from the retrospective 
or prospective analyses of the incubation period and serial interval, or the lifetime risks of 
developing disease. 
In any case, the lifetime risks of developing disease and the prospective analyses of 
the incubation period and serial interval are based on follow-up of individuals who have 
already been infected. Hence an age-dependent risk of infection would have affected only 
the estimated numbers of individuals infected in a given year and at a given age, but not 
the subsequent disease history of the individuals. 
It is also likely that the risk of reinfection increases with age, although the magnitude 
of the increase has never been determined. The effect of this assumption on the results de- 
scribed in this chapter is likely to be small, given that TBDYN3 probably overestimates the 
risk of reinfection by assuming that it is identical to that of first infection (see sections 3.1.1 
and 3.4.1). 
4.3.3.2 Effect of reinfection 
TBDYN3 assumes that a disease episode is attributable to the most recent infection or 
reinfection event, and that individuals cannot be reinfected whilst they are already at risk 
of developing their first primary episode or exogenous disease (see section 3 1.2). 
It is likely that reinfection can occur within five years of a previous infection or reinfection 
event, although it is probably rare (see section 3.1.1). The effect of such a reinfection event 
on the risks of developing disease is not known. If it is assumed that the risk of developing 
the first primary episode increases if individuals are also reinfected, for example, then the 
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overall lifetime risks of developing disease for those infected before 1950 would have exceeded 
those derived in this chapter. The extent to which this is realistic is unclear. 
4.3.3.3 Sputum-positivity assumptions 
TBDYN3 assumes that a fixed, age-dependent proportion of all respiratory disease is 
sputu m- positive, irrespective of whether individuals are experiencing disease for the first or 
a subsequent time (see section 3.1.3). This is probably unrealistic, particularly for the pre- 
chemotherapy era. Individuals who have already experienced a sputum-positive episode, 
for example, may be more likely to experience further sputum-positive disease than those 
who have never experienced disease at all. This simplifying assumption has probably not 
substantially affected the results obtained from these analyses, given the relatively small 
proportion of individuals found to be experiencing their second or subsequent episode (see 
section 4.3.1.1). 
4.3.3.4 Risks of developing endogenous disease 
TBDYN3 assumes that the annual risk of developing endogenous disease remains constant 
for individuals aged over 20 years. In reality, it is likely that this risk increases with age, 
although the magnitude of this increase is not known. The question is complicated, given 
that 20 year olds alive during the pre-chemotherapy era, for example, would in general have 
experienced better general living standards and nutrition when older, which could have 
led to a reduction in the risk of developing endogenous disease. Consequently, it is likely 
that the results for the retrospective and prospective analyses of the incubation period and 
serial interval presented here do not differ substantially from those which would have been 
observed in reality. 
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4.4 Discussion 
The work described in this chapter constitutes the first ever attempts to analyze the lifetime 
risks of developing respiratory disease. We began by noting that estimates of the incuba- 
tion period and serial interval could be based from either a 'prospective' or 'retrospective' 
perspective. 
The distributions of the time interval since the infection or reinfection event causing dis- 
ease among individuals of a given age and in a given year (Figures 4.4,4.5, and 4.6), or the 
'true retrospective' incubation periods and serial intervals, suggest that most of the disease 
occurring during the early part of this century was attributable to recent transmission. In 
contrast, most of the disease among the elderly in recent years is attributable to infections 
or reinfections acquired many years ago. Recently, there has been a growing interest in 
applying DNA fingerprinting techniques to understanding transmission patterns. in popula- 
tions (see section 1.1). The results from retrospective analyses of the incubation period and 
serial interval potentially provide some insight into how results from DNA fingerprinting of 
sputum isolates would have changed over time. A greater proportion of isolates taken from 
elderly individuals from before 1950, for example, should have been 'clustered', as compared 
with those taken in recent years. 
The fact that the lifetime risk of developing tuberculosis given infection is age-dependent 
is not widely appreciated. The only published discussion of this question is that of Com- 
stock [121] in 1975, who suggested that the lifetime risk of developing disease following 
infection was probably higher for infants than adolescents, as infants have more life years 
available in. which to develop disease. NVe draw the opposite conclusion using results from 
TBDYN3, namely that the high risk of developing the first primary episode during adols- 
cence exceed even the cumulative risk of developing disease during a lifetime following 
infection in infancy (see Figures 4.7 and 4.11). 
The lifetime risks of developing respiratory tuberculosis during the pre-chemotherapy 
era (e. g., 26% following infection 
, 
at age 20 years) seem high in comparison with the 10% 
lifetime risk which is often quoted (see e. g. [6]). This 10% lifetime risk is estimated from the 
disease incidence during 10 years following 'conversion' to tuberculin-positivity among 2,550 
adolescents participating in the UK MRC BCG trial during the 1950s (29] (see sections 1.1 
and 1.2.1). However, this estimated 'lifetime' risk from the UK MRC BCG trial-does 
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not represent that experienced by individuals alive when the risk of infection was 
high, 
e. g. during the early 1900s, given that the risk of infection during the 1950s was already 
relatively low in England and Wales (see section 2.3). 
Whilst the lifetime risks of developing disease estimated for individuals infected until 
1950 are high, they are not unrealistic. A 22-year follow-up study of children of sputum- 
positive cases in Williamson County (Tennessee) Ilealth Department during the period 
1931-1954, found risks of developing disease of 19.7% following 'exposure' (as measured by 
the estimated onset of 'cough' of the case first notified to the County Ilealth Department) for 
individuals aged over 15 years [48] (see section 1.2.1). These results may well be unreliable, 
given that they were based on small numbers of cases (e. g. 10 among individuals aged over 
15 years followed up after exposure). 
Intuitively, the secular decline in the overall lifetime risks of developing either respira- 
tory or sputum-positive disease seems reasonable. The decline estimated using TBDYN3 is 
attributable to the decline in the risk of infection, which meant that successive generations 
of individuals were less likely to experience reinfection and subsequent exogenous disease 
than their predecessors. These lifetime risks could have also declined as a consequence of 
improvements in general living standards and the nutritional and health status of individ- 
uals. This would have meant that once infected, individuals were less likely to develop 
disease than counterparts in preceding generations. However, the amount by which this 
actually diminished the lifetime risks is unclear, given that other factors, such as smoking 
could have also contributed to an increase in the risk of developing disease [122]. 
The slightly higher lifetime risk of developing sputum-positive disease following infection 
at age 70 years after 1950, as compared with that among 20 year olds follows from the 
assumption that the probability that a disease episode is sputum-positive increases with age. 
This probability was estimated from the relative contribution of sputum-positive disease 
to age-specific notifications of respiratory tuberculosis in Norway. The reliability of this 
estimate depends on both the efficiency of the notification system and the rigour with which 
sputum examinations were carried out. Potentially, only the most severe tuberculosis cases 
are investigated thoroughly, notified and found to be sputum-positive, and this could have 
led to an overestimate in the 'true' relative contribution of proportion of sputum-positive 
disease to the age-specific disease incidence. The extent to which this is true must also 
depend on the age group and the time period considered. 
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Given that consistent age-specific patterns in the relative contribution of sputum-positive 
disease to the respiratory disease incidence were obtained, irrespective of the time period 
considered, this suggests that the assumption of an age-increasing risk of developing sputum- 
positive disease is realistic. More reliable data would perhaps have led to slightly different 
magnitudes in the relative contribution of sputum-positive disease to the respiratory inci- 
dence but the overall age-specific patterns would have been similar. This suggests that the 
age-specific patterns in the lifetime risks of developing sputum-positive disease would not 
have changed substantially from those presented here. 
The results in this chapter illustrate that the distribution of the time interval until 
the first respiratory or sputum-positive episode, and that of the time interval since initial 
infection among diseased individuals (or the observed incubation periods and serial intervals 
among infected or diseased individuals respectively) depend on the trend and level of the 
risk of infection and on age. This means the distributions derived here differ from those 
applicable in developing countries, where the risk of infection is high and has changed little 
during the past few decades. The issue is even more complicated, given that the magnitude 
of the age-specific risks of developing the first primary, endogenous and exogenous disease 
may differ from those derived for England and Wales (see section 3.4.1). 
In reality, the serial interval of any infection depends on many factors, including the 
time interval between onset of infection and infectiousness, the duration of infectiousness, 
the degree of infectiousness and amount of contact between infectious and uninfected in- 
dividuals. As we have seen in this chapter, the definitions of the serial interval, and the 
incubation period are particularly complicated for tuberculosis, given that individuals can 
develop disease following reinfection, and the risks of developing disease are age depen- 
dent. These complications must also arise for other infectious diseases, for example, herpes 
varicella-zoster and leprosy, in which individuals may be able to develop disease following 
reinfection. 
The results for the distributions of the time interval between initial infection and the 
first sputum-positive episode have implications for the net reproduction numbers. The 
high risk of infection until 1950 in England and Wales, for example, implied that most 
of the new infections in these years were among infants. As shown in Figure 4.18, about 
20% of individuals infected in their first year of life in 1900, who developed disease as a 
consequence, did not manifest disease until about 20 years thereafter. Thus overall, these 
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individuals comprised a long link in the chain of transmission, which must have influenced 
the value for the net reproduction number. This is discussed in detail in the next chapter. 
Retrospective analyses provide more insight into the dynamics underlying the decline in 
tuberculosis than do prospective analyses, as they reflect the'true'and 'observed' incubation 
periods and serial intervals that diseased individuals actually experienced. Prospective 
analyses of the incubation period provide some insight into the incubation that would have 
been experienced given infection at specific ages in given years. 
Overall, the results obtained seem intuitively reasonable, in spite of the simplifying 
assumptions incorporated into TBDYN3, and it is likely that the actual lifetime risks of 
developing sputum-positive and respiratory tuberculosis and the incubation period and 
serial intervals behaved in a similar way to that described here. 
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4.5 Brief review of key findings 
For reference, we briefly summarize the key findings in this chapter below. 
1. The incubation period and serial interval for tuberculosis can be analyzed 'retrospec- 
tively' (as the time interval since initial infection for individuals diseased at a given 
age and in a given year) and 'prospectively' (as the time interval until the first disease 
episode for individuals infected simultaneously at a given age and in a given year). 
2. Retrospective analyses suggest that about 3% of'diseased 210 year olds in 1900 had 
first been infected during the preceding year, and the greatest proportion (; zý 25%) 
had first been infected in their first year of life. The proportions for diseased 20 year 
olds in 1990 are 38% and 6% respectively. 
3. Prospective analyses of the incubation period suggest that about 25% of infants infected 
in 1900 who developed respiratory disease, did so during the first five years, and the 
proportion doing so thereafter declined with time since initial infection. 
4. Prospective analyses of the serial interval (by 5 year periods) indicate that the pro- 
portion of individuals infected in the first year of life in 1900 who developed sputurn- 
positive disease sometime thereafter, was maximum between the 20th and 24th years 
after initial infection (; ý-, 
5. Twenty year olds faced higher lifetime risks of respiratory disease following infection 
than did any other age group (e. g. 26% and 17% in 1900 and after 1950). The 
estimated lifetime risks of developing sPutum-positive disease increased consistently 
with the age at infection and were about 19% and 12% for 20 year olds infected in 
1900 and after 1950 respectively. 
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Chapter 5 
The basic and net reproduction 
numbers for tuberculosis 
5.1 Introduction 
.0 
5.1.1 Relevance and definitions of the net and basic reproduction num- 
bers for infectious diseases 
Much of the thinking behind the basic and net reproduction numbers for infectious diseases 
stems from the work of Ross on malaria in 1910 [123]. Using a simple model, Ross illustrated 
that, by maintaining the density of mosquitoes below a critical value for a given human pop- 
ulation, malaria would disappear from that area. Macdonald extended this thinking during 
the 1950s [124,125], showing that if, on average, each infectious case (of malaria) leads to 
less than one other case in a given population, then transmission will eventually cease, and 
the infection will disappear from the area. Macdonald referred to the number of secondary 
cases resulting from an infectious individual as the 'reproduction rate', or the 'net effective 
reproduction rate', which depended, among other things, on the proportion of 'susceptible' 
individuals in the population. Macdonald formally defined the 'basic reproduction rate' as 
the limit of the'net effective reproduction rate'as the proportion of 'susceptible' individuals 
in the population approached 100%, and described it as 
'the potential reproductive capacity of a totally non-immune and untreated case 
surrounded by a non-immune population' [125]. 
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For complete control of the infection in an area, the 'net effective reproduction rate' had to 
remain below one. 
For many infectious diseases, transmission of infection and hence the 'reproductive ca- 
pacity' of an individual case depends on age and mixing patterns in the population. For 
such diseases, the basic, reproduction rate (now often referred to as the 'basic reproduction 
number') is defined as: 
'the average number of secondary [infectious] cases resulting from the introduc- 
tion of a typical infectious individual during its entire infectious period, in a 
[totally] susceptible population' [50,51]1. 
The 'typical' infectious case in this definition refers to a hypothetical individual who is 
representative of the different age groups and subgroups in the population. This implies that 
if the basic reproduction number is greater than one, there is a high likelihood of continued 
transmission following the introduction of any infectious individual with SOMC2 degree of 
contact with other individuals into a 'totally susceptible' population, and the infection 
does not persist otherwise. This, of course, assumes that there is no additional control 
or intervention subsequent to the introduction of the infectious case into the population. 
An intervention such as chemotherapy, or one which changes the behaviour of individuals, 
changes important epidemiological parameters, such as the duration of infectiousness, or 
the contact between individuals, and must therefore change the magnitude of the basic 
reproduction number, and hence the likelihood of continued transmission (126]. 
The net effective reproduction rate (now often referred to as the 'net reproduction 
number') can be defined in an analogous way to the basic reproduction number, as: 
'the average number of secondary infectious cases resulting from a typical infec- 
tious case during its entire infectious period, in a given population under any 
given conditions. ' 
For any immunizing infectious disease, the net reproduction number is initially ap- 
proximately equal to the basic reproduction number following the introduction of a typical 
'Note that the definitions given in these references use the word 'infected' rather than infectious'. The 
word 'infectious' is sometimes more appropriate in defining the basic reproduction number, given that for 
some diseases (e. g. tuberculosis), not all infected individuals develop infectious forms of disease. 2 Note that this excludes cases who have no contact with other individuals. 
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infectious case into a 'totally susceptible' population. By definition, the net reproduction 
number has to change as the prevalence of 'immune' individuals changes in a population. 
For diseases such as measles, mumps and rubella, the relationship between the basic 
and net reproduction numbers in terms of the prevalence of immune individuals provides 
a useful means of estimating the minimum effective vaccine coverage required in a given 
population for eradication. If a proportion p of individuals in a population are immune, 
for example, leaving a proportion 1-p 'susceptible' to infection, then the net and basic 
reproduction numbers (R,, and RO respectively) are related as follows [119]: 
Rn = Ro(l - (5.1) 
The infection does not persist when the net reproduction number is less than one, and thus 
when: 
Rn = Ro(l - P) <1 (5.2) 
Rearranging this expression, the effective vaccine coverage (p) has to satisfy: 
(5.3) 
Ro 
for eradication of the infection. 
The derivation of the basic and net reproduction numbers for diseases in which age and 
mixing patterns determine transmission of infection is often not straightforward. In theory, 
individual age or subgroup-specific 'basic reproduction numbers' can be obtained for all 
possible age groups or population subgroups. These are defined as the expected number 
of cases produced by an individual of a given age-group or population subgroup following 
his/her introduction into a 'totally susceptible' population. Analogously, individual age 
or subgroup-specific 'net reproduction numbers' can also be defined. The overall basic 
reproduction number can be interpreted as an overall average of these individual age or 
subgroup-specific basic reproduction numbers. 
These individual age or subgroup-specific basic reproduction numbers are rarely calcu- 
lated in practice, and more commonly, the basic reproduction number for a given disease is 
estimated by considering the number of cases resulting from each generation of infectious 
cases, shortly after the introduction of an infectious individual into a 'totally susceptible' 
population [50,5113. The derivation of the basic reproduction number by this method relies 
3 More formaUy, the basic reproduction number is often defined as the 'dominant eigenvalue of the next- 
generation matrix' [50,51]. 
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on assumptions relating to the density of infectious cases in the population shortly after 
introduction of the infectious case. 
5.1.2 Definitions of the basic and net reproduction numbers for tubercu- 
losis 
We begin our discussion of the basic and net reproduction numbers for tuberculosis by 
clarifying the definition of a 'totally susceptible population'. 
For many infectious diseases, individuals who have already experienced prior infection 
with or without disease are generally considered to be fully protected against subsequent 
infection. For these diseases, a 'totally susceptible population' is therefore one in which 
no individual has hitherto experienced infection or effective vaccination. For tuberculo- 
sis, both uninfected and infected individuals can be considered susceptible - uninfected 
individuals may be infected and develop disease attributable to this initial infection and 
infected individuals may be reinfected and develop disease attributable to the reinfection 
event. Given that the risk of developing disease subsequent to reinfection differs from that 
following initial infection, a'totally susceptible population', as used in the definition of 
the basic reproduction number is best defined for tuberculosis as one in which no individual 
has hitherto experienced infection or disease. 
On this basis, and given that pulmonary forms comprise the vast majority of infectious 
tuberculosis cases, the definition of the basic reproduction number given on page 188 might 
best be rephrased in the following way to be applicable to tuberculosis: 
The average number of secondary infectious (pulmonary) cases re- 
sulting from a typical infectious (pulmonary) case during its entire 
infectious period, following its introduction into a population in which 
no individual has hitherto been infected with the tubercle bacillus. 
Similarly, we propose the following definition for the net reproduction number for tu- 
berculosis: 
The average number of secondary infectious (pulmonary) cases result- 
ing from infection or reinfection by a typical infectious (pulmonary) 
"It is also likely that the risk of reinfection differs from that of initial infection - see section 3.4.1. 
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case during its entire infectious period in a given population under 
any given conditions. ' , 
In the following discussion, we shall refer to the infectious pulmonary tuberculosis case 
introduced into an uninfected population as the founder case. Similarly, we shall refer to 
the disease episode experienced by the founder case when introduced into the population 
as the founding disease episode. 
The definition of a 'typical' infectious case for tuberculosis has to take into account 
the fact that individuals can be reinfected or reactivate several times and thus have several 
episodes of infectiousness. These disease episodes can be viewed as 'continuations' of pre- 
ceding disease episodes if they are attributable to the same infect ion/re infection event i. e. 
if the case experiences no (further) reinfection in the meantime. The number of infectious 
pulmonary disease episodes experienced by an individual which are attributable to a given 
infection or reinfection depends mainly on two factors: 
1. the risk of subsequent (re)infection, and 
2. the age at (re)infection. This determines both 
(a) the number of years of life avaHable in which to develop disease (and/or experl- 
ence reinfection), and 
(b) the likelihood of the disease episode being sputum-positive. Less than 10% of 
respiratory disease among infants and children is sputum-positive, for example, 
as compared with over 50% of that in adults (see section 1.1). 
For these reasons, the definition of a 'typical infectious pulmonary tuberculosis case', 
as used in the definitions of the basic and net reproduction numbers above, should account 
for all possible ages of founder cases, and the risk of (re)Infection subsequent to his/her 
introduction into an uninfected population. 
These factors also determine the number of secondary infectious cases resulting 
from a given case. If a founder case is introduced into an uninfected population, for example, 
is reinjected and subsequently experiences disease several years after recovering from the 
founding episode, then the number of secondary cases arising from the second disease episode 
should not contribute to estimates of the basic reproduction number. The converse should 
hold if the founder case reactivates several years after recovering from the founding episode 
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without having been reinfected in the meantime. Similarly, if a secondary case is reinfected 
and subsequently experiences disease after recovering from disease attributable to infection 
by the founder case, then the subsequent episodes should not contribute to estimates of 
the basic reproduction number. The converse holds if a secondary case experiences further 
disease without having been reinfected. 
For these reasons, the number of secondary cases resulting from a given founder 
case must depend on the age of the individuals infected, and therefore on the age structure 
of the population, and on the risk of (re)infection experienced. 
The fact that cases who have been reinfected by the founder case can be defined as 
'secondary cases' also leads to the paradoxical result that, if a given founder case reactivates 
many years after being introduced into an uninfected population, then the basic reproduction 
number would also have to depend on the net reproduction number in the year in which the 
reactivation occurs. 
In practice, basic reproduction numbers for infectious diseases are usually estimated 
by assuming that the population is in a stable demographic state and that all disease 
parameters (e. g. those defining the contact between individuals) are constant over the time 
period considered. For diseases with short incubation periods and serial intervals (i. e. 
measured in days), occurring in developed countries, these are reasonable assumptions. IF-or 
tuberculosis, the potentially long incubation period and serial intervals, depending on both 
the age of individuals and the calendar year, mean that demographic and epiderniologic 
changes in the population will affect the number of cases attributable to a founder case, 
and hence the basic reproduction number. Because of this, we are led to define two variants 
of the basic reproduction number concept to take these temporal changes into account. This 
argument is presented in the following section. 
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5.2 Method 
5.2.1 Derivation of an effective contact number 
Following the discussion in the last section, TBDYN3 was used first to estimate the average 
number of individuals 'effectively contacted' by each sputum-positive case in a particular 
year, c(t), and to monitor its change over time. We refer to this measure as the 'effective 
contact number'. An 'effective contact' between a sputum-positive and any other indi- 
vidual is here defined, as by Frost [127], as one sufficient to lead to infection if the contacted 
individual had never been infected in the past. 
Considering the population in England and Wales modelled by TBDYN3, individuals 
contacted by a sputum-positive case at a given time t can belong to one of three categories: 
1. Those who have not hitherto been infected (U(t)). By definition, an effective contact 
between a sputum-positive case and such an individual must lead to infection. 
2. Those in the 'latent' class (L(t)). TBDYN3 assumes that the risk of reinfection among 
these individuals is identical to that of first infection among uninfected individuals. 
3. All other individuals (O(t)), who are either experiencing disease, or who have been 
recently infected/reinfected and who are at an already high risk of developing disease 
attributable to this infection/reinfection. We have assumed that these individuals 
cannot be reinfected (see section 3.1.2), and hence that an effective contact between a 
sputum-positive case and these individuals does not lead to transmission of tubercle 
bacilli. 
We denote the average number of individuals in each of the above classes effectively 
contacted by a sputum-positive case at time t by ci (t), q. (t), and c. (t) respectively. 
Assuming that individuals mix randomly in the population, then the total number of In- 
dividuals. effectively contacted at a given time t by each sputum-positive case is independent 
of the composition of uninfected, 'latent' and all other individuals in the population. Hence 
the effective contact number for a given time t, c(t), is given by the following expression: 
ci (t) + Cr (t) + Co (t) - 
(5.4) 
The annual risk of infection Y(t)) is defined as the proportion of uninfected individuals 
who become infected in a given year t. Given U(t) uninfected individuals present in the 
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population in a given year t, then the number of new infections is given by i(t)U(t). If there 
are D+(t) sputum-positive cases present, then, on average, the total number of individuals 
infected (i. e. effectively contacted) by each sputum-positive case (cj(t)) is given by: 
ci (t) = 
(t) (t) 
D+ (t) 
(5.5) 
Analogous expressions hold for the number of individuals in the 'latent' and 'other' 
classes contacted by each sputum-positive case. 
The assumption of homogeneous mixing means that the probability that a sputum- 
positive case has effective contact with individuals in the uninfected, or any other class, 
depends on their relative size in the population. Given U(t) uninfected individuals in a 
U(t) 
population of size N(t) at time t, a proportion g-(t) of all those effectively contacted by 
each sputum-positive case will be uninfected. Hence ci(t) is given by 
Ci(t) = C(t). 
U(t) (5.6) 
N (t) 
Equating this expression for ci(t) with that given above (equation 5.5) yields: 
Ci(t) = C(t) 
um 
= (5.7) N(t) D+ (t) 
Cancelling out U(t) gives: 
C(t) i(t) (5.8) 7-(-t) D+ (t) 
and then rearranging this expression implies: 
C(t) N (t) 
(5.9) 
D+ 
where D+(t) denotes the prevalence rate of sputum-positive cases at time t. Hence the 
effective contact number in a given year t is given by the ratio between the annual risk of 
infection and the prevalence of sputum-positive cases. This is analogous to the 'contagious 
parameter' defined by Styblo [52], which we described in section 1.2.2. 
Figure 5.1 summarizes the crude incidence and prevalence of sputum-positive cases 
during the period 1900-1990, as estimated using TBDYN3. This shows that at least until 
1950, the estimated prevalence of sputum-positive cases exceeded the incidence by a factor 
of a little over 1.5 (i. e. 1.65). This results from the assumption in TBDYN3 that individuals 
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Figure 5.1: Crude incidence and prevalence of sputum-positive tuberculosis per 100,000 
males aged 0-100 years in England and Wales during the period 1901-1990, as estimated 
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Figure 5.2: Annual effective contact number between sputum-positive and other individ- 
uals in the population in England and Wales during the period 1901-1990, as estimated 
using TBDYN3. 
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are sputum-positive for 2 years, and have a case fatality rate of 35% during the first year 
after disease onset during the pre-chemotherapy era. The relationship between the estimated 
sputum-positive disease incidence and prevalence changes after 1950, when we assume that 
the case-fatality decreased (see section 3.1.3). 
Figure 5.1 also shows that in 1900, there were about 620 sputum-positive cases for 
every 100,000 individuals in the male population. The estimated annual risk of infection 
in 1900 was about 14,500 per 100,000 uninfected individuals (14.5%) (see section 3.2-1), 
and hence, on average, each sputum-positive case effectively contacted approximately 23 
(ý- 14,500/620) individuals. Figure 5.2 summarizes the effective annual contact numbers 
derived in the same way for the period 1900-1990. This shows that the estimated effec- 
tive contact number declined steadily to about 10 by 1949, declined more rapidly for the 
subsequent three years, and then declined at about the pre-1950 rate thereafter. 
5.2.2 Analyses of the basic and 'founder case' reproduction numbers 
5.2.2.1 Definition of the founder case reproduction number I 
The secular decline in the effective contact number for tuberculosis is itself attributable to 
the effect of many 'interventions' (e. g. the reduction of crowding in living conditions, removal 
of infectious cases from the community to sanatoria (before 1950) or through treatment after 
1950, and general improvements in hygiene - see section 5.4). 
As we saw in section 5.1.1 the basic reproduction number for an Infectious disease is 
interpreted as a parameter which describes the likelihood of continued transmission in the 
absence of additional control or intervention. On this basis, the definition of the basic 
reproduction number for tuberculosis given on page 190 is more appropriately rephrased as: 
The average number of secondary infectious (pulmonary) cases re- 
sulting from a 'typical' infectious (pulmonary) case during its entire 
infectious period, following its introduction into a population where 
no individual has hitherto been infected with the tubercle bacillus, as- 
suming that environmental conditions and the effective contact num- 
ber do not change further over time. 
Henceforth in this thesis, this definition will be used for the basic reproduction number 
for tuberculosis. It is important to recognize that, given this definition, the magnitude 
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of the basic reproduction number for tuberculosis in a given year does not necessarily 
reflect the likely trend in disease incidence subsequent to the introduction of a founder case 
into an uninfected population, as it does not take into account changes in epidemiological 
parameters, which actually did occur. The basic reproduction number for tuberculosis for 
a given year during the pre-chemotherapy era, for example, does not even take into account 
the fact that chemotherapy was introduced during the 1950s. 
On this basis, a variant of the basic reproduction number, which is a function of future 
changes in the effective contact number and the introduction of chemotherapy, might be 
more appropriate for describing the likely trend in disease incidence subsequent to the 
introduction of a founder case into an uninfected population. In the following discussion, 
we refer to this parameter as the founder case reproduction number, and define it 
formally as: 
The average number of secondary infectious (pulmonary) cases re- 
sulting from a 'typical' infectious (pulmonary) case during its entire 
infectious period, following its introduction into a population where 
no individual has hitherto been infected with the tubercle bacillus, 
allowing for changes in the effective contact number. 
By definitioin, the magnitude of the founder case reproduction number changes over 
time as a function of changes in environmental and epidemiological parameters, and these 
changes determine the trend in disease incidences. 
We describe the methods used to analyze the basic and founder case reproduction num- 
bers for tuberculosis below. 
5.2.2.2 - Transmission dynamics in a 'totally susceptible' population 
The potentially long time interval between infection and onset of infectious pulmonary 
disease and the fact that individuals can experience reinfection mean that it is difficult to 
'We are aware of no published derivation of a parameter which describes the long-term persistence of 
an infectious disease for which environmental conditions or epidemiological parameters change continuously 
over time. Analogous issues have, however, been raised in the ecological modelling literature. Metz et 
al [128], for example, discuss the definition of a parameter describing the likelihood of long-term survival of 
a given species if mutations occur fol, lowing changes to the environment. Metz el al define this parameter 
as the dominant Lyapunov exponent of a given matrix process. The parameter is negative if the population 
is destined for extinction, and is positive otherwise. 
197 
obtain analytic expressions for the basic and founder case reproduction numbers. On this 
basis, we estimated these parameters for a given time t by direct simulation. 
To analyze the founder case reproduction number, we simulated the introduction of a 
founder case who was infectious for duration ij into a population of uninfected individuals, 
which was identical to that in England and Wales at time t and in subsequent years with 
respect to its: 
1. Age structure, 
2. Age and time specific mortality rate, 
3. Annual effective 'contact number' c(t), 
and tracking the individuals infected by the founder case, and summing the number who 
ultimately developed disease attributable to the initial infection (Foi, (t)). The basic re- 
production number was analyzed in an analogous way, i. e. by deriving the number who 
ultimately developed disease attributable to the initial infection (Roj, (t)), assuming that 
the effective contact number and the case-fatality rate did not change subsequent to the 
introduction of the founder case. For simplicity, the founder case was assumed to be infec- 
tious for either one or two years. Given that we intend only to explore the implications of 
a declining effective contact number on the disease dynamics, Individuals are not assumed 
to be vaccinated at any time. We related the magnitude of Roj, (t) and Roj, (t) for different 
values of if to the trend in disease incidence subsequent to the introduction of given founder 
cases in these simulations. 
The statistic Foif (t) can be expressed in terms of the effective contact number as follows: 
Suppose that a founder case is introduced into a population of uninfected, Individuals 
of size N(t) in year t and effectively contacts c(a, t) individuals of age a. Assuming homo- 
geneous mixing (see page 99), and that there are u(a, t) uninfected individuals of age a at 
. 
time t, then of all the individuals effectively contacted, a proportion N (t) will 
be of age a. 
c(a, t) is therefore given by 
c(a, t) = c(t) 
u (a, t) (5.10) 
Suppose that a proportion p(a, t) of those infected at age a at time t develop sputum- 
positive disease attributable to this infection episode (i. e. without having been reinfected 
in the meantime). If the sputum-positive case is infectious for duration ij, then out of all 
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those infected at age a during the infectious period (between time t and t+ if), a total of 
if 
c(a, t+ j)p(a, t+ j) 
ultimately develop disease attributable to the initial infection by the founder case. 
Hence summing over all the possible ages at infection, the number of secondary infectious 
cases resulting from a founder case introduced in year t who was infectious for duration ij, 
Foif (t), is given by 
Fo,, (t) c(a, t+ j)p(a, t+ j) 
a 
Analogous expressions hold for Roj, (t). We describe the extensions required to TBDYN3 
to analyze the basic and founder case reproduction numbers below. 
5.2.2.3 Extensions to TBDYN3 
Hitherto, TBDYN3 has tracked the disease incidence in a population only within cohorts 
of individuals, i. e. among individuals of the same age. The approach used, to analyze the 
basic and founder case reproduction numbers for tuberculosis was analogous, except that 
all individuals alive in a given year (and born thereafter) were followed up simultaneously. 
The system of equations describing the disease dynamics in these individuals is identical to 
that given in Appendix A. 1, except that 
1. we now assume that only 1 sputum-positive case was present at the start of the 
simulations in a given year, and 
2. the risk of infection at a given time t is given by the product of the prevalence of 
sputum-positive cases at that time, and the effective contact number, as follows: 
i(t) = c(t)D+(t) 
This follows from rearranging equation 5.9. 
(5.13) 
The whole system of equations was programmed in V using forward Euler differenc- 
ing [114] with time steps of 1 year in both age and time (i. e. secular time, and time since 
infection/disease)'. This required identical input data on the birth and the age and time- 
specific mortality rates to those used in the work described in the last two chapters. 
6Note that individuals can be (re)infected and develop disease in the same year - see section 3.1.2. To 
avoid the problem of individuals contributing to the risk of infection in the same year as that in which they 
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To establish the number of cases resulting from a founder case, infected individuals have 
to be followed up over their entire lives. Thus individuals infected by a sputum-positive 
case when aged 20 years in 1950, for example, would have to be followed up until they were 
aged 100 years (i. e. a lifetime, as considered by TBDYN3) in the year 2030. The proportion 
of these individuals who developed disease without further reinfection after 1990, depends 
on the assumptions made about the subsequent trend in the effective contact number and 
in demography. For simplicity, it is assumed that the effective contact number does not 
change after 1990, and that the number of births and age and time-specific mortality rates 
for individuals born after 1990 remain at the 1990 levels. 
-5.2.3 Analyses of the net reproduction number 
It is difficult to obtain analytic expressions for the net reproduction number for tuberculosis 
for a given year, given the potentially long time interval between infection and onset of 
infectious pulmonary disease and the fact that individuals can experience reinfection. 
Given these complexities, we first describe the relationship between the net reproduction 
number, the effective contact number, and the lifetime risk of developing sputum-positive 
disease attributable to a given i nfectio n /reinfection. 
Suppose that at time t each sputum-positive individual effectively contacts ci(a, t) indi- 
viduals of age a in the uninfected class, and a proportion pi(a, t) of these ultimately develop 
sputum-positive disease attributable to their infection event. If the sputum-positive case is 
infectious for duration if, then out of all those infected during the infectious period (between 
time t and time t+ if), a total of 
if 
ci (a, t +j)pi (a, t +j) 
will ultimately develop disease attributable to their initial infection. By an analogous ar- 
gument, a total of 
if 
Cr(a, t+ j)Pr(a, t+ j) 
develop disease attributable to reinfection at age a during the infectious period of the 
sputum-positive case, where q. (a, t) denotes the number of individuals in the 'latent' class 
are (re)infected (i. e. potentially (re)infecting themselves! ), we set the risk of infection in year t to be the 
product of the contact rate in year t, and the prevalence of sputum-positive cases in year t-1. 
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effectively contacted by each sputum-positive case at age a and time t, and Pr(a, t+ 
denotes the proportion of these individuals who ultimately develop sputum-positive disease 
attributable to this reinfection event. 
Summing these two components over all the possible ages at infection and reinfection, 
the number of secondary cases from a sputum-positive case who develops disease at time t 
and is infectious for duration if, R,, if (t), is given by 
Rnif (t) =I: Llci (a, t+j)pi (a, t+j) + Cr (a, t+j)Pr (a, t+j)} 
ia 
The average number of secondary cases resulting from individuals who developed disease 
at time t depends on the proportion surviving from year to year. As we saw in section 5.1.2, 
this depends on age, and is further complicated by the fact that individuals can be reinfected. 
We obtained a rough estimate of the net reproduction number for individuals who 
developed sputum-positive tuberculosis at time t directly from TBDYN3 by considering the 
ratio between: 
1. the total number of individuals who were infected or reinfected in a given year t, who 
ultimately developed disease attributable to this infection/reinfection event (D. (t)), 
and 
2. the total number of sputum-positive cases at time t (D+(t)). 
The relationship between these two statistics is described below. 
Suppose that in year t there are D,, (t) new sputum-positive cases. Given a total preva- 
lence of sputum-positive cases in year t of D+(t), a proportion 
Dn W 
of the new infections D+ (t) 
and reinfections occurring in that year will be attributable to individuals who developed 
sputum-positive disease in year t. 
Given that a total of D. (t) individuals ultimately develop sputum-positive disease at- 
tributable to their infection/reinfection event in year t, then 
D,, (t) 
T+ (5.17) 
secondary cases result from the first year of infectiousness of individuals who developed 
sputum-positive disease in year t. 
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By an analogous argument, assuming that D. (t + 1) of those who developed sputum- 
positive disease in year t survive until the subsequent year, t+1, then 
D. (t + 1) 
D+(t + 1) . 
D. (t + 1) 
secondary cases result from the second year of infectiousness of these individuals. 
TBDYN3 assumes that sputum-positive cases are infectious for 2 years, unless they die 
in the meantime (see section 3.1.3). Hence, summing these two components, 
D(t) D. (t + 1) 
D+(t) . 
D (t) + D+(t + 1) . 
D. (t + 1) (5.19) 
secondary cases result from individuals who developed sputum-positive disease in year t 
Dividing through by D,, (t), the average number of secondary cases attributable to indi- 
viduals who developed sputum-positive disease in year t (R,, (t)) is given by 
D,, (t) D. (t) + D. (t + 1) (5,20) D,, (t) 
f 
D+(t) D+(t + 1) 
1 
This expression simplifies to: 
D. (t) 
+ 
D. (t + 1) D. (t + 1) 
D+(t) DO) *D+(t+l) 
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Figure 5.3: Number of secondary sputum-positive cases resulting from a founder case who 
was infectious for one or two years, introduced into an uninfected population similar in 
structure to that in England and Wales during the period 1900-1990, as estimated using 
TBDYN3. 
5.3 Results 
5.3.1 Analyses of the basic and founder case reproduction numbers , 
5.3.1.1 The founder case reproduction number 
Figure 5.3 summarizes the number of secondary sputum-positive cases attributable to in- 
fection by a founder case who was introduced between 1900 and 1990 into a population 
similar to that in England and Wales, and was infectious for one or two years, assuming 
that the effective contact number declined subsequent to his/her introduction. This shows 
that the founder case who was infectious only for one year led to about 1.6 secondary cases 
if introduced in 1900, and first led to less than one other case if he/she was introduced after 
1940. 
In contrast, the founder case who was infectious for two years led to about 3.2 secondary 
cases if introduced in 1900, and led to less than one other case if introduced after 1960. NVC 
discuss how closely a founder case who was infectious for one or two years approximates 
a 'typical' founder case, and hence whether the number of secondary cases resulting from 
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these individuals approximates the founder case reproduction number below. 
TBDYN3 assumes that sputum-positive cases are infectious for two years, unless they 
die in the meantime. During the pre-chemotherapy- era, the case-fatality rate is assumed to 
be 35% during the first year after disease onset. Consequently, only 65% of sputum-positive 
cases are assumed to be infectious for 2 years during this time. Assuming that a negligible 
proportion of cases also develop further sputum-positive disease at some stage thereafter 
(which is not always realistic), then this implies that the number of secondary cases pre- 
dicted to result from a founder case who is infectious for two years slightly overestimates 
the founder case reproduction number during the pre-chemotherapy era. 
The case-fatality rate is assumed to decline after 1950, and is the same as the mortality 
rate in the general population after 1976 (see section 3.1.3). Hence a large (age-dependent) 
proportion of individuals who develop sputum-positive disease are assumed to be, infectious 
for a full two years. Applying reasoning similar to that above, we can conclude that the 
number of secondary cases resulting from a founder case who is infectious for 2 years closely 
approximates the founder case reproduction number after 1950. Hence the founder case 
reproduction number probably first fell below one in about 1960. 
Henceforth in this thesis, we use the number of secondary cases resulting from an indi- 
vidual who is infectious for the full two years to reflect the magnitude of the founder case 
reproduction number for tuberculosis. We discuss the implications of the magnitude of the 
founder case reproduction number in a given year for the disease dynamics subsequent to 
the introduction of a founder case into an uninfected population below. 
Figure 5.4 summarizes the total expected number of cases occurring after the intro- 
duction of a founder case, who was infectious for two years into an uninfected population 
identical to that in England and Wales in terms of its demography and subsequent trend in 
the effective contact number in 1900,1920,1940 and 1960. Figure 5.5 shows these statistics 
on a log scale to facilitate comparison of their rates of increase for these years. 
Figure 5.4 shows that, following the, introduction of the founder case in 1900, the total 
number of sputum-positive cases increased for the first 40 years to about 200,000 in around 
1940 and then started'to decrease. The introduction of the founder case in 1920 and 1940, 
led to considerably lower peak numbers of sputum-positive cases, namely 4,000 and 13 
respectively. Figure 5.5 shows that the incidence of sputum-positive cases increased more 
rapidly for the epidemic initiated in 1900, as compared with that for epidemics initiated in 
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Figure 5.4: Number of incident and prevalent sputum-positive cases following the intro- 
duction of one sputum-positive individual into an uninfected population similar in structure 
to that in England and Wales in 1900,1920,1940 and 1960, as estimated using TBDYN3. 
This assumes that the sputum-positive case was infectious for two years. 
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introduction of one sputum-positive individual into an uninfected. population similar in 
structure to that in England and Wales in 1900,1920,1940 and 1960, as estimated using 
TBDYN3. This assumes that the sputum-positive case was infectious for two years. 
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subsequent years. This is consistent with the higher effective contact number estimated for 
1900, than in later years (see Figure 5.2). 
Figure 5.6 shows that the incidence rate for the epidemics initiated in 1920 and 1940 
started to decline at the same time (i. e. in about 1954) irrespective of whether the founder 
case had been infectious for one or two years. The reason for this decline is interesting and 
important. 
For simple infectious diseases in which infection confers protection against reinfection 
and for which the basic reproduction number exceeds one, the incidence of disease should 
initially increase following the introduction of a founder case into a 'totally susceptible' 
population, and then decrease as the proportion and number of 'susceptibles' decreases. 
Figure 5.7 shows the corresponding crude prevalence of infection for the years subsequent 
to the initiation of the epidemics during the period 1900-1960. This shows that the peak 
prevalence of infection for the epidemic initiated in 1900 occurred in the same year as that 
in which the disease incidence peaked, i. e. 1940. Given the high prevalence of infection for 
this epidemic, the majority of the population alive during the years in which the epidemic 
peaked could develop disease only through endogenous reactivation or after reinfection. 
This is illustrated in Figure 5.8, which shows the relative contribution of disease at- 
tributable to first primary episodes, exogenous and endogenous disease for these epidemics. 
Hence most of the disease incidence in the population during the first 40 years after the 
introduction of the founder case in 1900 is attributable to first primary episodes. Subse- 
quently, an increasing proportion is attributable to exogenous disease, and then, 60 years 
after the introduction of the sputum-positive case, most is attributable to endogenous dis- 
ease. The estimated peak in exogenous disease occurs about 10 years after the overall 
disease incidence started to decline. These results are generally consistent with the magni- 
tude of the annual risk of infection (see Figure 5.9) subsequent to the introduction of the 
founder into the population, which peaks in about the same year as the'disease '. incidence. 
The estimated risks of developing both endogenous and exogenous disease are lower 
than those for developing the first primary episode for most age-groups (see Table 3.3 in 
section 3.3.1). Hence we can conclude that the ultimate decline in the epidemic initiated 
in 1900 is attributable in large part to a high prevalence'of infection in the population, and 
hence the relatively low risks of developing (endogenous and exogenous) disease experienced 
by most individuals. 
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Figure 5.7 shows that the peak prevalence of infection was about 1.8% and 0.006% 
respectively for the epidemics initiated in 1920 and 1940. These extremely low levels in the 
prevalence of infection indicates that the decline in these epidemics was not attributable to 
a depletion in the proportion of uninfected individuals in the population, and is attributable 
to other factors, which we discuss below. 
The trend in disease incidence at a given time is a function of the rate at which secondary 
cases from infectious cases at that time, and at all previous times, develop disease. Virtually 
none of the disease incidence for the epidemics initiated in 1920 and 1940 is attributable 
to exogenous disease (see Figure 5.8). Hence the trend in the disease incidence for these 
epidemics at a given time is a function of 
1. the rate at which individuals infected many years previously develop endogenous dis- 
ease, and 
2. the number of first primary episodes generated by each sputum-positive case, which 
depends on the magnitude of the effective contact number. 
These factors depend on the age distribution of infected and uninfected individuals respec- 
tively in the population. 
Figure 5.8 shows that epidemics initiated in both 1920 and 1940 declined at the same 
time as the incidence of endogenous disease was increasing. This suggests that at the time 
of decline of these epidemics, each infectious case was leading to less than one case (of first 
primary disease episodes) during the following year. This is attributable to a low effective 
contact number at this time. 
5.3.1.2 The basic reproduction number 
Figure 5.10 summarizes the number of secondary cases attributable to infection by a founder 
case who was introduced between 1900 and 1990 into a population similar to that in England 
and Wales, and was infectious for one or two years, assuming that the effective contact 
number did not decline subsequent to his/her introduction. This shows that such a founder 
case introduced in 1900 would have led to about 1.5 and 3.1 secondary cases if he/she was 
infectious for one and two years respectively. By applying a similar argument to that in 
section 5.3.1.1 on page 204, we will use the number of secondary cases resulting from an 
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Figure 5.10: Number of secondary sputum-positive cases resulting from a founder case 
who was infectious for one or two years, introduced into an uninfected population similar 
in structure to that in England and Wales during the period 1900-1990, as estimated using 
TBDYN3, assuming that there was no decline in the effective contact number subsequent 
to his/her introduction. 
individual who is infectious for the full two years, under the corresponding circumstances 
to reflect the magnitude of the basic reproduction number for tuberculosis. 
Figure 5.11 compares the basic and founder case reproduction numbers for tuberculosis 
during the period 1900-1990. This shows that the founder case reproduction number slightly 
exceeded the basic reproduction number until 1950. This is paradoxical, given that a founder 
case leads to fewer new infections if the effective contact number declines in a population 
subsequent to his/her introduction, as compared with that when there is no such decline 
in the effective contact number. In practice, the decline in the effective contact number 
over time means that the risk of (re)infection will be lower subsequent to the introduction 
of a founder case than in the situation in which there is no decline in effective contact 
number. This means that individuals are less likely to be reinfected and hence more likely 
to develop disease attributable to infection by a founder case, as estimated using TBDYN3 
if the effective contact number declines, than in the'converse situation. 
This is illustrated in Figure 5.12, which compares the annual risk of infection subsequent 
to the introduction of a founder case in England and Wales in 1900,1920,1940 and 1960, 
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Figure 5.11: Comparison between the basic and founder case reproduction numbers for 
tuberculosis during the period 1900-1990, as estimated using TBDYN3. 
assuming that the effective contact number did and did not subsequently decline. This 
shows that had there been no change in the effective contact number after 1900 under these 
circumstances, the annual risk of infection would have peaked at about 50% about 20 years 
thereafter, and ultimately would have remained relatively static thereafter at about 20%. 
In contrast, the decline in the effective contact number subsequent to the introduction of 
the founder case meant that the maximum risk of infection was about 10%, which is about 
the level of the estimated annual risk of infection in England and Wales in 1910. 
The level of the risk of infection subsequent to the introduction of the founder case in 
1900, assuming no decline in effective contact number, seems unrealistically high, and far 
exceeds that found in any other developing or developed country during this century (see 
section 2.3). - The implications of such high, risks of infection for the relative contribution 
of first primary, endogenous and exogenous forms to the disease incidence are illustrated in 
Figure 5.13. This shows that the peak disease incidence subsequent to the introduction of 
the case in 1900 would have been about 1,200 per 100,000, and that the disease incidence 
would have stabilized thereafter at about 500 per 100,000. Most of the disease incidence 
among individuals in the population for this epidemic would have been attributable to 
exogenous reinfection. 
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to the predicted incidence (per 100,000 general male population) of sputum-positive tuber- 
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was no subsequent change in the case-fatality rate and the effective contact number. 
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Overall, these results show that, whereas the magnitudes of the basic and founder case 
reproduction number for tuberculosis differed only slightly until 1950, the implications for 
the disease dynamics subsequent to the introduction of a founder case into an uninfected 
population for corresponding assumptions relating to the effective contact number are sub- 
stantially different. The epidemic initiated in 1940, for example, would have peaked during 
the early 1950s at about 0.03 sputum-positive cases per 100,000 if the effective contact 
number had declined subsequent to the introduction of the founder case, and the disease 
incidence would have subsequently declined dramatically. The peak incidence rate of about 
450 sputum-positive cases per 100,000 would have occurred in the year 2000 if there had 
been no such decline in the effective contact number, and the disease incidence would have 
probably remained relatively static thereafter at over 100 sputum-positive cases per 100,000. 
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5.3.2 The net reproduction number 
As given in equation 5.16, the number of secondary sputum-positive cases resulting from 
an individual who developed disease in a given year is determined by 
1. the total number (and the age-distribution) of individuals first infected or reinfected 
by that case during the infectious period and, 
2. the risk of developing sputum-positive disease attributable to this infection or rein- 
fection. 
Before describing the results obtalned for the net reproduction number we first present 
results for these two statistics. 
5.3.2.1 Number of new infect io ns/reinfect ions per sputum-positive case 
Figure 5.14 shows the numbers of individuals infected for the first time or reinfected by 
each sputum-positive case during the period 1900-1990, as estimated using TBDYN3. This 
is given by the ratio between the number of new infections or reinfections in that year, and 
the total number of sputum-positive cases respectively (see equation 5.5 in section 5.2.1). 
This shows that of the 23 individuals effectively contacted by each sputum-positive case 
in 1900, about 12 were reinfected, 3 were infected and the contact did not lead to infection 
or (further) reinfection for the remaining 8. By 1950, each sputum-positive case effectively 
contacted 11 individuals: 6 were reinfected, 4 were infected for the first time and the contact 
did not lead to infection or reinfection in only 1 individual. 
It is important to recognize that these results depend on the definitions of individuals 
assumed to be at risk of infection or reinfection. The comparatively large number of indi- 
viduals for whom effective contact did not lead to infection or reinfection for the early 1900, 
for example, follows from 
1. the fact that many individuals during this time were estimated to have recently ex- 
perienced infection or reinfection, and 
2. these individuals were not assumed to be at risk of further reinfection at that time 
(see sections 3.1.2 and 5.2.1). 
The secular trend in the number of individuals infected or reinfected by each sputum- 
positive case is a function of the changing composition of guninfected' and 'latent' individuals 
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Figure 5.14: Comparison between the estimated effective contact number and estimated 
number of individuals infected for the first time or reinfected in England and Wales during 
the period 1900-1990 
in the population during this time, and in the effective contact number. We see, for example, 
that the average number of new infections resulting from each sputum-positive case changed 
little over most of the century. This follows from the fact that the effective contact number 
decreased at the same time as the proportion of uninfected individuals in the population 
increased. Hence sputum-positive cases in 1960 were more likely to come into contact with 
uninfected individuals, as compared with such individuals in 1900. 
Figures 5.15 and 5.16 summarize the age-distributions of uninfected individuals and 
'latent' individuals for given years between 1900 and 1980 who, by definition, were at risk 
of infection or reinfection by a given sputum-positive case. Both these distributions in a 
given year are functions of past trends in the annual risk of infection. Figure 5.15 shows 
that uninfected 10 year olds comprised about 0.3% of the population in 1900, and that 
almost all uninfected individuals were aged under 20 years. This is consistent with the high 
risk of infection estimated for the early part of this century (see section 2.3), which meant 
that few individuals reached adolescence without having been infected. 
By 1980, on the other hand, uninfected 10 year olds comprised about 1.5% of the popu- 
lation and over half of the uninfected population was aged over 20 years. Analogous shifts 
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Figure 5.15: Percentage composition (by age) of uninfected individuals in the population 
in England and Wales between 1900 and 1980, as estimated using TBDYN3. 
3 
2.5 
02 
CL 
E 
0 Q 
0 cm 
0.5 
0 
0 10 20 30 40 50 60 70 80 90 100 
Age (years) 
Figure 5.16: Percentage composition (by age) of individuals in the 'latent' class in the 
population in England and Wales between 1900 and 1980, as estimated using TBDYN3. 
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occurred in the age-distribution of individuals in the 'latent' class, as shown in Figures 5.16. 
In deriving the proportion of individuals in both these categories, individuals assumed to 
be protected by BCG vaccination have been excluded from the uninfected population, but 
are included in the estimates of the size of the overall population. 
5.3.2.2 Lifetime risk of developing sputum-positive disease attributable to a 
given infect ion/ reinfect ion 
Figure 5.17 shows the estimated proportion of individuals infected for first time during 
the period 1900-1990, who developed sputum-positive disease attributable to their initial 
infection. This shows that of the 30 year olds infected for the first time in 1900, about 10% 
developed sputum-positive disease attributable to this infection, as compared with about 
11% of the corresponding individuals in 1980. Though this is a relatively small difference, it 
reflects the fact that a greater proportion of those infected in 1980 could potentially develop 
their first disease episode without being reinfected, as compared with similar individuals 
infected in 1900, whose disease was, according to TBDYN3, attributable to subsequent 
reinfection. We discussed these patterns in section 4.3.2.3, when we considered the lifetime 
risks of developing sputum-positive disease attributable to initial infection. Similar patterns 
are also seen in, Figure 5.18, which shows the proportion of individuals reinfected during 
the period 1900-1990, who develop sputum-positive disease attributable to this reinfection 
event. 
5.3.2.3 Estimates of the net reproduction number 
The effect on the net reproduction number of changes in the age distribution of individuals 
infected and reinfected each year, and in the proportion subsequently developing disease 
during the period 1900-1990 is illustrated in Figure 5.19. 
This shows'that overall, there was very little change in the net reproduction number 
between 1900 and 1950, and that it was first below one during the late 1930s. This is 
paradoxical, given the decline in the tuberculosis mortality rate in' England and Wales 
since the mid 1850s and the decline in the incidence predicted by TBDYN3 during this 
time. We discuss the reasons underlying this result below. 
As described in section 5.1.1, a net reproduction number of greater than one for an 
infectious disease in which all disease parameters (such as the contact between individuals) 
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Figure 5.17: Percentage of individuals infected for the first time during the period 1900- 
1990 when aged 0-100 years who develop sputum-positive disease attributable to their infec- 
tion episode, as estimated using TBDYN3. 
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Figure 5.18: Percentage of individuals reinfected during the period 1900-1990 when aged 
0-100 years who develop sputum-positive disease attributable to this reinfection episode, as 
estimated using TBDYN3. 
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Figure 5.19: Estimates of the 'net reproduction number' for tuberculosis, as derived using 
TBDYN3 
change little over time, typically leads to an increase in the disease incidence. The situation 
is complicated for tuberculosis, since the effective contact between individuals declined over 
time and the time interval between infection or reinfection and subsequent sputum-positive 
disease attributable to that infection/reinfection event (i. e. the 'true' serial interval - see 
definition in section 4.1) can be many years. 
As we saw in section 4.3.2.3, the distribution of the time interval between infection or 
reinfection and sputum-positive disease attributable to the 1 nfectio n /reinfection event de- 
pends on both the age at infection/reinfection and on the subsequent risk of reinfection 
experienced. In 1900, for example, 0-10 year olds constituted most of the uninfected cat- 
egory (see Figure 5.15). These individuals faced low risks of developing (spu tu m- positive) 
disease immediately after infection, and hence first contributed to the sputum-positive in- 
cidence when they became young adults up to twenty years later. The same holds for 1920, 
when 0-20 year olds constituted most of the uninfected category. 
Intuitively, if only a slightly greater proportion of individuals infected at age 0-10 years 
in 1900, for example, had developed disease earlier, when the number of secondary cases 
resulting shortly after initial infection/reinfection by a given sputum-positive case was just 
slightly smaller than one, then it is likely that the disease incidence would have increased 
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Figure 5.20: Comparison between the estimated net And founder case reproduction num- 
bers for tuberculosis, as derived using TBDYN3. 
during the 1900s. By this argument, the disease incidence did not increase during the period 
considered since only a proportion of secondary cases developed disease shortly after initial 
infection /reinfection, and the net reproduction number was only slightly greater than one 
until 1925 (i. e. ; ýý 1.001). 
Figure 5.20 compares the values obtained for the net reproduction number since 1900 
against the estimated basic and founder case reproduction numbers for these years. We see 
that whilst the basic and founder case reproduction numbers declined over time, largely as 
a consequence of the decline in the effective contact number, the net reproduction number 
remained relatively static until about 1950, and then declined more rapidly. The compar- 
atively small effect of the decline in the effective contact number on the not reproduction 
number, as compared with that on the basic and founder case reproduction numbers follows 
from the fact that overall, the proportion of individuals developing sputum-positive disease 
attributable to a given infection increased over time. This is attributable to the combination 
of two factors. 
First, the high annual risk of infection (and effective contact number) estimated for the 
early 1900s meant that most of the individuals experiencing initial infection/reinfection at 
this time faced low risks of developing sputum-positive disease, given that 
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1. infants and young children comprised most of those newly infected, and 
2. the estimated risk of developing exogenous disease after reinfection in adult life is 
relatively low (slightly over half the risk of developing the first primary episode - see 
Table 3.3 in section 3.3.1). 
The decline in the effective contact number meant that by 1930, on the other hand, adoles- 
cents and adults comprised large proportions of those experiencing initial infections. The 
high risks of developing sputum-positive disease experienced by these individuals meant 
that, overall, a greater proportion of all newly infected individuals went on to develop 
sputum-positive disease attributable to a given infection, as compared with similar indi- 
viduals in 1900. The situation is more complicated after 1950, given that a proportion of 
individuals in England and Wales are assumed to be immune to infection following BCG vac- 
cination. This changes the age distribution of individuals defined to be at risk of infection, 
and hence the overall proportion of individuals who go on to develop disease attributable 
to initial infection. 
Second, the decline in the effective contact number over time meant that individuals 
infected in 1960, for example, were less likely to experience further reinfection, as compared 
with counterparts infected in 1900. Any disease episode after an individual has experienced 
reinfection is attributed to the reinfection event, and this led to an increase over time in the 
proportion of individuals who developed sputum-positive disease attributable to an infection 
or reinfection event. 
225 
5.3.3 Effect of simplifying assumptions on the results obtained 
It is important to recognize that the results obtained in this chapter depend on the sim- 
plifying assumptions incorporated into TBDYN3. We discuss the implications of the main 
simplifying assumptions below. 
5.3.3.1 Effect of reinfection 
TBDYN3 assumes that, the risk of reinfection is identical to that of first infection, which 
may be unrealistic. As a result of this assumption, TBDYN3 estimates that about half 
of the individuals effectively contacted by sputum-positive cases during the early 1900s 
became reinfected, and less than one sixth experienced initial infections, which could well 
be overestimates and underestimates respectively. 
In practice, it is unlikely that this assumption affected estimates of the founder case and 
net reproduction number over time, given that the estimated risk of developing exogenous 
disease after reinfection was estimated to be lower than that of developing the first primary 
episode. As discussed in section 3.4.1, reinfected individuals may face similar or greater 
risks of developing disease than individuals infected for the first time, given that the immune 
response must already be low, by definition, for reinfection to occur. Hence any overestimate 
in the number of secondary cases of resulting from a 'typical' infectious case, derived by 
assuming that the risk of reinfection is identical to that of first infection, is likely to have 
been balanced out by an underestimate in the 'true' risk of developing exogenous disease 
subsequent to reinfection. 
5.3.3.2 Homogeneous mixing 
Throughout these analyses, TBDYN3 has assumed that individuals mix randomly in the 
population, which is unrealistic, especially for more recent years. 
In practice, is likely that'the effective contact number, and the risk of developing disease, 
varies widely between different subgroups within the population. It is also plausible that 
for some subgroups, e. g. the homeless, the magnitude of the effective contact number may 
have changed little over time, and, in recent times, could even be as high as that estimated 
for the beginning of this century in England and Wales as a whole. This suggests that 
the estimates of the basic reproduction number for these individuals could, in turn, be of a 
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similar order of magnitude to that for 1900. 
5.4 Discussion 
We began our analyses of the basic and net reproduction numbers for tuberculosis by noting 
that the definitions and interpretation of both these measures should account for the, facts 
that individuals can be reinfected, the serial interval can be long and variable, the risks of 
developing disease are age-dependent and that the effective contact number declined over 
time. 
The decline in the effective contact number is intuitively reasonable and is attributable 
to several factors: 
1. the reduction of crowding in living conditions, 
2. removal of infectious individuals from the community either to sanatoria before the 
1950s or through treatment after 1950, 
3. an improvement in nutrition over time, which probably increased resistance to infec- 
tion, 
4. an improvement in general hygiene in the community (attributable to increasing health 
consciousness, which encouraged people to be careful when coughing, sneezing and 
spitting), 
5. increased ventilation in buildings, which reduced the intensity of exposure of individ- 
uals to tubercle bacilli. 
It is likely that, a few years after the introduction of chemotherapy, the proportion 
of sputum-positive cases who were treated and hence removed as sources of infection from 
the community remained comparatively static. Consequently, the prediction from TBDYN3 
that the rate of the decline in the effective contact number only temporarily accelerated with 
the introduction of chemotherapy in 1950 is also realistic. For many developing countries 
today the effective contact number could be as high as that estimated for England and 
Wales during the pre-chemotherapy era. The implications for the corresponding basic and 
net reproduction numbers are unclear, given that the magnitude of the risks of developing 
disease may differ from those in England and Wales (see discussion in section 3.4.1). 
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The fact that the decline in the effective contact number is a consequence of many 
changes and interventions complicates the definition of the basic reproduction number for 
tuberculosis, given its interpretation as a parameter which describes the likelihood of con- 
tinued transmission in the absence of any further control or intervention. As demonstrated 
in Figure 5.13, the time interval until the peak in disease incidence in the hypothetical 
situation in which there is no decline in the effective contact number subsequent to the 
introduction of a founder case into an uninfected population differs according to the mag- 
nitude of the effective contact number at the start. This peak would have occurred about 
20 and 30 years after the introduction of the founder case in 1900 and 1920 respectively, 
i. e. over the same time period during which the actual effective contact number declined 
dramatically. 
Given the potentially long and variable serial interval for tuberculosis, neither the basic 
nor the founder case reproduction numbers provide much information on the magnitude 
of the trend in disease incidence subsequent to the introduction of a founder case into 
an uninfected population. Analogous issues were raised recently by Levin in relation to 
the variable duration of infectiousness of HIV-positive individuals, the basic reproduction 
number and the rate of increase of HIV/AIDS incidence in a population [129]. The main use 
of the basic and founder case reproduction numbers for tuberculosis is that they provide 
insight into the 'potential for successful transmission of a sputum-positive case' (or the 
'potential reproductive capacity', as described by Macdonald [125] - see page 187). Of 
the two measures, the founder case reproduction number is more appropriate for measuring 
this 'potential for successful transmission' than the basic reproduction number, given that 
it takes into account the decline in the effective contact number. ý 
The secular decline in the basic and founder case reproduction numbers is intuitively 
reasonable, and occurred despite changes in the age-structure of the population over time. 
During the 1900s, for example, a large proportion of, the population in England and Wales 
comprised infants and young children, as compared with that in later years, as illustrated 
in Figure 5.21. As demonstrated in section 4.3.2, infants and young children have lower 
lifetime risks of developing sputum-positive disease than adults. Hence, had there been no 
change in the effective contact number over time, a founder case would have led to fewer 
secondary cases if introduced during the early 1900s, as compared with a similar founder 
case introduced in 1930, for example. 
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Figure 5.21: Age distribution of the male population in England and Wales during the 
period 1900-1990 in England and Wales. 
In these analyses, the decline in the basic and founder case reproduction numbers is 
attributed to the decline in the effective contact number. In reality, such a decline could 
have also occurred as a consequence of a decline in the lifetime risks of developing sputum- 
positive disease, attributable to factors discussed in section 4.4. 
Overall, the analyses suggests that neither the basic nor net reproduction numbers is 
ideal for analyzing the transmission dynamics of Al. tuberculosis, given that fundamental 
epidemiological parameters, such as the effective contact number can change appreciably 
during a serial interval. This issue is also potentially relevant to other diseases with long 
serial intervals (e. g. AIDS, leprosy). On the other hand, we can obtain some insight into 
the short-term trend in disease incidence by studying parameters which are related to the 
basic and net reproduction numbers, but which describe the expected number of secondary 
cases arising from an infectious source per unit time in an uninfected population (11o(t)) 
and in a population consisting of both infected and uninfected individuals (ft"(t)). 
The relationship between fto(t) and k(t) is analogous to that between the basic and net 
reproduction numbers for tuberculosis in a hypothetical population without age-structure 
and in which there is no change in the effective contact number. This relationship is 
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described by the following equation (see also Appendix C. 1) 
Rn = Ro(l - prd) (5.22) 
where p denotes the prevalence of infected individuals in the population, and rj denotes the 
protection imparted against reinfection and subsequent sputum-positive disease by having 
experienced infection in the past. Thus &(t) and ft,, (t) are related in the following way: 
li,,, (t) = f? o(t) (1 - prd) (5.23) 
The magnitude of ii,, (t), as given by this expression, should reflect the likely magni- 
tude of the short-term trend in the incidence of disease attributable to recent infection or 
reinfection. An k(t) of less than 1 per year, for example, occurring when: 
rd 
(5.24) 
would be associated with a decreasing incidence of disease attributable to recent infec- 
tion /reinfection. 
This logic could be extended to derive expressions for the minimum proportion of a pop- 
ulation which would have to be immunized for the short-term disease incidence attributable 
to recent infection/reinfection to decrease. Though the practical utility of these expressions 
is complicated by the variable protection afforded by BCG vaccination, which may depend 
on geographical location or other factors [81], we describe the kind of reasoning which could 
be applied below. 
Suppose that a proportion p,, in the population is totally protected against initial infec- 
tion (in the short-term) by vaccination, then k(t) and fto(t) are related in the following 
way (see Appendix C-2): 
lk (t) = 
fto (t) (1 - pu - prd) (5.25) 
For the disease incidence attributable to recent infection/reinfection to decrease in the 
short-term as a consequence of vaccination, k(t) has to be less than 1 (secondary case per 
year), and hence p,, has to satisfy: 
P, > 1-prd- 
1 
0 
f? 
o 
(5.26) 
If initial infection imparts 50% protection against reinfection and subsequent sputum- 
positive exogenous disease, the prevalence of infection is 60%, and fta(t) is 2 (secondary 
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cases per year), for example, then by this equation, the prevalence of immunized individuals 
should exceed 20% for the disease incidence attributable to recent infection/reinfection 
to decrease in the short-term. Although equations 5.25 and 5.23 reflect the relationship 
between R,, (t) and RO(t) in a population without age-structure, and hence are over simplistic 
for describing the tuberculosis situation in a realistic setting, they nevertheless indicate the 
kind of measures and logic which, if extended, might be useful for assessing short-term 
trends in the disease incidence. 
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Chapter 6 
Discussion and conclusions 
"However, for the eventual eradication of tuberculosis it is not necessary that 
transmission be immediately and completely prevented. It is necessary only 
that the rate of transmission be held permanently below the level at which a 
given number of iniection-spreading (i. e. open) cases succeed in establishing an 
equivalent number to carry on the succession. If, in successive periods of time, 
the number of infectious hosts is continuously reduced, the end result of this 
diminishing ratio, if continued long enough, must be the extermination of the 
tubercle bacillus. 
Bearing in mind this principle, it is a fair inference that in this country as a whole 
we have already reached the stage at which the biological balance is against the 
survival of the tubercle bacillus, for year by year the mortality from tuberculosis 
is decreasing. " 
Frost (1937) [2] 
For tuberculosis, the issue of how and whether a given infectious case leads to subsequent 
cases is complicated, given that 
1. only a small proportion of infected individuals develop (infectious pulmonary) disease 
during their lifetime, 
2. the risk of developing disease, and hence the time interval between infection and 
disease onset, is a function of the age at infection, and 
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3. infection with or without an early disease episode does not confer solid immunity 
against subsequent reinfection and disease. 
As a result of these complexities, the secular decline in the overall mortality rates over 
the past century in developed countries (in the absence of effective treatment until the 1950s) 
masks many changes in the underlying age and time-specific patterns in the overall disease 
incidence and in the incidence of disease attributable to either initial infection or subsequent 
reinfection. The objective of this thesis has been to explore these underlying changes on 
the basis that they should first be understood before we can make sound inferences about 
the necessary criteria for the eventual eradication of tuberculosis, and whether or not 'the 
biological balance' was 'against the survival of the tubercle bacillus' in the past. This work 
has provided insights in three areas of tuberculosis and infectious disease epidemiology, 
which we discuss below. The key findings are summarized on pages 246-249. 
6.1 Insights obtained 
6.1.1 The natural history of tuberculosis 
One of the benefits of using a theoretical modelling approach to explore long-term disease 
dynamics is that it provides an opportunity to collate knowledge on the pathogenesis of 
disease and to identify the most important processes which require further understanding. In 
developing this model we have found that the conventional definitions of tuberculous disease, 
as being either 'primary'or 'post-primary', depending on whether it occurs within five years 
of initial infection or sometime thereafter [16), do not adequately distinguish between the 
different risks of developing disease experienced by individuals (see section 3.1.1). Tile model 
developed, TBDYN3, has therefore assumed that these risks differ by age and according to 
whether individuals are at risk of developing their first primary disease episode, endogenous 
and exogenous disease, where exogenous disease has been defined as the first disease episode 
within 5 years of reinfection, and the definition of endogenous disease is extended to include 
disease occurring within five years of infection/reinfection if individuals have experienced 
disease but no further reinfection. 
The modelling work has highlighted the need for better understanding of the mechanism 
of reinfection. Although there is much evidence showing that reinfection can and does 
occur (see section 1.1), there are no data indicating whether the age and sex-specific risk 
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of reinfection is higher, lower or identical to that of first infection, and how soon after an 
initial infection it can occur. This uncertainty probably explains why most of the models 
of the transmission dynamics of M. tuberculosis created hitherto (all, excepting the work of 
Sutherland et al [7)) have neglected to consider the effect of reinfection on the overall disease 
incidence. In developing TBDYN3, we have assumed that it is important to incorporate 
this factor and to examine its implications, rather than avoid it. 
Overall, the estimates of theage-specific risks of developing the first primary, endogenous 
and exogenous disease for England and Wales, as derived using TBDYN3, are of a realistic 
order of magnitude. The risk of developing the first primary episode among adults, for 
example, compares well against the estimate obtained from the UK MRC BCG trial during 
the 1950s [29], and the corresponding risk of developing endogenous disease is similar to 
that obtained by Styblo [6] and Horwitz [49] for the Netherlands and Denmark respectively 
(see section 1.2.1.4). The fact that the estimated risk of developing the first primary episode 
exceeds the risks of developing both endogenous and exogenous disease (for all age groups, 
excepting 0-10 year olds) suggests that initial infection and/or disease episode may confer 
some protection against subsequent disease. This finding is consistent with results from 
observational studies in developed countries, which have found a lower disease incidence 
among individuals presumed to be 'infected' (i. e. weakly tu berculi n- positive), as compared 
with that among tuberculin-negative individuals (see section 1.2.1). 
The disease risk estimates derived here lead to realistic patterns in the age-specific 
disease incidence among cohorts born during the pre-chemotherapy era, and compare well 
against those reflected in the observed mortality rates. The similarity between the predicted 
and observed mortality rates for this era is especially striking (see section 3.4.2). 
The results suggest that the single most important factor which determined the magni- 
tude of the disease incidence over the past century in England and Wales was the level and 
decline in the risk of infection. This determined 
1. the age pattern of initial infection and hence the risk of developing disease, and 
2. the risk of reinfection. 
Model predictions suggest that most of the adult disease incidence during the pre- 
chemotherapy era, when the risk of infection was higher than that in many developing 
countries today, was attributable to exogenous disease and only a small proportion was 
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attributable to first primary episodes and to endogenous reactivation. Although these 
results were obtained by assuming that the risk of first infection is identical to that of 
reinfection, which may not be strictly realistic (see section 3.1.1), three observations indicate 
that reinfection must have been important in determining patterns of disease incidence in 
the past. 
First, exclusion of exogenous disease from TBDYN3 led to unrealistically high estimates 
of the risks of developing the first primary episode for adults (i. e. 23% during the first 
five years after initial infection), and failed to match the decline in the notification rates 
especially for middle aged and elderly individuals (see section 3.3.3.1). Most individuals 
in this age-range during this period must have been infected during infancy, and hence 
the decline in the notification rates could not have been attributable to a reduction in the 
incidence of first primary episodes. Alternatively, if we assume that these individuals did 
not experience reinfection, this reduction could only have been achieved with a dramatic 
reduction in the risk of developing endogenous disease, which seems unlikely. By this logic, 
the reduction in the overall disease incidence for these individuals was most likely to have 
been attributable to a decline in the incidence of exogenous disease, which occurred as a 
consequence of the rapid decline in the risk of reinfection. 
Second, the 
-mortality 
rates among 45-54 and 55-64 year olds halved between 1901 and 
1930 (e. g. from 313 to 157 per 100,000 between 1901 and 1930 for 45-54 year olds). By 
applying an argument similar to that above, we can conclude that it is unlikely that this 
was attributable either to a reduction in the incidence of first primary episodes, or to a 
dramatic reduction in the risk of developing endogenous disease. Consequently, it is most 
likely to have occurred as a consequence of a decline in the exogenous disease Incidence. 
The third reason relates to the mortality rates among adolescents and young adults dur- 
ing the pre-chemotherapy era, which declined more slowly than for infants. By definition, 
morbidity among infants is primary in origin and hence reflects recent transmission and the 
current trend in the annual risk of infection. The fact that the mortality among adolescents 
and young adults declined more slowly than for infants suggests that the disease Incidence 
among adolescents was not entirely attributable to first primary episodes. Model predic- 
tions suggest that, as a consequence of the decline in the risk of infection, the proportion 
of individuals reaching adolescence and young adult life without experiencing infection in- 
creased during the first half of this century. According to TBDYN3, this should have led 
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to an increase in the incidence of first primary episodes among these individuals. Styblo 
predicted a similar increase in the incidence of first infections for adolescents in the Nether- 
lands during this time [6]. If it is assumed that individuals did not experience reinfection, 
then given the higher risks of developing disease shortly after infection, as compared with 
those many years thereafter, this increase in the incidence offirsi primary episodes would 
have translated into an increase in the overall disease incidence for adolescents during this 
time, unless the risk of developing endogenous disease declined dramatically during this 
time, which seems unlikely. The fact that the mortality rates among adolescents actually 
declined suggests that another factor must have also affected the disease incidence. The 
most likely factor which could have contributed to this decline is the declining annual risk 
of infection, which implies that some adolescents and young adults in the early years of this 
century were reinfected and developed exogenous disease. 
In his classic paper considering the decline in tuberculosis over time, Frost [2] also fore- 
saw that a decline in the risk of infection would postpone infection until later in life or 
adolescence, when the risk of developing disease exceeds that in early childhood. Anal- 
ogous issues have been discussed in relation to other diseases such as polio, mumps and 
rubella [119]. The decline in the risk of infection with the polio virus, for example, is be- 
lieved to have led to an increase in the average age at infection, and hence an increase in 
paralytic polio among young adults in developed countries during the 1950s. 
6.1.2 The incubation period, serial interval and lifetime risks of develo- 
ping tuberculosis 
The incubation period and the serial interval are two of the most important parameters 
underlying the dynamics of any infectious disease. The incubation period describes when, 
given infection, an individual is likely to develop disease and the serial interval indicates 
when that individual is likely to infect others. 
Much of the literature on these statistics is based on observational studies of the trans- 
mission dynamics of 'simple' diseases, such as measles, in which 
1. most diseased individuals are infectious, 
2. infection induces a permanent solid immunity and, 
3. the single disease episode experienced is attributable to one (initial) infection event. 
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The fact that individuals can develop disease following reinfection means that the con- 
ventional definitions of the incubation period and serial interval must be modified before 
they can be applied to tuberculosis. As demonstrated in this thesis, these definitions must 
account for age, secular trend in the risk of infection and mortality rates experienced. 
Both the incubation period and the serial interval of tuberculosis can be analyzed either 
4 retrospectively' (as the time interval since initial infection for individuals diseased at a 
given age and in a given year) or 'prospectively' (as the time interval until the first disease 
or infectious episode for individuals infected at the same age in a given year). For both 
retrospective and prospective analyses, the ultimate distributions obtained also depend on 
whether we distinguish between disease attributable to an initial infection or to a subsequent 
reinfection. If we explore the time interval from initial infection at a given age In a given 
year until the first subsequent sputum-positive episode, for example, then the distribution 
obtained resembles an 'observed prospective' serial interval. If we explore the time Interval 
from initial infection at a given age in a given year until the first subsequent sputum- 
positive episode attributable to that infection, then the distribution obtained corresponds 
to an 4actual prospective' serial interval. Both these distributions are also related to the 
overall lifetime risks of developing disease. 
It is probably because of these complexities that the incubation period, serial interval 
and lifetime risks of developing tuberculosis have not previously been analyzed in detail. 
It is not even widely appreciated that the lifetime risks are age-dependent - tile only 
detailed published discussion of this issue is that of Comstock [121), who, while recognizing 
that individuals face high risks of developing disease after infection during adolescence, 
suggested that the overall lifetime risk following infection in infancy might be higher as a 
consequence of a low annual risk operating over many years. In contrast, the estimated 
lifetime risk predicted by TBDYN3 for twenty year olds infected after 1950, for example, 
exceeds that for 10 year olds by a factor of about three (i. e. corresponding to lifetime risks 
of 17% vs 6% for 20 year olds and 10 year olds respectively). The corresponding risks of 
developing infectious pulmonary disease differ by a factor of about 4 (i. e. 12% Vs 3% ) (See 
section 4.3.2). 
The fact that the distributions of the serial interval and incubation periods depend on 
both the age of individuals and on calendar year, and hence on assumptions as to the trend 
in the risk of (re)infection, complicates their utility. This also applies to the incubation 
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periods and serial intervals for other infectious diseases, for which the time interval between 
infection and disease onset can be very long. The analogy between leprosy and tuberculosis 
is obvious. The time interval between infection and onset of leprosy can be long and variable, 
ranging between 9 months and at least 20 years [130] although the mode of transmission is 
still poorly understood. The fact that both diseases are caused by mycobacterial pathogens 
enhances this analogy. 
Herpes varicella-zoster (HVZ) also shares some similarities with tuberculosis. After first 
exposure to the HVZ virus, individuals usually develop chickenpox ('varicella'), and can 
subsequently experience shingles ('zoster') sometime later in their lives. The occurrence 
of zoster is typically associated with immunosuppression although it may also occur after 
reinfection w. ith HVZ [131]. The estimated lifetime risk of developing zoster given infection 
with HVZ is about 23% [1311, although this may be unreliable, given that the estimate has 
not been broken down by age, and is based only on reports from general practitioners. This 
overall lifetime risk is similar in magnitude to that of developing respiratory tuberculosis 
for 20 year olds in 1900 (see section 4.3.2). 
6.1.3 The basic and net reproduction numbers 
The basic reproduction number is generally defined as the average number of secondary cases 
resulting from a typical infectious case in a 'totally' susceptible population (see page 188). 
There have been two ma: in areas in which the basic reproduction number has been used in 
the past to elucidate the dynamics of infectious diseases. 
First, for'simple' viral diseases, the relationship between the basic and net reproduction 
numbers (see definition on page 188) has been applied to assess the impact of interventions, 
such as vaccination, on the trend in disease incidence [119] (see section 5.1.1). Second, it has 
been used to explore the likely growth rate in disease incidence, and the 'epidemic doubling 
time' subsequent to the introduction of an infectious case into a 'totally susceptible popu- 
lation'. Such calculations have been applied in particular to the growth of the IIIV/AIDS 
epidemic in developing and developed countries [119], and in particular subgroups of these 
populations. 
As demonstrated in this thesis, the definitions and interpretation of the basic and net 
reproduction numbers for tuberculosis are complicated by three facts: 
1. individuals can be reinfected, 
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2. the serial interval is long and variable, and 
3. the effective contact number (see definition on page 193) appears to have declined 
dramatically over time. 
The fact that individuals can be reinfected with AL tuberculosis and develop exogenous 
disease, for example, means that even infected individuals can be considered 'susceptible'. 
A 'totally susceptible' population in the definition of the basic reproduction number for 
tuberculosis is therefore more adequately described as one in which no individuals have 
hitherto been infected. 
There has been little discussion of the basic reproduction number and its biological 
interpretation for diseases for which epidemiological parameters, such as the rates of contact 
between individuals, undergo long-term secular changes. Most analyses of the basic and not 
reproduction numbers for various diseases, have assumed that, in the absence of an obvious 
intervention, such parameters do not change over the time period considered. This is a 
reasonable assumption if we explore only the short-term dynamics spanning several years 
or 2-3 decades for a given disease. This assumption is not appropriate for analysing the 
dynamics underlying the decline in tuberculosis over many decades, or even centuries, given 
that the effective contact number appears to have declined appreciably over time. 
Most analyses of the basic reproduction number for infectious diseases also assume that 
interventions, such as chemotherapy or behavioural changes, lead to permanent changes In 
epidemiological parameters, such as the duration of infectiousness, or the contact between 
individuals, and hence to fixed changes in the basic reproduction number. In these instances, 
the magnitude of this modified basic reproduction number determines the persistence of 
infection in the population [126]. It is important to recognize that few interventions lead 
to an instantaneous reduction in a given epidemiological parameter and hence in the basic 
reproduction number. 
The secular decline in the effective contact number for tuberculosis is attributable to the 
effect of many 'Interventions', including the reduction of crowding and Improved ventilation 
in living conditions, removal of infectious cases from the community to sanatoria (before 
1950) or through treatment after 1950, an improvement in nutrition, which increased indi- 
viduals' resistance to infection (and probably, also to disease following infection), and an 
improvement in general hygiene. The fact that the effective contact number declined over 
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a long time period suggests that these 'interventions' for tuberculosis were continuously 
improving. 
This complicates the relevance of the basic reproduction number for tuberculosis, given 
that it is interpreted as a parameter which describes the likelihood of continued transmission 
in a population in the absence of any (further) control or intervention. To be consistent 
with this interpretation and on the basis of the above discussion, for example, we have 
defined the basic reproduction number for tuberculosis as (see page 196): 
The average number of secondary infectious (pulmonary) cases resulting from 
a 'typical' infectious (pulmonary) case during its entire infectious period, fol- 
lowing its introduction into a population where no individual has hitherto been 
infected with the tubercle bacillus, assuming that environmental conditions and 
the effective contact number do not change further over time. 
The fact that the effective contact number declined over time means that the magni- 
tude of the basic reproduction number for tuberculosis in a given year in the hypothetical 
situation in which a founder case is introduced into an uninfected population in that year, 
does not necessarily reflect the likely subsequent trend in the disease incidence. For this 
reason, the basic reproduction number is also less appropriate for interpreting the decline 
in tuberculosis during the past century than the founder case reproduction number (see 
definition on page 197), which we have defined to be a function of the declining effective 
contact number. 
This thesis has also raised issues relating to the interpretability of the net reproduction 
number for tuberculosis. This was estimated to have fallen below one only after the late 
1920s (see section 5.3.2.3), even though the observed mortality rates and the disease inci- 
dence predicted by TBDYN3 declined at least since 1900. This paradoxical outcome is a 
consequence of the long and variable serial interval for tuberculosis, depending on both the 
age of newly infected or reinfected individuals and the calendar year, which means that the 
disease incidence in a given year is a function of the net reproduction numbers over many 
years. Some secondary cases from an infectious case in 1900, for example, had onset only 
many years thereafter, when there were relatively few cases attributable to recent infec- 
tion/reinfection. Hence a net reproduction number for tuberculosis exceeding one In 1900 
did not translate into an increase in the overall disease incidence. 
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By a similar reasoning, it would also be possible for the net reproduction number to be 
less than one in a given year, but for the disease incidence to increase at the same time. ' 
This leads to the question of how best to describe the "biological balance" of the tubercle 
bacillus or of any infectious disease-causing agentj as described by Frost (see quote on 
page 232). Intuitively there are two aspects to the biological balance of any infectious 
disease: 
1. the biological balance at the level of an individual in the population. 1 
This reflects 
whether a given infectious source leads to more than one other case on average. The 
state of this balance is reflected by whether or not the net reproduction number 
exceeds one, and 
2. the biological balance at the population level. This represents the net effect of all the 
net reproduction numbers in the past (including that of the present) on the current 
disease incidence in the population. This can be given by an overall weighted average, 
Rw, of the net reproduction numbers during preceding years. Intuitively, the magni- 
tude of R,, at a given time t should reflect the trend in the disease incidence at that 
time. 
For infectious diseases which have short serial intervals of duration s, which do not vary 
substantially between individuals, the trend in disease incidence at a given time t reflects 
the magnitude of the net reproduction number at time t-s. A declining disease incidence 
at time t indicates that the net reproduction number was less than one at time t-s, and 
an increasing disease incidence reflects a net reproduction number of greater than one at 
time t-s. Hence for these diseases, the biological balance at the individual level effectivelY 
reflects that at the population level. 
As demonstrated in this thesis, there is a substantial difference between these two mea- 
sures of the biological balance for tuberculosis. Until the mid 1920s, for example, the 
biological balance favoured the survival of the tubercle bacillus in the individual, but was 
against its survival in the population. Of the two measures, the decline in tuberculosis is 
therefore best described by the biological balance of the tubercle bacillus in the population. 
Overall, we see that neither the basic nor net reproduction numbers is really appro- 
priate for analysing the transmission dynamics of AL tuberculosis, given that fundamental 
epidemiological parameters, such as the effective contact number may undergo a secular 
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decline during a period of time as long as a serial interval. Our analyses of these measures 
have nevertheless raised other issues relating to the dynamics underlying the decline in tu- 
berculosis. The fact that individuals can be reinfected and experience exogenous disease, 
and the decline in the effective contact number meant that the mechanism by which in- 
fectious cases led to secondary cases changed over time. The high risk of infection (and 
hence the high effective contact number) during the 19th century meant that, at the turn 
of the century, only infants and young children were still at risk of first infection. Hence 
each sputum-positive case alive in 1900 could generate secondary cases 'only' through in- 
fecting infants and young children or through reinjecting infected adults. The decline in 
the effective contact number after 1900 led to a gradual increase in the prevalence of unin- 
fected adults. By 1970, sputum-positive cases on average led to secondary cases mainly by 
inducing primary infections rather than reinfections. 
The reduction of crowding and improvements in general hygiene and nutrition may 
have also led to declines in the effective contact numbers, and in the basic reproduction 
numbers for other diseases, such as diphtheria, polio and measles, which were endemic 
in developed countries during the first half of this century. The proportion of children 
attending schools and cr6ches has increased over time, which implies that the decline In the 
effective contact number, and hence the basic reproduction numbers for these disease, which 
are associated with serial transmission in children, could have decelerated. This increased 
mixing among children is less important in determining the basic reproduction number 
for tuberculosis, given that only a small proportion of children develop sputum-positive 
pulmonary tuberculosis and are infectious. Hitherto, there have been no published analyses 
exploring whether long-term changes in the effective contact number have affected the basic 
reproduction number for any infectious disease, although various authors have speculated 
whether the basic reproduction number for polio could have declined as a consequence of 
improving standards of cleanliness [119]. 
Results from TBDYN3 suggest that the founder case reproduction number for tubercu- 
losis was only slightly greater than 3, even at the start of the twentieth century. The basic 
reproduction number for scarlet fever, on the other hand, has been estimated to have been 
about 5-8 during the period 1908 and 1916, as compared with 4-5 for diphtheria and 11-17 
for measles [119]. The results from TBDYN3 are therefore consistent with the general belief 
that tuberculosis is "less infectious" at some level than these other diseases. 
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6.1.4 Concluding remark 
Overall, we see that the complicated natural history of tuberculosis, depending on the dif- 
ferent risks of developing disease according to both age and time since infection, and on 
whether individuals experience reinfection, led to complex patterns and changes in the dy- 
namics underlying the decline in mortality in developed countries. Given these complexities, 
the intuition of Frost's conclusion regarding the biological balance of the tubercle bacillus 
is all the more remarkable. 
6.2 Directions for future work 
Given that this thesis has provided new insights into the risks of developing disease, and Into 
the changes in the age-specific patterns underlying the decline In tuberculosis in developed 
countries, there are several ways in which this work should be extended further. 
Intuitively, similar estimates for the risks of developing disease should be obtained if 
the model were to be applied to other developed countries. As we saw in section 3.3.4, 
the estimated risk of developing the first primary episode for Dutch adults exceeded that 
for England and Wales by a factor of two. There are several reasons why this may have 
occurred (see section 3.3.4), and further insight into these factors could be obtained by 
applying the model to data from other developed countries. 
Our analyses have focused only on the natural history of respiratory tuberculosis among 
males. There are important gender differences in the epidemiology of tuberculosis which 
have not been studied extensively. During the pre-chemotherapy era and after 1950 respec- 
tively, for example, the mortality rates and notification rates among adolescent and young 
adult females in England and Wales exceeded those among males. At older ages, these 
rates have been higher among males. Additionally, the rate of decline in the notification 
rates among older women since the mid 1950s has been slower than that among males. This 
could be attributable to many factors, such as differences between the risks of developing 
disease, in case- recognition, or in changing smoking patterns (see e. g. [122]). Alternatively, 
this suggests that the morbidity among elderly females was less sensitive to the decline in 
the risk of infection and hence a greater proportion was endogenous in origin, as compared 
with that in males. This might be attributable to a lower risk of reinjeclion among elderly 
females as compared with that among males. 
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This conclusion could well be consistent with results from tuberculin surveys in both 
developed and developing countries. The greater prevalence of tuberculin sensitivity among 
adult males, as compared with that among females, for example, could be attributable to 
the fact that a greater proportion of males had been reinfected, and hence their tuberculin 
response boosted, as compared with females. The mechanism behind these trends could be 
explored using the modelling approach developed in this thesis. 
It is unclear whether the risks of developing disease obtained in this thesis apply also to 
extrapulmonary forms. In the US and England and Wales, for example, the notifications of 
extrapulmonary tuberculosis have been declining at a slower rate than those of respiratory 
tuberculosis even before the start of the IIIV epidemic [96,132]. The reasons are not fully 
understood, although they are partly attributable to changes in immigration patterns from 
countries with a high prevalence of tuberculosis. These trends can also be analyzed using 
the approach developed in this thesis. 
Most of the research of the epidemiology of tuberculosis has been carried out In devel- 
oped countries, where tuberculosis has been declining since the beginning of this century, 
and at least since the middle of the 19th century in England and Wales. It is likely that the 
basic natural history of tuberculosis differs between developed and developing countries. In 
South India, for example, the risk of infection was about 2-6% during the 1970s [26), which 
is similar to that in England and Wales during the period 1920-1950, but there is little evi- 
dence of a secular decline since then. The few data that exist on the age-specific incidence of 
disease in developing countries (e. g. [25,26]), suggest that there is no peak in the incidence 
during young adult life and that BCG vaccination affords little protection against tubercu- 
losis in many developing countries, as compared with the approximately 77% efficacy found 
for England and Wales [39]. Some of these differences in the epidemiology of tuberculo- 
sis between developing and developed countries may be attributable to differences in the 
prevalence of environmental mycobacteria, which are thought to impart some protection 
against infection (e. g. > 95% of 15-19 year olds in the South India/Chingleput vaccine trial 
population were strongly positive to Alycobacterium avium-intracellulare antigens [26]). 
All these factors suggest that the age-specific risks of developing the first primary, en- 
dogenous and exogenous disease in developing countries must differ from those In England 
and Wales, and, given the high risks of infection, a large proportion may be exogenous 'in 
origin. They may also imply that the risks of reinfection differ between developing and 
244 
developed countries. The approach employed in this thesis could be adapted to study these 
differences and hence further the understanding of the natural history of tuberculosis. 
The application of DNA fingerprinting to distinguish between strains of tubercle bacilli 
in sputum isolates potentially provides the opportunity to understand the natural history 
of tuberculosis in greater depth. These data can themselves be analyzed further using 
modelling techniques, such as those described in this thesis to yield further insight into the 
temporal change in the relative frequency of reinfection and reactivation disease and thus 
into the risks of being reinfected subsequent to initial infection. 
The emphasis in the thesis has been on understanding the basic natural history of tu- 
berculosis without the complication of 111V. Studies suggest that HIV-positive individuals 
face higher risks of developing tuberculosis than do those who remain IIIV-negative [44], 
although this depends on the degree of immuno-suppression, e. g. as measured by CM 
count [133]. The likelihood of a disease episode being sputum-positive and hence the con. 
tribution of HIV-positive individuals to the overall risk of infection also depends on the stage 
of immuno-suppression at which infection is acquired. The modelling approach employed 
here could also be adapted to assess the relative contribution to the disease Incidence and 
risk of infection in the past and how HIV is likely to shape the epidemiology of tuberculosis 
in the future. 
Given secular trends and cohort patterns in age-specific disease incidence and tile long 
duration of the incubation period and serial interval, the application of appropriate mathe- 
matical models should make an important contribution to our understanding of tile natural 
history and control of tuberculosis in the future. 
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Summary 
1. An age-structured deterministic model (TBDYN3) of the transmission dynamics of Al. 
tuberculosis in England and Wales since 1900 has been developed, using infection risks 
estimated from tuberculin surveys and childhood meningitis statistics, and published 
demographic and vaccination data. The model extends the work of Sutherland et al [7), 
and is applied to estimate the age-specific risks of developing 'primary', lendogenous' 
and 'exogenous' disease by fitting model predictions to notifications of respiratory 
tuberculosis from England and Wales over the period 1953-1988. TBDYN3 has been 
used to estimate the secular trend in the relative contribution of these disease forms to 
the overall incidence and to derive definitions and estimates of the incubation period, 
serial interval, basic and net reproduction numbers. 
2. TBDYN3 assumes that the risks of infection are time-dependent (i. e. 14% in 1900, 
declining by 4% pa until 1950 and by 13% pa thereafter), but not age-dependent. 
The risk of reinfection is assumed to be identical to that of first infection. The 
risks of developing disease during the first five years after initial infection (the 'first 
primary episode') or reinfection (exogenous disease) depend on the age at infection and 
reinfection respectively (i. e. constant for 0-10 year olds, increasing linearly between 
the ages 10 and 20 years, and constant above age 20 years) and decline with time since 
infection and reinfection. The risk of developing endogenous disease depends only on 
the current age of an individual. 
3. The estimated risks of developing the 'first primary episode' were about 4%, 9%, and 
14% for individuals infected when aged 0-10,15 and over 20 years respectively. For 
all age groups, except for 0-10 year olds, these risks exceeded those of developing 
exogenous disease. The annual risks of endogenous disease were negligible for 0-10 
year olds, 0.014% and 0.029% for 15 year olds and those aged over 20 years respectively. 
4. Disease, risk estimates are also obtained by applying TBDYN3 to data from the 
Netherlands used by Sutherland et at. The estimates compare well against those 
of Sutherland et al [7], but the risks of developing the first primary episode exceed 
those obtained for England and Wales. Reasons for the apparent discrepancy are 
discussed. 
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5. The disease risk estimates predict a peak in both the disease incidence and mortality 
rates during young adult life for successive birth cohorts during the pre-chemotherapy 
era. This is consistent with the observed patterns in age-specific mortality in successive 
cohorts [3,4,27]. 
6. Estimates of the relative contribution of first primary, endogenous and exogenous 
disease to the overall age-specific disease incidence since 1900 are derived. These 
suggest that much of the disease experienced by individuals aged over 30 years, at least 
until 1940, was attributable to exogenous disease. The introduction of chemotherapy 
during the 1950s, which accelerated the decline in the risk of infection after 1950, 
led to a sharp decline in the overall incidence of disease for all age groups. For 
older individuals this was associated with a sharp reduction in the exogenous disease 
incidence. 
7. Estimated lifetime risks of developing respiratory and sputum-positive tuberculosis 
depend on age and declined with calendar year of infection. Individuals first infected 
when aged 20 years faced higher lifetime risks of respiratory disease than did any other 
age group (e. g. 26% and 17% in 1900 and after 1950), which were three times greater 
than the risks for 10 year olds. The estimated lifetime risks of developing sputum- 
positive disease increased consistently with the age at infection and were about 19% 
and 12% for 20 year olds infected in 1900 and after 1950 respectively. 
8. Definitions of the incubation period and serial interval are complicated for tuberculo- 
sis, as they must take into account the age of individuals, the secular trend in the risk 
of infection and the mortality experienced. Both can be analyzed 'retrospectively' (as 
the time interval since initial infection for individuals diseased at a given age and in 
a given year) and 'prospectively' (as the time interval until the first disease episode 
for individuals infected simultaneously at a given age and in a given year). 
9. Retrospective analyses of the incubation period and serial interval suggest that about 
3% of diseased 20 year olds in 1900 had experienced initial infections in the same year, 
and the greatest proportion (;:: ý 25%) had been infected in their first year of life. The 
infection /reinfection event responsible for the disease episode among these individuals 
occurred during the preceding year for 60% and in the first year of life for less than 
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1%. 
10. Prospective analyses of the incubation period show that about 25% of infants infected 
in 1900 who developed respiratory disease, did so during the first five years. The 
proportion doing so thereafter declined as the time since initial infection increased. 
Similar patterns are seen for individuals infected at other ages in 1900, except that 
the proportion developing disease during the first five years increases with the age at 
infection. Most of the disease occurring among individuals infected at any age in 1990 
is estimated to have occurred within five years of infection. 
11. Prospective analyses of the serial interval (by successive 5 year periods) indicate that 
the proportion of individuals infected in the first year of life in 1900 who developed 
sputum-positive disease sometime thereafter, was maximum between the 20th and 
24th years after initial infection (; zý 15%). The greatest proportion of such individuals 
infected in 1990 (23%) did so during the first five years after infection. 
12. Definitions of the basic and net reproduction numbers for tuberculosis have to take 
into account the fact that both infected and uninfected individuals are susceptible', 
given that reinfection can occur. 
13. Both the basic and net reproduction numbers depend on the 'effective contact number' 
(the number of individuals 'effectively contacted, by a sputum-positive case in a given 
year. An 'effective contact' by a sputum-positive case is here defined as one which 
would lead to infection if the contacted individual had never been infected in tile 
past). Estimates of the effective contact number are derived for the period 1900-1990 
by comparing the annual risk of infection against the prevalence of sputum-positive 
cases. 
14. Estimates suggest that on average, each sputum-positive case effectively contacted 
23 other individuals in 1900, of whom 12 were reinfected, 3 were infected and the 
contact did not lead to transmission in the remaining 8, because they were either 
already experiencing disease or were at high risk of developing disease attributable to 
a preceding infection/reinfection event. The effective contact number declined over 
time, and by 1950, each sputum-positive case effectively contacted 11 other individuals 
on average. 
248 
15. Estimates of the net reproduction number suggest that it was slightly greater than one 
between 1900 and 1930, declined slowly until 1950, after which the decline accelerated. 
This is interpreted in the context of the decline in mortality from tuberculosis at least 
since 1900. 
16. Inferences about the biological definition of the basic reproduction number since 1900 
are obtained by simulating the introduction of a sputum-positive case into a popula- 
tion identical in age-structure, demographic trends and in its effective contact number 
to that of England and Wales in given years and estimating the number of sputum- 
positive cases arising as a result of the 'founder case'. We define this measure as the 
'founder case reproduction number'. 
17. A 'founder' case would have led to about 3 other cases in 1900, to about 2 by 1950, 
and to less than 1 after 1960. The implications for the relationship between the basic 
and net reproduction numbers for tuberculosis are discussed. 
18. Directions for future research stemming from the work in this thesis are described. 
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Appendix A 
Formulation and results from 
TBDYN3 
A. 1 PDEs describing the model formulation for TBDYN3 
OU(a, t) + 
8U(a, t) +v (a, t) + (a, t)) U (a, t) Oa at 
OV(a, t) +W 
(a, t) 
= v(a, t)U(a, t)-m, (a, t)V(a, t) (A. 2) 8a at 
OI(a, t, s) DI (a, t, s) OI(a, t, s) 
-((dp(a-s, s)+m, (a, t))I(a, t, s) Da 5t 
+ as 
- kL (S) I (a, t, s) (o <s< 5) (A. 3) 
OP(a, t, 
+ 
OP(a, t, 
+ 
OP(a, t, 10 5 dp(a - s, s)I(a, t, s)ds Oa at ai 
(m+ (t, i) d+ (a) + m,, (a, t) d- (a)) P(a ,t 
-r(a, t, ý) P(a, t, 9) (A. 4) 
H (a, t) + 
11 a at 
+r (a, t, 2) (P (a, t, 2) + E,, (a, t, 2) + E., (a, t, 
-(i(t) + dn (a)+ m, (a, t))L (a, t) (A-5) 
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81,. (a, t, s) +01, 
(a, t, s) F 
81,. (a, t, s) 
=- (d., (a - s, s) + m,, (a, t)) I, (a, t, 
's) ' 
Oa at as 
- kL (S) Ir (a, t, s) (0 <s< 5) (A. 6) 
0 
aE-- (a, t, 
+ 
aE,., (a, t, 9) 
+ 
OE., (a, t, g) 
= 
f5 d., (a - s, s) Ir (as t, s) ds aa at 0 
- (m+ (t, ý) d+ (a) + m. (a, t) d- (a)) E., (a, t, 9) 
-r (a, t, ý) E-, (a, t, ý) (A. 7) 
OE,, (a, t, 
+ 
8E,, (a, t, 
+ 
8E,, (a, 
(a) L (a, t) r 9) Oa at 89 
- (m+ (t, i) d+ (a) + m,, (a, t) d- (a)) E,, (a, t, ý) 
(A. 8) 
Boundary conditions: 
U(O, t) = 
I(a, t, O) = i(t)U(a, t); 
Ir(a, t, 0) = i(t)L(a, t) 
For notational convenience, we denote 1- d+ (a) by d- (a). 
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A. 2 Approximations for the partial derivatives of the age 
and time-specific disease incidence with respect to fitted 
parameter estimates 
For notational convenience in this appendix, we denote the 6 parameters to be estimated in 
the fitting procedure, Idp(10,0), dp(20,0)}, {d,, (10), d,, (20)} and {d., (10,0), d. ý(20,0)} 
by: 
{dpioldp2O}, IdnlO, d, 20}, Idlo9dx2O} 
respectively. 
The risk of developing the first primary episode for an individual first infected at age a, 
who has been infected for duration s, dp(a, s) can be expressed as: 
dpiodr(S) for a< 10, 
dp (a, s) 
(dp20 
- dplo) a+ 2dplo - 
dp2o dr (S) for 10 <a< 20, 
1 
10 
dp2odr (S) for a> 20. 
where d, (s) is the risk of developing disease s years after initial infection, relative to that 
experienced in the first year. The expressions for the risk of developing exogenous disease 
for an individual reinfected at age a, and who has been reinfected for duration S, (d-. (a, 8)) 
are analogous. 
Similarly, the risk of developing endogenous disease for an individual of age a, d,, (a) is 
given by: 
4(a) = 
for a< 10, dnIO 
(dn20 
- dnio) a+ 2dnlO - 
dn20 
10 
d,, 20 
for 10< a<20, 
for a> 20. 
The number of new cases of first primary episodes (P(a, t, 0)), endogenous (E,, (a, t, 0)) 
and exogenous disease (E,, (a, t, 0)) among individuals of age a at time t, in terms of I(a, t, 
(a, t) and I,. (a, t, s) (see definitions in Table 3.1), using a discrete, rather than continuous- 
time formulation, are given by: 
P(a, t, 0) (A. 9) 
s=O 
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E,, (a, t, 0) L (a, t) d,, (a) (A. 10) 
4 
E,., (a, t, 0) E I, (a, t, s) d., (a - s, s) (A. 11) 
8=0 
The total disease incidence rate among individuals of age a at time t, Y(a, t), is given 
by: 
P (a, t, 0) + E, (a, t, 0) + E_. (a, t, 0) Y(a, t) =IN (a, t) 
(A. 12) 
(see also expression on page 105). 
The corresponding disease incidence rate in specific age-groups (e. g. 5-14 year olds) is 
given by: 
E14 
a=51P(a, t, 0) + E,, 
(a, t, 0) + E., (a, t, 0)} (A. 13) Y (a5_14 , t) F14 
, a=5 
N (a, t) 
We use the short-hand notation 
N(a5-14) for E14 
a =5 N 
(a, t) 
The partial derivatives of the total disease incidence rate in specific age groups (e. g. 
5-14 year olds), Y(a5-14,0, with respect to 
1. dpio and dp2o are approximately: 
14 OP(a, t, 0) 
and 
1 14 OP(a, t, 0) 
respectively, 7, Odpio -R(as-14) E Odp2O N(a5-14) 
=5 a=5 
(A. 14) 
2. d,, 10 and d,, 20 are approximately: 
14 Mn (a, t, 0) 1 14 DEn (a, t, 0) 
A-I A) and Od respectively, N(a5-14) OdnIO N(a5-14) 
=5 n20 a=5 
3. d,, 10 and 
dx2o are approximately: 
1 14 OE-, (a, t, 0) 
and 
1 14 OE-. (a, t, 0) 
respectively. N(W5-- E- Od,, Io 14) N(a5-14) 
Odr2O 
a=5 a=5 
(A. 16) 
We use the following approximations for the partial derivative of the age-specific incl- 
dence of first primary episodes with respect to 
(i) dplo: 
4 
EI (a, t, s) d, (s) 
8=0 OP(a, t, 0) 4 
Odplo E I(a, t, s) + 21 d, (s) 
3=0 10 
o 
for a-s< 10, 
for 10< a-s<20, 
for a-s> 20. 
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and (H) dp20: 
0 for a-s< 10, 
OP(a, t, 0) 4 (a - s) 
Odp2O 
E I(a, s) 
1 
10 11d,. 
(s) for 10 <a-s< 20, 
8=0 4 
EI (a, s) d, (s) for a-s> 20. 
8=0 
The expressions for the approximations used for the partial derivative of the incidence 
of exogenous disease with respect to dxjO and dx20 are analogous. 
NVe use the following approximations for the partial derivative of the age-specific inci- 
dence of endogenous disease with respect to 
(i) dnIO: 
L (a, t) 
OE, (a, t, 0) 
L (a, t) a +2 
49d,, Io 
f 
-TO 
0 
for a< 10, 
for 10 <a< 20, 
for a> 20. 
and (ii) d,, 20: 
0 
cl E,, (a, t, 0) L (a, t) a Odn2O 
( 
To 
L (a, t) 
for a< 10, 
for 10 <a< 20, 
for a> 20. 
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A. 3 Methods used for sensitivity analyses of disease risk es- 
timates 
The method used to generate the notification rates for a given age group in the age range 
0-54 years in a simulated data set is described by the following algorithm: 
1. Randomly generate the number of cases of all forms of tuberculosis in 1953 and in 
each of the survey years, assuming that it follows a Poisson distribution with mean 
n,,,, where n. is the 'actual' number of cases of all forms of tuberculosis in the age 
groups in the survey year. Calculate the notification rate of all forms of tuberculosis 
for this age group and each survey year resulting from these random estimates. 
Note that the surveys were carried out for only part of a, year, and reports of the 
surveys published only the annual notification rates. The tactual' numbers of cases 
used in this algorithm refer to the numbers of cases which would have occurred during 
the entire year. Population estimates for most years were published in the national 
reports of the surveys; otherwise, we used sources described in Table 2.2. 
2. Calculate the rate of decline since 1953 and between the survey years for these ran- 
domly generated notification rates of all fOrms of tuberculosis. 
3. Randomly generate, the number of cases of respiratory tuberculosis for 1953, assuming 
that this follows a Poisson distribution with mean n, (where n, is the 'actual' number 
of cases of respiratory tuberculosis in the age group in 1953. Note that for 45-54 year 
olds, nr was derived assuming that it was 95% of n. - see section 2.2.3). Calculate the 
corresponding notification rate of respiratory tuberculosis for 1953 using this randomly 
generated estimate. 
4. Derive estimates of the notifications of respiratory tuberculosis for the period 1954- 
1988 assuming that they declined from the level in 1953 calculated in step 3 at the 
rates calculated instep 2 above. 
The notification rate for a given year for 55-64 and 65-74 year olds in a'simulated data 
set was generated more simply, i. e. by repeating step 3 for each year (between 1965 and 
1988, and 1975 and 1988 respectively) using the published number of cases of respiratory 
tuberculosis for that year. 
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Figure A. I: Summary of the 95% range of the age-specific notification rates of respira- 
tory tuberculosis during the survey years (for 0-54 year olds) and for all years (for 55-74 
year olds) used in the 50 simulated data sets to analyze the sensitivity of the disease risk 
estimates. 
See previous page for further details. 
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A. 4 Results from applying TBDYN3 to Dutch data 
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Appendix B 
Methods and results for the 
incubation period and serial 
interval for tuberculosis 
B. 1 PDEs illustrating the methods used to analyze the in- 
cubation period/serial interval using TBDYN3 
NVe provide the equations used to derive the number of individuals who were infected at 
age A at time T, and who develop disease at time s thereafter without having experienced 
reinfection. These illustrate the kind of approach used to analyze aspects of the incubation 
period and serial interval of tuberculosis in chapter 4. 
We use the subscript "A, T" to denote individuals who were infected at age A at time 
T (without having been reinfected). These individuals pass through the following classes: 
Class Definition 
IA, T (S) the number of individuals have been infected for duration s, 
PA, T (S, i) the number of individuals who have been infected for duration s, who have 
been experiencing their first primary episode for i years. 
LA, T(S) the number of individuals in the 'latent' class who have infected for duration 
S. 
E,, 
A, T 
(SI ý) the number of individuals who have been infected for duration s, and who 
have been experiencing the endogenous disease for i years. 
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The definitions of these classes are analogous to those in table 3.1. 
NVe use the following shorthand notation: 
Parameter Notation 
m. q(A+s, T+s) Mg(s) 
m+ (T + s, 9) M+ (S) 
d+(A+s) d+(s) 
d-(A+s) d-(s) 
i(T + s) i(s) 
r(A + s, T+s, r. (i) 
(See Table 3.2 for the definitions of these parameters). 
The disease dynamics among individuals are given by the following four equations: 
dIA, T(S) 
ds 
OPA, T(St + 
OPA, T(St 
as 89 
= -(dp(A, s)+mg(s)tkL(S))IA, T(S) (B. 1) 
= -(m+(s)d+(s)+ma(s)d-(s)+r. (i))PA, T(si) 
+dp (A, s) IA, T (s) (B. 2) 
dLA, T(S) 
ds ý 
IA, T(5)kL(5)+rs(2)(PA, T(2)+E-nA, T(8,2)) 
+ d,, (A + s) + mg(s))LA, T(S) (B. 3) 
, 
DE, 
'A, T 
(Sl 
+ 
OE,, 
A,, r 
(s, 
as ag = dn (A + s) LAX (S) - r. (2) E,, A. T(, sl2) 
-(M+(s)d+(s) + mg(S)d-(s))EnA, T(Sli) 
(B. 4) 
The total number of individuals experiencing disease having been infected for duration 8, 
who were first infected at age A at time T, without having been reinfected in the meantime 
is given by: 
PA, T(St 0) + EnAj (SI 0) (B. 5) 
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0 B. 2 Further results from analyses of the incubation period 
and serial interval 
B. 2.1 Retrospective analyses 
262 
50 
40 
30 
20 
1c 
CD 
U) 
cz 
0) 
Cl) 
0 
CD 
(D 
"D 
(1) 
0) 
cz 
(D 
EL 
Diseased in 19001 Diseased in 191 
0 10 20 30 40 50 0 10 20 
Years since infection F71stPrimary MExog MEndo 
30 40 50 
Figure B. 1: Distribution of the time interval since first infection of individuals who devel- 
oped respiratory tuberculosis when aged 50 years during the period 1900-1990, as estimated 
using TBDYN3. 
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B. 2.2 -Prospective analyses 
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Figure BA: Distribution of the time interval between first infection and the first episode 
of respiratory disease for individuals infected at different ages in 1930, as estimated using 
TBDYN3. These correspond to 'observed incubation periods'. 
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TBDYN3. These correspond to -observed incubation periods'. 
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Figure B. 6: Distribution of the time interval between first infection and the first episode 
of respiratory disease for individuals infected at different ages in 1990, as estimated using 
TBDYN3. These correspond to 'observed incubation periods'. 
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Figure B. 7: Distribution of the time interval between first infection and the first episode 
of sputum-positive disease for individuals infected at di rent ages in 1930, as estimated Iffe 
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Figure B. 8: Distribution of the time interval between first infection and the first episode 
of sputum-positive disease for individuals infected at different ages in 1960, as estimated 
using TBDYN3. These correspond to 'observed serial intervals'. 
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Figure B. 9: Distribution of the time interval between first infection and the first episode 
of sputum-positive disease for individuals infected at different ages in 1990, as estimated 
using TBDYN3. These correspond to 'observed serial intervals'. 
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Figure B. 10: Distribution of the time interval between first infection and the first episode 
of respiratory disease attributable to initial infection for individuals infected at different ages 
in 1900, as estimated using TBDYN3. These correspond to 'actual incubation periods'. 
272 
CD 
En cz CD 
U) 
'D 
CD 
0) 
ca 
CD 
EL 
Years since infection F-IlstPrimary MExog §§§Endo 
Figure B. 11: Distribution of the time interval between first infection and the first episode 
of respiratory disease attributable to initial infection for individuals infected at different ages 
in 1960, as estimated using TBDYN3. These correspond to 'actual incubation periods'. 
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Figure B. 12: Distribution of the time interval between first infection and the first episode 
of respiratory disease attributable to initial infection for individuals infected at different ages 
in 1900, as estimated using TBDYN3. These correspond to 'actual incubation periods. 
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Figure B. 13: Distribution of the time interval between first infection and the first episode 
of sputum-positive disease attributable to initial infection for individuals infected at different 
ages in 1900, as estimated using TBDYN3. These correspond to 'actual serial intervals'. 
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Figure B. 14: Distribution of the time interval between first infection and the first episode 
of sputum-positive disease attributable to initial infection for individuals infected at different 
ages in 1930, as estimated using TBDYN3. These correspond to 'actual serial intervals'. 
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Appendix C 
The basic and net reproduction 
numbers for tuberculosis 
CA Relationship between the basic and net reproduction 
numbers for tuberculosis under hypothetical situations 
We consider a simplistic, hypothetical, non-age-structured, stable population for which a 
proportion p of individuals (who have been infected) face a risk d.. of developing sputum- 
positive (exogenous) disease if reinfected (i. e. effectively contacted), and the remainder 1-p, 
who have not yet been infected, face a risk dp of developing (the first primary) Isputum- 
positive episode. 
If a given sputum-positive case effectively contacts c other Individuals, then the net 
reproduction number is given by: 
cpd., + c(l - P)4 
and the basic reproduction number is given by: 
Ro = cdp (C. 2) 
The ratio between RO and R,, is thus given by: 
Ro 
- 
cdp (C. 3) Rn cd,, + c(l - P)dp 
Rearranging this expression, we see that the net reproduction number is given by: 
Rn = Ro P 
(i 
- 
ýX-) I 
(C. 4) dp 
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The protective protection imparted against reinfection and subsequent sputum-positive dis- 
ease by having experienced infection in the past rd is given by: 
rd 
d., 
(C. 5) dp 
Hence equation CA simplifies to: 
Rn = Ro(l - prd) 
(C. 6) 
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C. 2 The relationship between Ro(t) and R,, (t) for tubercu- 
losis 
Suppose we consider a simplistic, hypothetical, non-age-structured population in which 
a proportion p of individuals are infected and face a risk d__ of developing sputum- 
positive exogenous disease, if reinfected (i. e. effectively contacted by a sputum-positive 
case), 
2. a proportion p,, in the population is protected in the short-term against initial infection 
by vaccination, and 
3. the remainder 1 -p-p,, who have not yet been infected or have not been immunized, 
face a risk dp of developing the first primary sputum-positive episode if infected. 
Suppose that at time t, a given sputum-positive case effectively contacts c(t) other indi- 
viduals, where effective contact is assumed to be equally likely for infected and uninfected 
individuals. ft,, (t) is therefore given by: 
i?,, (t) = c(t)pd,,, + c(t) (1 -p-p,, ) dp (C. 7) 
and &(t) is given by: 
Ro(t) = c(t)dp (C. 8) 
The ratio between R,, (t) and Ro(t) is thus eiven by: 
c(t)d p (C. 9) 
R,, (t) c (t) pd. ý +c (t) (1 -p-p,, ) dp 
Cancelling out c(t) and rearranging this expression, we see that the !?,, (t) is given by: 
ýX- 
+1 -pv -P 
ko (t) 
lp 
dp 
I 
ko(t) 1- pv -p1 
LZ 
(C. 10) 
t 
dp) 
The protection rj conferred against reinfection and subsequent sputum-positive exoge. 
nous disease by initial infection is given by: 
rd= 
d., 
TP (C. 11) 
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(see equation C. 5). 
Substituting for rd into equation C-10, we see that: 
Ro(t){l - p,, - prd) (C. 12) 
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